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Thesis Abstract 
 
Background 
Psychological formulation is a central process in many contemporary evidence-
based psychological therapies.  Formulation is also considered a core 
competency of clinical psychology training and practice and is heavily 
referenced throughout professional standards and guidelines.  Despite the 
significance of formulation in clinical psychology and within wider mental health 
professions, there is limited evidence to show that formulation benefits the client 
or improves outcomes in therapy, including the working alliance and measures 
of distress.  Considering the status of psychological formulation, further 
research is required to examine whether formulation impacts outcomes in 
therapy. 
 
Aims 
The key aims of this study was to investigate whether (1) formulation impacts 
on working alliance and (2) there is a relationship between formulation, working 
alliance and psychosocial outcomes.  To address these research questions, the 
study delivered a CBT intervention, incorporating ‘product’ and ‘process’ 
formulations to adults experiencing low mood.   
 
Method 
The study used a repeated single-case A-B, mixed methods design.  The 
design included a non-treatment baseline phase (A), measuring weekly 
symptoms of low mood and was followed by the intervention phase (B), which 
consisted of eight weeks of CBT focussing on low mood.  The CBT intervention 
incorporated two ‘product’ formulations (in session 3 and 7) and ‘process’ 
formulations, which were delivered throughout.  Participants and the therapist 
completed weekly measures at the end of each session, which included 
measures of working alliance, depression and well-being.  Change interviews 
were also undertaken at the end of therapy to triangulate results.  Data analysis 
mainly included visual analysis, simulation modelling analysis and 
clinical/reliable change.   
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Results 
Seven participants were recruited, with five participants completing the full eight 
week CBT intervention.  The analysis showed a slight relationship between 
formulation and working alliance, although evidence was not robust enough to 
confirm whether formulation directly impacts working alliance.  The results 
showed mixed findings in terms of the relationship between formulation, working 
alliance and psychosocial outcomes measured.  Although over half of 
participants showed an improvement in depression and two improved in 
wellbeing, it was not possible to attribute these changes specifically to 
formulation.   
 
Discussion  
This study contributes to a dearth in the literature surrounding the impact of 
formulation on outcomes in CBT.  The findings discussed are mixed and 
although tentative conclusions can be made that formulation, particularly the 
product formulation may have contributed to elements of the working alliance, it 
is not possible to state that formulation directly impacted on the working 
alliance. The study also highlights the complexity of psychotherapeutic research 
and the challenges of disentangling processes to draw conclusions on what 
variables contribute to changes in outcomes.  The utility of single-case designs 
enables researchers to study complex therapeutic processes using a scientific 
methodology, ultimately bridging the gap between research and clinical 
practice.  This study provides a platform for future research into formulation and 
should further consider some of the limitations discussed, e.g., does the 
accuracy of process formulations mediate the working alliance, is it possible to 
separate the working alliance from the process of formulation. 
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Abstract 
Objectives 
The purpose of this review was to systematically search, critically appraise and 
synthesise qualitative research exploring client’s experiences of receiving a 
formulation. 
Methods 
The review was conducted in four stages, including a comprehensive search of 
the literature, data extraction, quality appraisal of identified articles and meta-
ethnographic synthesis.  Ten studies met the inclusion criteria for the synthesis.   
Results 
The meta-ethnographic synthesis identified five third-order themes: 
Collaboration and development of formulation, impact of realisation, relationship 
with themselves, therapeutic relationship and looking to the future.  Themes 
appeared closely linked and inter-dependant of each other and shaped client’s 
overall experiences of formulation.  
Conclusions 
The findings of the synthesis emphasise the importance of the therapeutic 
relationship during the development of formulation, influencing the impact of 
realisation, the client’s level of perceived accuracy and overall engagement with 
therapy.  Clinical implications highlight the importance for clinicians to consider 
the findings discussed to adapt and develop clinical practice.  Future research is 
recommended into further investigation of the impact of formulation, using both 
qualitative and quantitative methods.  Additionally, the impact of realisation may 
also be an interesting and valuable area of future research.  
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Practitioner points 
 There are several factors that influence client’s experiences of receiving 
a formulation; however the therapeutic relationship is central to each of 
these. 
 Formulation may not always have a positive impact for clients and the 
impact of realisation may result in feelings of distress. 
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Introduction 
Formulation is a frequently used skill practiced by Applied Psychologists 
(British Psychological Society (BPS), 2008).  In clinical psychology, the term 
‘formulation’ was first referenced within professional regulations in 1969 (Crellin, 
1998).  Now, formulation is a core competency of the profession and is a skill at 
the centre of training and at all levels of practice (Division of Clinical Psychology 
(DCP, 2011; Harper & Moss, 2003).  It provides a way to consider psychological 
distress without using diagnostic categorisation that minimises individual 
experiences (Johnston & Dallos, 2013).  Professional bodies recommend that 
formulation should be integrated into all aspects of clinical practice and is 
heavily referenced within current professional documents (BPS, 2010; Health 
Professions Council, 2009). 
 
Definition of Formulation 
There are many published definitions of formulation, which may explain 
some of the difficulties when attempting to measure impact.  Variance often 
depends on the therapeutic modality adopted and therefore alters the focus of 
the formulation.  For example, in Cognitive Behavioural Therapy (CBT), the 
formulation may focus on the development of cognitions and the emotions, 
physical sensations and behaviours associated with these.  Whereas in 
Cognitive Analytic Therapy (CAT), formulation is referred to as reformulation 
and the emphasis is placed on the patterns of client’s interactions with 
themselves and with others.   
Within CBT, the definition of formulation is suggested as a foundation for 
developing an understanding of the client’s difficulties (Beck, 1995; Eells, 2007).  
Formulation involves ‘collaborative empiricism’, a two-way process between the 
client and therapist to generate a shared understanding of the client’s problems 
(Beck, 1995).  This joint process is not just unique to CBT and is also detailed in 
the Good Practice Guidelines on the use of Formulation (DCP, 2011).  The 
Division of Clinical Psychology (DCP) (2010) proposes that formulation is the 
summation and integration of knowledge that is retrieved through the 
assessment process.  Furthermore, formulation draws on psychological theory 
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and research giving a framework to describe the nature of a client’s problem, 
how it developed and how it is maintained.   
 
Background Literature 
Despite the clinical and theoretical interest into formulation, there is a 
distinct paucity of evidence to support its effectiveness as an intervention (DCP, 
2011).  Kuyken (2006) drew attention to the complexity of researching the 
effectiveness of formulation, outlining the differences between ‘top-down’ and 
‘bottom-up’ forms of evidence.  Top-down refers to the evidence of key models 
and theories that formulations are based on and bottom-up is in relation to the 
evidence of reliability and validity, the process of developing the formulation, i.e. 
the usefulness for clients and the impact of formulation on clinical outcomes.   
As Thew and Krohnert (2015) discuss, top-down evidence is more 
established in the literature, proposing strong empirical evidence to support 
theoretical models and constructs that formulations are based on.  For example, 
Clark and Beck (1999) detail a review of the evidence for Beck’s cognitive 
theory of depression and McManus, Sacadura and Clark (2008) suggest robust 
evidence for a cognitive model of social anxiety.   
There is a distinct lack of bottom up evidence to support the use of 
formulation.  Research into the reliability of formulation has mainly focussed on 
inter-rater reliability (Flinn, Braham & das Nair, 2015) and less on test-retest 
reliability (Bieling & Kuyken, 2003).  In summary, reviews of the evidence 
suggests that reliability of formulation is mixed across studies (Bieling & 
Kuyken, 2003; Flinn et al., 2015).  Limitations are highlighted in the variability of 
studies, for example, the level of competency and qualification of the clinician 
and the different methods used to measure reliability (Flinn et al., 2015).  Bieling 
and Kuyken (2003) stress that reliability does not necessarily equate to validity, 
which is a related but also separate area of research.    
A review of the impact of formulation on therapeutic alliance and 
treatment outcomes demonstrates that the evidence is mixed (Stewart, 2014).  
There is no published evidence to suggest that the process of formulation 
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improves the therapeutic alliance when measured by clients.  Interestingly, 
studies have shown significant results when therapeutic alliance is rated by the 
therapist, but this is not supported by client ratings (Chadwick, Williams & 
Mackenzie, 2003; Piper, Azim, Joyce & McCallum, 1991).  An increase in 
perceived accuracy has been correlated with improved therapeutic alliance, 
however due to limitations of the study design, no cause and effect link can be 
established (Crits-Chrisoph, Barber & Kurcias, 1993).  Methodological 
limitations, such as small sample sizes, means that we cannot conclude that 
formulation does not improve therapeutic alliance (Stewart, 2014).  Further 
research, potentially considering a mixed-methods approach is required to 
explore this further.   
Although some studies have investigated the impact of formulation on 
therapy outcomes, there is no established evidence to support the claim that 
formulation improves them  (DCP, 2011).  Chadwick et al. (2003) explored the 
impact of CBT formulation on clients with experiences of psychosis.  They found 
no significant differences self-reported anxiety and depression ratings pre and 
post sharing the formulation.  Additionally, Evans and Parry (1996) and Shine 
and Westacott (2010) also found that sharing a reformulation letter in CAT had 
no impact on clinical outcomes, including, working alliance, client identified 
problems, and perceived helpfulness of therapy.  
It is clear that research into the reliability and impact of formulation is 
sparse and evidence is mixed.  As already discussed, the variability of the 
definition, different therapeutic modalities and the limited control of variables in 
naturalistic studies all contribute to the challenges when measuring the impact 
of formulation.  Having looked at the literature, undoubtedly formulation requires 
greater attention in research, in order to have a better understanding of the 
processes involved and the impact on outcomes and client experiences.   
Chase Gray and Grant (2005) emphasise the absence of the client voice 
throughout the literature and this is additionally supported by the DCP’s 
recommendation to research client and carer experiences of formulation (DCP, 
2011).  There is increased attention in the National Health Service (NHS) to 
obtain service-user perspectives. Their first hand experiences of using services 
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offers a unique insight into what is required to improve practice and develop 
organisations (National Health Service England, 2015).  Considering 
formulation is a core skill of a Clinical Psychologist and the limited empirical 
evidence to support the use of it, this further stresses the need to explore the 
client’s experience of the formulation process.   
 
Previous Reviews 
Previously published reviews have appraised the evidence on the 
reliability, validity and impact of formulation (Aston, 2009; Bieling & Kuyken, 
2003; Flinn et al., 2015; Mumma, 2011).  Aston (2009), Bieling and Kuyken 
(2003) and Mumma (2011) conducted narrative, none systematic reviews and 
therefore highlight limitations of transparency and replicability.  Flinn et al. 
(2015) detail a comprehensive systematic review of the literature on the 
reliability of case formulations and outline conclusions consistent with the 
evidence discussed in the background literature.  A review of the literature 
exploring client’s experiences of receiving a formulation has not yet been 
undertaken, but is clearly required.  This would be useful to gain a new insight 
into client’s experiences and contribute to the paucity of literature within this 
field. 
 
Aims of Review 
This review will aim to answer the following question: 
How do clients experience receiving a psychological formulation? 
Firstly a systematic search and critical appraisal of the literature will be 
undertaken.  Using a systematic methodology will allow the author to reduce the 
chance of bias imposed on the searching process and will also decrease the 
chance of papers being missed.  The methodology will be transparent and 
replicable, improving the overall rigour of the review.   
The review question will also be answered by undertaking a meta-
synthesis, specifically using a meta-ethnography, outlined by Noblit and Hare 
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(1988).  A meta-ethnography is a comparative textual analysis which aims to 
synthesise and interpret findings across multiple qualitative studies.  This 
involves a process of examining concepts or themes within and between 
studies and considers how these can be translated into existing or new 
concepts that encompass all studies in the meta-synthesis. 
It is recognised that there are debates surrounding the approaches taken 
in interpretative research.  Some argue that synthesis of qualitative findings is 
reductionist and destroys the integrity and richness of participant accounts 
(Sandelowski, Docherty & Emden, 1997).  Opposing these arguments, it is 
suggested that qualitative researchers are at risk of isolating their studies from 
clinicians and the development of policy documents (Silverman, 1997).  Walsh 
and Downe (2005) propose that synthesising qualitative studies in a related field 
allows for nuances, assumptions and varying accounts to be explored and 
discussed, opening opportunities for new perspectives.   
 
Methods 
This review was conducted in four stages, i) systematic and thorough 
search of the literature, ii) data extraction iii) quality appraisal of identified 
articles and iv) meta-ethnographic synthesis (Nobilt & Hare, 1988).   
Searching 
Prior to undertaking a  systematic search of the literature, scoping 
searches were carried out to provide the researcher with a clearer 
understanding of previous reviews and studies conducted into formulation.  
Previous reviews were read (Aston, 2009; Bieling & Kuyken, 2003; Flinn et al., 
2014; Mumma, 2011) and their limitations were also considered.  
Two methods were used to undertake a comprehensive search of the 
literature.  Firstly, four electronic, peer-reviewed databases were systematically 
searched in June 2016: PsycINFO (1806 – present); MEDLINE (1946 – 
present); AMED (1985 – present); EMBASE (1980 – present).  In addition, two 
electronic, grey literature databases were also searched: Ethos and Open Grey.  
It was not possible to search these databases using the systematic search 
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strategy, therefore they were searched using the key terms for ‘formulation’.  
Grey literature databases were added to broaden the search, including a range 
of resources to ensure full exploration of the phenomena of formulation  
(Boland, Cherry & Dickson, 2014).  Books were excluded from this review as 
the aim of the review was to obtain first-person, client perspectives of receiving 
a formulation and the author did not consider books would capture original, 
empirical research.  Doctoral theses were included in this review as they would 
be assessed against doctoral standard criteria.   A manual search of reference 
lists of previous reviews of formulation was also undertaken.  
 
Terms 
The researcher considered the terms and search strategy that previous 
reviews had used and utilised these for this current review:   
formulation*1 OR psychological formulation* OR case conceptuali?2ation* OR 
case formulation* OR clinical formulation*OR reformulation* AND service-user* 
OR client* OR patient AND experience* OR perception* OR view* OR 
understanding.   
Due to a large number of irrelevant studies from pharmaceutical research 
being captured in the search, the following NOT term was added: pharm*.   
All searches included the limits of human participants, participants aged 
18 and over, studies written in the English language and excluded book 
reviews.   
 
Definition of Terms 
In this review the definition of experience is the client’s lived process of 
receiving a formulation.  Experience may include both internal and external 
processes, such as emotional, cognitive or behavioural responses. 
                                                          
1 The suffix * provides a truncation for the search terms in the databases. 
 
2 The suffix ? provides a wild card for the search terms in the databases 
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The definition of formulation will be taken from the DCP (2010) guidelines, 
which is the summation and integration of knowledge about the client that is 
retrieved through the assessment process.  The formulation will draw on 
psychological theory to provide an explanation of the client’s problem, how it 
developed and how it is maintained. 
 
Selection 
Figure 1 provides a flow diagram, outlining the process of article selection in 
accordance with the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) statement (Moher, Liberati, Tetzlaff & Altman, 2009).  
 
 
 
 
 
 
 
 
 
    
 
 
 
 
 
Figure 1.  Flow diagram of article selection and exclusion (Moher et al., 2009) 
Records identified through 
database searching 
(n = 3121) 
Additional records identified 
through other sources 
(n = 3) 
Records after duplicates removed 
(n = 2088) 
Records screened 
(n = 2088) 
Records excluded 
(n = 2045) 
Full-text articles 
assessed for 
eligibility 
(n = 40) 
Full-text articles 
excluded, with 
reasons 
(n = 30) 
Studies included in 
qualitative synthesis 
(n = 10) 
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The search strategy retrieved 3114 articles from PsycINFO, MEDLINE, 
AMED and EMBASE and seven articles from Ethos and Open Grey.  Once 
duplicates had been removed, titles and abstracts were then reviewed applying 
the following inclusion and exclusion criteria. Three articles were also retrieved 
from the reference lists of potential identified articles.  40 full-text articles were 
then reviewed in more detail, also using inclusion and exclusion criteria.  
Rationale for the inclusion and exclusion criteria were developed through 
reference to previous reviews on formulation (Aston, 2009; Bieling & Kuyken, 
2003; Flinn et al., 2015; Mumma, 2011).   
In order to answer the question posed in this review, the following criteria 
needed to be adhered to. 
Inclusion criteria 
 Investigated participant’s experiences of formulation from a first-person 
perspective. 
 Detailed theoretical model used in the formulation in accordance with the 
Good Practice Guidelines (DCP, 2011) 
 Clearly stated that they were specifically exploring the client’s experience 
of formulation and not other psychological techniques used in the 
therapy.  For example, in CAT, the paper stated they were exploring 
client’s experiences of ‘reformulation’ and not client’s overall experiences 
of the therapy. 
 Qualitative or mixed-methods design 
 Used client/service-user participants. 
 Participants over 18 years. 
 Written in the English language. 
 
Exclusion criteria 
 Investigated second person experiences of formulation, e.g. 
professionals, teams. 
 Makes reference to formulation but does not explore client’s experiences 
of formulation. 
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 Quantitative design. 
 Participants under 18 years. 
 
For reference, the researcher recorded reasons for exclusion.  23 articles 
were excluded as they had not specifically explored client’s experiences of 
formulation and four were excluded as they had focussed on clinician’s 
experiences of formulation.  Two articles were excluded, as they had not been 
explicit in the results whether their data represented participant’s experiences of 
formulation or their experiences of the therapy or other psychological 
techniques (Kellett & Hardy, 2014; Ryle & Beard, 1993).  One article was 
excluded as the researcher could not differentiate between participant’s 
experiences of the reformulation letters and goodbye letters, and therefore it 
was not explicit which data explored experiences of the formulation specifically 
(Hamill, Ried & Reynolds, 2008). 
It should also be noted that two unpublished theses were also excluded 
from the review (Hargate, 2006; Osborne, 2011) as the author was unable to 
make contact with the author or obtain the thesis from the relevant universities.   
 
Quality appraisal 
 Quality appraisal is vital for qualitative research, so it can robustly 
contribute to evidence and inform best clinical practice.  The literature provides 
little consensus as to what the essential criteria are to classify the quality of 
qualitative research (Ring, Ritchie, Mandava, & Jepson, 2011).  This review 
used the Critical Appraisal Skills Programme (CASP) tool, specifically designed 
to evaluate qualitative research (Critical Appraisal Skills Programme, 2013).  
The researcher made an adaption to the CASP tool, by adding one item, which 
assessed whether the researcher’s epistemological position had been 
considered.  In total, 11 quality criteria were applied to each article and were 
scored either zero if the item was not met, one if it was unclear and two if was 
definitely met.  
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 The review used the CASP tool as a means to explore and develop a 
further understanding of the papers included in the review.  It was recognised 
that whilst some papers may demonstrate higher quality on the CASP tool, all 
studies may offer valuable findings (Sandelowski et al., 1997).    
 
Data abstraction 
There is no agreed preferred method to synthesise qualitative research, 
however meta-ethnography is the most frequently used and published (Noblit & 
Hare, 1988).  This review followed the seven steps of meta-ethnography 
outlined by Noblit and Hare (1988).  Each article was read, reread and quality 
appraisal was completed.  Data was then systematically abstracted for each 
article, noting down research aims, methodology, research findings and the 
authors’ interpretation of the data.   
A meta-ethnography involves the synthesis of first and second order 
constructs into a new interpretation, defined as third order constructs (Britten et 
al., 2002).  Malpass et al. (2009) outline a working definition of first, second and 
third order constructs which has been adapted for this review and is presented 
in Figure 2.  When undertaking a meta-ethnography, accessing first order 
constructs can be problematic, as the data extracts used in the articles have 
been abstracted by the authors from the original data set (Atkins et al., 2008).  
For the purpose of this review, when quotes were provided in the articles, it was 
considered whether they supported the second order constructs or whether they 
suggested a new third order construct.    
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Figure 2. Diagrammatic explanation of first, second and third order constructs. 
(Malpass et al., 2009)  
 
A meta-ethnography synthesises and interprets the concepts across the 
identified studies in three possible ways (Noblit & Hare, 1988), each of which 
have been employed within this review.   
1) Reciprocal translation: Identifies similar accounts across studies 
which can be grouped together or translated into one another.  
Over-arching concepts are developed using existing concepts 
from one of the studies or new metaphors that can account for 
common findings across the papers. 
Participant’s’ views, 
accounts and 
interpretations of 
receiving a 
formulation. 
First order constructs 
Second order 
constructs 
Author’s views and 
interpretations 
participant’s views 
of receiving a 
formulation.  
Expressed in terms 
of themes and 
concepts. 
Third order constructs The views and 
interpretations of the 
synthesis team.  
Expressed in terms 
of themes and 
concepts. 
Interpretations 
of experience. 
 
Interpretations 
of 
interpretations 
of experience. 
 
Interpretations of 
interpretations of 
interpretations of 
experience. 
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2) Refutational synthesis: accounts for conflicting or contradictory 
concepts between studies identified in the synthesis. 
3) Line of argument synthesis: develops a new interpretation of the 
similarities and differences identified across the studies.   
 
Reflexivity 
Consideration of the reviewer’s reflexivity is important when interpreting 
qualitative research.  Within this review, the author has used an inductive 
approach to understand client’s experiences of formulation.  Utilising 
supervision has enabled the reviewer to develop third order interpretations 
whilst remaining truthful to participant’s original, first-order accounts. 
 
Results 
This synthesis interpreted the findings of 10 papers, eight peer-reviewed, 
published articles and two unpublished doctoral theses.  The synthesis included 
a total of 69 participants and the age of participants was reported in all but one 
paper (Stewart, 2016), ages ranging from 19 to 78 years of age.  Most studies 
used a qualitative design, three used a mixed-methods design (Chadwick et al., 
2003; Evans & Parry, 1996; Shine & Westacott, 2010) and one detailed a case 
report (Thew & Khronert, 2015).  All studies used semi-structured interviews for 
data collection and papers varied on the chosen method of analysis. Each study 
referred to the definition of formulation in the introduction, however only one 
explicitly outlined the definition of formulation used in the study (Redhead, 
Johnstone & Nightingale, 2015).  CAT studies referred to formulation as 
‘reformulation’ and was shared using a reformulation letter or sequential 
diagrammatic formulation (Rayner, Thompson & Walsh, 2011; Shine & 
Westacott, 2010). Two studies detailed exactly what information was included in 
the developmental diagrams and accompanying letters used to share the 
formulation (Chadwick et al., 2003; Pain, Chadwick & Abba, 2008).  The 
characteristics of studies included in the synthesis are detailed in Table 1. 
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Table 1. 
Characteristics of studies included in the review 
Study 
Number 
Authors and 
year of 
publication 
Journal/Thesis Methodology N Data 
analysis 
Theoretical 
model used 
in 
formulation 
Research aims 
1 Evans and 
Parry (1996) 
Clinical 
Psychology 
and 
Psychotherapy 
Mixed 
methods 
 
 
4 Descriptive 
analysis of 
key themes 
Cognitive 
Analytic 
Therapy 
(CAT) 
Investigate the following 
hypotheses: 
1. Clients will perceive 
the session in which 
the reformulation was 
presented as 
especially helpful. 
2. The measure of 
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therapeutic alliance 
would increase 
following the 
reformulation. 
3. The measure of 
magnitude of client’s 
problems would 
decrease following 
the reformulation 
2 Chadwick, 
Williams & 
Mackenzie 
(2003) 
Behaviour 
Research and 
Therapy 
Mixed 
methods 
 
  
11 Descriptive 
analysis of 
key themes 
Cognitive 
Behaviour 
therapy 
(CBT) 
Assess the impact of 
case formulation in CBT 
or psychosis.   
Investigate the following 
hypotheses: 
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1. Formulation 
enhances therapeutic 
alliance 
2. Formulation eases 
distress 
Research question: 
How relevant and helpful 
is case formulation?  
3 Brown (2008) Unpublished 
thesis 
Submitted for 
Doctorate in 
Clinical 
Psychology at 
Qualitative 
 
6 Grounded 
theory 
CBT, CAT, 
Dynamic 
and 
Integrative 
To explore clients’ 
experience of 
formulation. 
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the University 
of Coventry 
4 Pain, 
Chadwick & 
Abba (2008) 
British Journal 
of Clinical 
Psychology 
Qualitative 
 
 
13 Content 
analysis 
CBT Explore clients’ 
experience of case 
formulation in CBT for 
psychosis. 
5 Shine & 
Westcott 
(2010) 
Psychology 
and 
Psychotherapy: 
Theory, 
Research and 
Practice 
Mixed 
methods 
 
 
5 Template 
analysis 
CAT To investigate whether 
the reformulation process 
in CAT has an impact 
upon a measure of 
working alliance and to 
explore client’s 
perspective on the 
reformulation process. 
Page 34 of 261 
 
6 Rayner, 
Thompson & 
Walsh (2011) 
Psychology 
and 
Psychotherapy: 
Theory, 
Research and 
Practice 
Qualitative 
 
Semi-
structured 
interviews 
9 Grounded 
theory 
CAT 1. To explore and 
describe the 
experience of 
receiving CAT. 
2. To gain a better 
understanding of the 
use of reformulation 
and specific CAT 
tools. 
3. To explore how the 
use of the 
reformulation and 
CAT tools link to 
clients’ understanding 
of change. 
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7 Kahlon, Neal 
& Patterson 
(2014) 
The Cognitive 
Behaviour 
Therapist 
Qualitative 
 
 
7 Thematic 
analysis 
CBT Explore experiences of 
CBT formulation in 
clients with depression. 
8 Redhead, 
Johnstone & 
Nightingale 
(2015) 
Psychology 
and 
Psychotherapy: 
Theory, 
Research and 
Practice 
Qualitative 
 
 
10 Inductive 
thematic 
analysis 
CBT Explore clients’ 
experiences of 
formulation in CBT for 
depression and/or 
anxiety.  
9 Thew & 
Khronert 
(2015) 
The Cognitive 
Behaviour 
Therapist 
Mixed 
Methods 
 
 
1 Framework 
analysis 
techniques 
CBT Explore the use of 
formulation as 
intervention and evaluate 
ways in which it may or 
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Single case 
report 
may not prove helpful. 
10 Stewart 
(2016) 
Unpublished 
thesis 
Submitted for 
Doctorate in 
Clinical 
Psychology at 
the University 
of Sheffield 
Qualitative 3 Grounded 
theory 
CBT and 
Integrative  
To develop a model of 
formulation-sharing 
based on patients’ 
perspective of the 
process. 
 
Page 37 of 261 
 
Quality Appraisal 
There was some variation in the overall quality of the studies included in 
the review, with total scores ranging from 14 to 22.  It should be noted that both 
studies deemed the highest quality are doctoral theses and were therefore not 
restricted by word counts specified by journals.  The scoring of each study 
included in the review are outlined in Table 2. 
All but one study included in the synthesis (Thew & Khronert, 2015), 
clearly outlined the aims of the research and demonstrated the relevance of the 
study in relation to existing literature on formulation.  Although there was some 
variance in the designs used across the studies, all studies used an appropriate 
methodology to address the research aims.  Half of the studies were not explicit 
about recruitment methods, which limited the assessment of whether the 
studies had used appropriate recruitment strategies to address the research 
aims (Chadwick et al., 2003; Evans & Parry, 1996; Rayner et al., 2011; Shine & 
Westacott, 2010; Thew & Khronert, 2015).   
     Despite the influence of subjectivity during the process of interpretation, the 
relationship between the researcher and participant was acknowledged in only 
half of the studies (Brown, 2008; Kahlon, Neal & Patterson, 2014; Rayner et al., 
2011; Shine & Westacott, 2010; Stewart, 2016).  Most studies, with the 
exception of both doctoral theses (Brown, 2008; Stewart, 2016) failed to 
consider the epistemological position of the researchers.  As a result, this limits 
the author’s ability to fully assess the impact of the researcher’s epistemological 
positions on the design, data collection and interpretation of the findings of all 
the studies included. 
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Table 2 
Quality criteria scores for studies included in the review 
CASP Criteria Study Number 
 1 2 3 4 5 6 7 8 9 10 
Was there a clear statement of the aims of the research? 2 2 2 2 2 2 2 2 0 2 
Is a qualitative methodology appropriate? 2 2 2 2 2 2 2 2 2 2 
Was the research design appropriate to address the aims of the research? 2 2 2 2 2 2 2 2 2 2 
Was the recruitment strategy appropriate to the aims of the research? 1 1 2 2 1 1 2 2 1 2 
Was the data collected in a way that addressed the research issue? 2 2 2 2 2 2 2 2 2 2 
Has the relationship between researcher and participants been adequately 
considered? 
0 0 2 0 2 2 2 0 1 2 
Have ethical issues been taken into consideration? 1 1 2 2 1 2 2 2 1 2 
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Has the epistemological position of the researcher been considered? 0 0 2 0 0 0 0 0 0 2 
Was the data analysis sufficiently rigorous? 0 0 2 2 2 2 2 2 1 2 
Is there a clear statement of findings? 2 2 2 2 2 2 2 2 2 2 
How valuable is the research? 2 2 2 2 2 2 2 2 2 2 
Total score 14 14 22 18 18 19 20 18 14 22 
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Interpretation of findings 
This meta-ethnography identified five third order constructs: (1) 
Collaboration and development of formulation; (2) Impact of realisation; (3) 
Relationship with themselves; (4) Therapeutic relationship and (5) Looking to 
the future.  Constructs were explicitly inter-connected, with each theme 
influencing another.  The results will outline each construct in turn, considering 
both reciprocal and refutational synthesis, before presenting a line of argument.  
Table 3 presents a cross-comparison of themes across the selected studies. 
 
Collaboration and development of formulation.  
Reciprocal translation identified collaboration and development of 
formulation as a key and recurring theme in all but two papers (Chadwick et al., 
2003; Evans & Parry, 1996).  The process of how the formulation was 
developed, i.e. the active participation of both the client and therapist and how 
the formulation was shared, i.e. diagrammatically or within a letter appeared 
fundamental in how participants experienced the formulation.  Four papers 
discussed the usefulness of having a tangible tool to help them visualise the 
links between aspects of their difficulties (Pain et al., 2008; Rayner et al., 2011; 
Redhead et al., 2015; Shine & Westacott, 2010).  Potentially important to their 
progress and recovery, one participant reflected on the value of having a tool to 
reference back to; “They’ve been quite useful to bring away with me, to have a 
look at and use them when I think they might be helpful…I’m not sure I would 
have remembered everything without them” 3 (Shine & Westacott, 2010, p.171).   
     Contradictory to this, two papers (Kahlon et al., 2014; Rayner et al., 2011) 
discussed some participants’ experiences of formulation diagrams as too 
complex and technical.  Feeling confined and restricted by the diagram was a 
concept explored by Brown (2008), which resulted in feelings of invalidation and 
impacted on participant’s engagement with the formulation process.  One 
participant described, “It could be an over neat, over tidy way of doing 
                                                          
3 Speech marks indicate direct quotations of participants from original studies. 
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things…like a scientific formula, cause and effect, whereas maybe things are a 
bit more irrational than that?” and another participant reflected “It did seem cold 
and calculated at first…I was insulted a bit, because it is just a piece of paper 
and you are basically putting your entire being on one piece of paper” (Brown, 
2008, p. 71).   
Four papers referred to the concept of collaboration between the client 
and therapist in the development of the formulation (Brown, 2008; Kahlon et al., 
2014; Rayner et al., 2011; Stewart, 2016).  Developing the formulation in 
collaboration with the client appeared to be closely linked with the level of 
perceived accuracy and in turn the participant’s perception of the usefulness of 
their formulation.   The theme of perceived accuracy was discussed by 
Redhead et al. (2015), highlighting the importance of accuracy in facilitating 
understanding.  For example, one participant explained, “It all just made sense.  
I got it (the formulation), because it was true.  It seemed true to me anyway, it 
was all what (sic) I felt.” (Redhead et al., 2015, p.459) 
 
Impact of realisation.  
The theme impact of realisation was identified through reciprocal and 
refutational synthesis across all papers included in the study.  Two subthemes 
were created to clearly outline the conflicting accounts at a second-order level: 
positive emotional response and negative emotional response.  
All but one study discussed the positive impact the formulation process 
had for participants (Evans & Parry, 1996).  This positive impact appeared to be 
in relation to several factors, firstly in relation to participants experiencing a 
sense of relief.  For some, this was a result of receiving an explanation for their 
difficulties and was pertinent in contributing to feeling understood (Kahlon et al., 
2014; Redhead et al., 2015; Shine & Westacott, 2010).  This was demonstrated 
in one participant’s account of hearing her reformulation letter; “…felt like a 
huge relief and that I was well and truly heard” (Shine & Westacott, 2010, 
p.169).   
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In contrast, all studies but one discussed the negative impact of the 
formulation (Thew & Khronert, 2015).  Papers detailed a range of negative 
emotional reactions experienced by participants in relation to receiving the 
formulation, including “sadness” (Chadwick et al., 2003; Rayner et al., 2011) 
‘over-whelmed’4 (Brown, 2008; Evans & Parry, 1996), “doubt” (Brown, 2008) 
and “worry” (Chadwick et al., 2003).  During the process of realisation, an 
increased awareness of difficulties that have either been unconsciously 
supressed or actively avoided by the participant arose to the surface (Brown, 
2008; Kahlon et al., 2014; Redhead et al., 2015; Stewart, 2016).  One 
participant described the process as “I think she hit the nail on the head again 
actually, I think she was just reaffirming something that I perhaps knew deep-
down…” (Stewart, 2016, p. 57).  Shine and Westacott (2010) identify a theme of 
‘feeling exposed’, resulting in feelings of discomfort for participants due to the 
realisation of their difficulties.  Brown (2008) and Rayner et al. (2011) suggest 
that discomfort should not necessarily be unwelcomed and could be a 
necessary stepping stone in a participant’s recovery.  The impact of realisation 
appears to change over time and is possibly addressed through the active 
agent of the therapeutic relationship.   
 
 Relationship with themselves.  
Six studies clearly discussed a recurrent theme of a change in 
participant’s relationships with themselves (Kahlon et al., 2014; Pain et al., 
2008; Rayner et al., 2011; Redhead et al., 2015; Shine & Westacott, 2010; 
Stewart, 2016 ).  This appeared to be mainly in relation to an increased 
understanding of their difficulties.  Exploration and recognition of patterns and 
links within the formulation often appeared to provide participants with an 
alternative perspective and understanding of their problems (Brown, 2008; 
Kahlon et al., 2014; Redhead et al., 2015; Shine & Westacott, 2010; Stewart, 
2016).  One participant demonstrated this stating, “Yeah, it made a bit more 
sense actually, it seemed to make sense of why I’d been feeling the way I’d 
                                                          
4 Inverted commas indicate direct quotes from the authors of original studies. 
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been feeling and how I could change things and change the way I think about 
things…” (Kahlon et al., 2014, p. 10).   
     This enlightenment into their difficulties (Brown, 2008) seemed to be linked 
to participant’s improved relationships with themselves.  Five studies discussed 
a less judgemental, less critical and more accepting relationship with 
themselves (Kahlon et al, 2014; Rayner et al., 2011; Redhead et al., 2015; 
Shine & Westacott, 2010; Stewart, 2016).  For example, one participant 
described their experience of receiving a reformulation letter, 
…it made it so much more ordinary.  It put me in the position of an 
observer.  It helped me think, well, if this had happened to a stranger and 
they had coped like this, would I think that they were dreadful? No I 
wouldn’t…it was a huge relief (Shine & Westacott, 2010, p. 170).   
 
Therapeutic relationship. 
Reciprocal translation identified the importance of the therapeutic 
relationship in all but two studies (Kahlon et al., 2014; Thew & Khronert, 2015).  
Studies established a symbiotic relationship between the formulation process 
and the therapeutic relationship.  For example, Rayner et al. (2011) discussed 
the contribution formulation had to ‘cement the therapeutic relationship’.   This 
suggests that the collaborative process during the development of the 
formulation plays a significant role in the growth of the therapeutic relationship.  
A participant demonstrated this, reflecting on her reformulation, 
The reformulation was proof that she really did know what I felt like.  The 
other doctors listened, but I thought, are they taking it all in, do they care.  I 
couldn’t trust them, but it’s different now.  At first I felt the same with my 
therapist, but since I’ve had the reformulation I’ve had 100% trust in her and 
don’t hold anything back now (Evans & Parry, 1996, p. 112).    
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Stewart (2016) proposed that sharing a formulation was like a ‘dynamic 
shift’ and participants progressed from being a ‘passive recipient of therapy 
towards being an active agent in the therapeutic process’ (Stewart, 2016, p. 57).  
The importance of establishing a trusting therapeutic relationship at the point of 
sharing the formulation with participants was also highlighted (Rayner et al., 
2011).  In some studies where participants had reported feeling sceptical 
(Brown, 2008) and frightened of the formulation process (Redhead et al., 2015), 
the therapeutic relationship a vehicle to work through and address participant’s 
anxiety.  
 
Looking to the Future. 
Seven studies referenced participant’s expectations of their future and 
how the formulation had impacted upon this (Brown, 2008; Chadwick et al., 
2003; Pain et al., 2008; Rayner et al., 2011; Redhead et al., 2015; Stewart, 
2016; Thew & Khronert, 2015).  A recurring theme of optimism and 
encouragement for the future was established in seven papers (Brown, 2008; 
Chadwick et al., 2003; Pain et al., 2008; Rayner et al., 2011; Redhead et al., 
2015; Stewart, 2016; Thew & Khronert, 2015).  Redhead et al. (2015) identified 
the theme of a sense of empowerment to move forwards and work through their 
difficulties.  For example, “seeing it all there, it gives you a different 
perspective…I just felt empowered that I could do something about them (the 
problems)” (Redhead et al., 2015, p. 462).   
Formulation providing a context and rationale for treatment was 
discussed in two papers (Evans & Parry, 1996; Thew & Khronert, 2015).  It 
seems that the development of the formulation provided participants with a 
focus for the rest of therapy, which may have not made sense without sharing 
the formulation.    
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Table 3 
Cross-Comparison of Third-Order Themes 
Third order themes and subthemes Study Number 
 1 2 3 4 5 6 7 8 9 10 
Development and use of formulation   * * * * * * * * 
Impact of realisation * * * * * * * * * * 
Positive emotional response  * * * * * * * * * 
Negative emotional response  * * * * * * * *  * 
Relationship with themselves    * * * * *  * 
Therapeutic relationship * * * * * *  *  * 
Looking to the future * * * *  *  * * * 
Note. * Indicates if theme is identified in the study. 
RPV 1718 4263846 15591139 ThesisVol1 Page 46 of 261 
Line of argument synthesis 
A line of argument synthesis involves the creation of an interpretation, 
drawing together and presenting the findings of the review as a whole (Noblit & 
Hare, 1988).  Synthesis of the 10 studies included in this review present five key 
constructs, all of which are closely inter-connected with each other.  Figure 3 
presents a Venn diagram, depicting the interaction between each theme. 
The method in which the formulation is developed and shared appears 
strongly linked with the therapeutic relationship and potentially impacts the 
process of realisation for the participant.   Findings across the studies suggest 
that developing the formulation in collaboration with the client is key for the 
quality of the therapeutic relationship and participants overall engagement with 
the formulation process.  The therapeutic relationship appears to be at the core 
of participant’s experiences of formulation.  As already discussed, the findings 
suggest that participants often experience a negative reaction in response to 
the realisation of their difficulties.  The therapeutic relationship is crucial to 
provide a non-judgemental and containing space to process their responses. 
The inter-connection between the therapeutic relationship and the 
development of the relationship with the self is significant in participant’s 
experiences of formulation.  There appears to be a shift during the formulation 
process, whereby participant’s dependence on the therapist reduces as their 
self-awareness develops.  Stewart (2016) also referred to this process, 
describing participants taking a more active role in therapy.   
Participant’s expectations for the future and progress in their recovery 
may be shaped by the development and mileu of the other themes.  This 
highlights the importance of consideration of the issues discussed in the 
findings when utilising formulation in clinical practice.   
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Discussion 
This meta-ethnography aimed to critically appraise and synthesise 
qualitative research that explored client’s experiences of receiving a 
formulation.  The review identified five inter-connected key themes that shaped 
overall experiences of formulation. 
This review helpfully synthesises the current literature exploring the 
usefulness of formulation, from a client’s perspective.  Highlighting and 
interpreting findings encourages clinicians to develop and adapt their clinical 
practice to best meet the needs of the client.  As previously discussed, the 
evidence to support the use of formulation is limited, therefore the findings 
presented in this meta-ethnography are a useful contribution to the literature.  
The findings discussed support the DCP’s Good Practice Guidelines on 
the use of formulation (DCP, 2011).  It seems reasonable to suggest that the 
experiences of receiving a formulation are consistent with the main purpose of 
formulation; to identify the best way forward and to inform future interventions.  
In addition, the findings also support other aims that a formulation intends to 
achieve, including, providing an overall picture or map, helping the client to feel 
understood and contained, strengthening the therapeutic alliance and 
normalising problems and self-blame.  This is a useful finding, confirming that 
there is consistency between what professional guidelines state are the aims of 
formulation and what clients perceive they are receiving.   
Exploration of the impact of realisation for clients is an interesting finding, 
particularly the recurrent theme of a negative emotional response from clients.  
It is important not to take this finding at face value and requires some further 
consideration.  Given that negative findings are often unreported within 
research papers (Dickersin & Chalmers, 2011), it is reasonable to suggest that 
feelings of distress are potentially experienced more frequently than is reported 
within the literature.  Negative emotional responses to the formulation, for 
example, feeling overwhelmed, may indicate a process that is more complex 
and dynamic, potentially where change has occurred (Stewart, 2016).  The 
interpretations presented in this review also support the idea suggested by Eells 
(2007) that formulation may reduce client’s engagement.  This may be as a 
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result of a conflict between the content of the formulation and a suppressed 
understanding of their difficulties.  Brown (2008) proposes discomfort may be a 
necessary transition to pass through in order to progress through recovery. 
Without further exploration of this issue, it is impossible to draw any firm 
conclusions; however this may highlight an area for future research. 
The finding highlighting the importance of the therapeutic relationship 
during the process of formulation supports existing literature that the therapeutic 
relationship is key in predicting therapy outcomes (Martin, Garsle & Davis, 
2000).  The central role of the therapeutic relationship further emphasises the 
rationale for developing the formulation in collaboration with the client.  
Supporting previous literature (Crits-Christoph et al., 1992), the review also 
suggests that the level of perceived accuracy also influenced the therapeutic 
relationship and the client’s overall engagement in therapy.   
 
Limitations 
There are several limitations of this review and synthesis.  As discussed 
within existing literature (DCP, 2011), the definition of formulation is open to 
interpretation and is often dependant on the therapeutic modality used.  In 
addition, the method of sharing or delivery of the formulation may vary amongst 
clinicians, for example some may use a more formalised, diagrammatic 
framework and others may deliver a more informal ‘micro’ formulation, i.e. an 
interpretation.  If authors have not used one of the terms for formulation outlined 
in the search strategy, they may not have been captured within this review.  
This does not necessarily mean that these potentially missed papers were not 
suitable for this meta-ethnography, but highlights the difficulty in the variability of 
definition when undertaking a literature review. 
A strength of this review, is the inclusion of a range of experiences of 
mental health difficulties amongst participants.  Britten et al. (2002) suggest that 
inclusion of heterogeneous studies can be favourable to obtain richer 
interpretations in a meta-ethnography.  On the other hand, this may also be a 
limitation as we cannot account for the individual differences amongst 
participants.  For example, participants in Evans and Parry’s (1996) study, 
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described as ‘difficult to help’, which included two or more episodes with a 
professional and two or more admissions to hospital, may have very different 
experiences to those participants included in the Redhead et al. (2015) study.  
This study included participants from an Improving Access to Psychological 
Therapies (IAPT) services and excluded significant co-morbidity.  Due to the 
unfeasibility of accessing raw data, it is beyond the scope of this review to 
conclude how past experiences may have impacted on participant’s 
experiences of receiving a formulation.  This could be potentially highlight an 
area for future research.   
This review focussed on the appraisal and synthesis of qualitative 
research to answer the question; ‘how do client’s experience receiving a 
psychological formulation?’.  Focussing on qualitative research allowed the 
reviewer to synthesise the perspectives of participants on their lived 
experiences of receiving a formulation.  Whilst qualitative research allows 
participants perspectives to be explored in depth, quantitative research allows 
investigation as to whether an intervention, i.e. formulation, works or not 
(Boland et al., 2014).  Inclusion of quantitative research may have added to this 
review and allowed further exploration of the impact of formulation.   
 
Future research and recommendations for practice 
In conclusion, this review highlights the importance of exploring client’s 
views of formulation in order to further contribute to the evidence.  Reviewing 
the evidence and considering adaptions to practice will enable clinicians to 
deliver formulations that are most beneficial and attentive to client’s needs.  
Further research investigating the impact of formulation, using both qualitative 
and quantitative approaches is certainly required.  Consideration of the impact 
of realisation may also provide an interesting and valuable area for future 
research.  
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Abstract 
Psychological formulation is a central process in many contemporary evidence-
based psychological therapies and is a core competency of clinical psychology 
training and practice. Currently there is limited evidence to show that 
formulation benefits the client or improves outcomes in therapy.   
This study aimed to investigate whether (1) formulation impacts on working 
alliance and (2) there is a relationship between formulation, working alliance 
and psychosocial outcomes.   
A repeated single-case A-B design was used, including a non-treatment 
baseline phase (A) followed by the intervention phase (B); eight weeks of CBT, 
incorporating formulation, across five participants. 
Results showed a slight relationship between formulation and working alliance, 
although evidence was not robust enough to confirm whether formulation 
directly impacts working alliance.  Results were mixed in terms of the 
relationship between formulation, working alliance and psychosocial outcomes 
measured.   
Findings discussed are complex and although tentative conclusions can be 
made it is not possible to state that formulation impacted on outcomes. The 
study highlights the complexity of psychotherapeutic research and the 
challenges of disentangling processes in therapy.  Findings provide a platform 
for future research into formulation and should further consider some of 
limitations discussed.    
 
Keywords: psychological formulation, cognitive-behavioural therapy, working 
alliance and outcomes 
 
Highlights: 
 Investigation of formulation and outcomes in CBT.  
 Complex and mixed findings. 
 Highlights complexity of psychotherapeutic research. 
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Introduction 
Psychological formulation (often referred to as case formulation, case 
conceptualisation or clinical formulation) can broadly be understood as a tool, 
which applies psychological theory to develop a number of hypotheses that 
offer an explanation of the development and maintenance of a client’s 
difficulties (Butler, 1998; Division of Clinical Psychology (DCP), 2010).  The 
process of formulation should be collaborative and inform the intervention 
delivered (DCP, 2010). Psychological formulation is considered a core process 
in many contemporary evidenced-based psychological therapies, for example, 
in Cognitive Behavioural Therapy (CBT), formulation is described as the 
foundation for understanding an individual’s difficulties, which involves 
collaborative empiricism between the client and therapist (Beck, 1995; Eells, 
2007). As such, formulation is considered a ‘core competency’ within Clinical 
Psychology training and practice within the UK and within wider mental health 
professions (Health and Care Professions Council, 2015; Johnstone, 2018)6.    
However, despite the centrality of formulation to the profession and the 
recommendation of professional bodies to use ideographic formulation above 
structural diagnostic frameworks (Johnstone, 2006), there is limited research to 
show the benefits of formulation7.  This includes inconsistent evidence to 
suggest improved outcomes of distress and the working alliance (Bieling & 
Kuyken, 2003).  There is, however, equivocal evidence that formulation is 
beneficial to therapy in terms of client’s reporting feelings of relief (Redhead, 
Johnstone, & Nightingale, 2015), optimism and reassurance (Chadwick, 
Williams, & Mackenzie, 2003).  Although, studies have also reported client’s 
negative responses to formulation, such as feeling overwhelmed, frightened 
(Evans & Parry, 1996) and a sense of realisation, which can reportedly 
contribute to feelings of sadness and worry (Chadwick et al., 2003).  Research 
has not yet established whether these negative responses are permanent or 
whether they are latterly followed by a more positive trajectory (Johnstone, 
2018).  Few studies have examined the impact of formulation on the working 
alliance. Chadwick et al. (2003) demonstrated that client and therapist 
experiences of the therapeutic relationship were inconsistent; while some 
individual participants indicated improved therapeutic alliance, this was not 
unanimous and was not attributable to the formulation.  Furthermore, whilst 
therapists reported an increase in alliance over the time points in which the 
formulation was delivered this was not supported by client-reported measures.  
Similarly, other studies investigating formulation in Cognitive Analytic Therapy 
                                                          
6 See extended paper sections 1.1 and 1.2 for further detail on conceptualisation of formulation 
and a background and content of formulation in clinical psychology. 
7 See extended paper section 1.3 for further discussion on formulation as an alternative to 
diagnosis. 
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(CAT) have found no significant impact on reported levels of working alliance or 
perceived helpfulness following the formulation (Evans & Parry, 1996; Shine & 
Westacott, 2010)8. 
Reasons for such an absence of evidence are perhaps to be found in the 
nature of formulation itself; the term is difficult to operationalise and can relate 
to both a process and an outcome, it may look different across therapies and 
there are issues of quality and reliability.  In terms of operationalisation, within 
the literature, the definition of formulation varies and it is therefore difficult to 
compare across studies and between therapists.  Formulation can be 
considered as a ‘process’, via a continuous process of assessment, intervention 
and discussions when providing an insight into the client’s difficulties during a 
therapy session (British Psychological Society, 2011).  In contrast, formulation 
can be delivered as a ‘product’, which may be presented diagrammatically or in 
a written format.  With regards to reliability, a recent review of case formulations 
showed mixed results, with reliability ranging from ‘slight to substantial’ (Flinn, 
Braham, & das Nair, 2015).  Arguably, low-reliability in formulation is inevitable, 
as there is not one correct way to formulate (Butler, 2006).  Research highlights 
a lack of agreement over what constitutes a good quality formulation, with 
minimal guidance or tools available to assess quality (Flitcroft, James, Freeston, 
& Wood-Mitchell, 2007).  Quality can be considered from a top-down or bottom-
up approach (Kuyken, Fothergill, Musa, & Chadwick, 2005).  A top-down 
approach would assess the theoretical framework in which the formulation is 
based on; ensuring the psychological theory used has an evidence-base for the 
difficulty being formulated and checking whether the clinician is using the 
psychological theory coherently.  A bottom-up approach would assess the 
quality of the formulation from the client’s perspective; considering how helpful 
the formulation is for the client9. 
It is difficult to disentangle the process of formulation from factors such 
as the therapeutic model used and the working alliance.  Furthermore, it is 
possible that formulation might drive some of these processes or there may be 
a bidirectional relationship between them.  Researching such complex 
processes has become a significant area of interest within psychotherapy 
studies, contributing to a debate about the role of common and specific factors 
in therapy.  The common factors approach proposes that if all necessary factors 
are present (see Table 4), any therapy regardless of the therapeutic model, will 
                                                          
8 See extended paper section 1.4 for further discussion on existing research on formulation and 
outcomes. 
9 See extended paper section 1.5 for discussion on reliability and quality of formulation. See 
extended paper section 1.6 for discussion on the debate of Evidence Based Practice (EBP) and 
Practice Based Evidence (PBE). 
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be efficacious (Wampold, 2001)10.  A recent meta-analysis showed a robust and 
moderate correlation (.25 - .30) between the alliance and outcomes, across a 
range of client presentations and therapies (Horvath, Del Re, Flückiger, & 
Symonds, 2011).  Although there is substantial research to support the 
importance of the working alliance in therapy, the evidence is criticised due to 
the correlational rather than causal relationship between these two variables 
(Castonguay, Constantino, & Holtforth, 2006)11.   
 
Table 4 
Components of the Common Factors Model (Wampold, 2001) 
 Common Factors 
 
(a) An emotionally charged bond between the therapist and client. 
(b) A confiding and healing setting for the therapy to take place. 
(c) A therapist who provides a psychologically developed and culturally 
sensitive explanation for the client’s emotional distress. 
(d) An explanation that is adaptive (i.e., provides realistic options for 
overcoming difficulties) and is accepted by the client. 
(e) A set of procedures engaged by the client and therapist that leads the 
client to enact a positive, helpful or adaptive change.   
 
Specifically to CBT, psychological formulation and the working alliance are 
both deemed to be essential components of the therapy (Beck, Rush, Shaw, & 
Emery, 1979).  Conceptually, it is important to consider the overlap between 
these processes and question whether it is possible to have one without the 
other.  A factor analysis showed that Bordin’s (1979) definition of working 
alliance fits CBT well (Andrusyna, Tang, DeRubeis, & Luborsky, 2001).  
Establishing mutually agreed goals, the tasks involved to achieve the goals, 
along with the working alliance are all fundamental to CBT (Beck, Rush, Shaw, 
& Emery, 1979).  Considering some of the professional guidelines surrounding 
psychological formulation (BPS, 2011; DCP, 2010), formulation should be a 
collaborative process of developing a psychological understanding of the 
development and maintenance of an individual’s difficulties.  One might expect 
that the process of developing a collaborative formulation, which guides the 
goals of the intervention should contribute to the client feeling understood by 
their therapist.  If so, it might be assumed that the process of formulation 
contributes to a bond between the client and therapist, thus fostering an 
                                                          
10 See extended paper section 1.7 for further detail on the common factors approach.  
11 See extended paper section 1.8 for further information on specific factors and Empirically 
Supported Treatments (EST). 
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effective working alliance.   Although there is an assumed linear relationship 
between psychological formulation and working alliance (BPS, 2011), this is 
unsupported by empirical evidence (Bieling & Kuyken, 2003) and does not 
consider other potential issues, such as the formulation quality, method of 
delivery and the client’s perceived accuracy of the formulation they receive. 
Given that some of the literature suggests that clients may experience mixed 
emotional responses, including feeling frightened and overwhelmed following 
receiving a psychological formulation (Chadwick et al., 2003; Evans & Parry, 
1996), it is important to consider the point in which a formulation is delivered.  It 
could be that establishing a positive working alliance prior to sharing a 
formulation is essential, so that any negative emotional responses can be 
worked through therapeutically during the course of therapy12. 
It is clear that given the status of psychological formulation in the 
profession, more research is required to examine whether formulation impacts 
outcomes in therapy and to disentangle whether formulation drives outcomes or 
other non-specific processes.  Specifically, we wanted to examine whether 
formulation impacts the working alliance and other secondary outcomes in eight 
sessions of CBT, primarily targeting low mood.  Given Beck et al. (1979) utilises 
a specific diagrammatic formulation framework, these were referred to as 
‘product formulations’ and delivered twice during therapy.  Additionally, more 
subtle ‘process’ formulations were also delivered throughout therapy. These 
were informed by cognitive-behavioural theory and consisted of three key 
components Antecedent (A), Belief/Cognition (B) and Consequence (C)13.   
 
Research Aims and Questions14 
Specifically, the research aimed to examine whether: (1) formulation 
impacts on working alliance; (2) there is a relationship between formulation, 
working alliance and psychosocial outcomes. To answer these research 
questions, the study delivered a CBT intervention, incorporating ‘product’ and 
‘process’ formulations, to adults experiencing low mood. 
 
 
 
                                                          
12 See extended paper for section 1.9 and 1.10 on the development of the concept of alliance 
and an overview of working alliance and outcomes 
13 See extended paper section 1.12 for detail on the clinical relevance of the study.   
14 See extended paper section 1.13 for further detail on definition of impact. 
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Method15  
Design16 
This study utilised a mixed methods, repeated single-case (inter-case 
replication), AB design (Barlow,, Nock, , & Hersen, 2009).  Single Case Design 
(SCD) studies, which track outcome variables across baseline and intervention 
phases, are well suited to investigating the relationships between variables at a 
micro level (Borckardt et al., 2008). In this case, the design of this study 
facilitates the examination of formulation (as a product and a process), in a 
naturalistic setting, which is therefore generalisable to clinical practice.   
 
Participants17 
Participants were invited to take part in the study if they met the following 
inclusion criteria: (a) currently accessing a Community Mental Health Team 
(CMHT); (b) between the age of 18 and 65; (c) presented with symptoms of 
depression or experiencing low mood; (d) able to give informed consent; and (e) 
able to speak and understand English.  Participants were not considered for the 
study if members of their care team considered their risk of harm to themselves 
or others as too high, e.g. intention to act on a suicide plan.  
Four females and one male from adult UK CMHTs participated (age range; 
35 - 61, mean age; 44.8). Two additional participants disengaged from the study 
after one session; one due to a deterioration in her mental health and 
consequently losing capacity to consent and the other due to choosing to 
access a different psychological service.   
While the primary diagnosis of clients differed, their reason for accessing 
therapy was to address their experiences of low mood.  All participants were 
prescribed and taking medication to treat their mental health difficulties, two 
participants had previously received CBT and one had previously received 
counselling. See Table 5 for participant’s demographics. 
 
                                                          
15 See extended paper section 2.1 for discussion on epistemology of the study. 
16 See extended paper section 2.2 for extended rationale for study design and critique of SCD 
approach. 
17 See extended paper sections 2.3 for detail on justification for sample size and section 2.4 for 
further information about the participants.   
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Table 5 
Participant demographics 
Participant 
Number 
Pseudonym Gender Ethnicity Diagnosis Previous Psychological 
Treatment 
Type of Medication 
1 Luke Male White European FEP None Antipsychotic 
Antidepressant 
2 Louise Female White British BPD 
 
CBT Antidepressant 
3 Julie Female White British Bipolar Disorder None Mood Stabiliser 
Antidepressant 
4 Heather Female White British Paranoid 
Schizophrenia 
CBT Antipsychotic 
Antidepressant 
5 Amy Female White British BPD Counselling Antidepressant 
Note.   FEP = First Episode Psychosis.  BPD = Borderline Personality Disorder.  CBT = Cognitive Behavioural Therapy.
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Measures18 
 A combination of established measures and purpose-built recording 
sheets (to count the frequency of process formulations delivered) were utilised 
in the study.  (See Appendix A – D for copy of measures; Appendix E for 
process formulation recording sheet). 
During the baseline phase, the Patient-Reported Outcomes 
Measurement Information System (PROMIS) depression – short form measure 
(Cella et al., 2010) was administered at three data points prior to the 
intervention phase to assess for stability, against which intervention could be 
compared.  The PROMIS depression measure was then administered weekly 
throughout the intervention.  
In addition to a measure of low mood, measures relating to working 
alliance (Working Alliance Inventory-Short Form; WAI-SF) and wellbeing 
(Mental Health Continuum-Short Form; MHC-SF) were administered weekly 
(following each therapy session delivered; see Table 6 below).  Finally, the 
Clinical Outcomes in Research Evaluation – Outcome Measure (CORE-OM) 
(Evans, Mellor-Clark & Mar, 2000), used as a standard outcome measure at the 
recruitment sites was administered pre and post intervention.  
 
Formulations19  
Given the research aims, the researchers needed to measure process 
and product formulations throughout the intervention.  Therefore, we defined 
and measured these in the following ways; 
i) Process formulation  
Process formulations were coded as verbal summaries or insights that 
aimed to assist the client’s understanding of their difficulties.  These were 
delivered at any point throughout the intervention when the therapist utilised 
their clinical judgement and felt it was an appropriate instant to share the 
formulation.  In order to be coded as a process formulation, these 
summaries had to explicitly specify a three terms contingency; antecedent 
(A), belief/cognition (B) and consequence (C), which may have consisted of 
parts of the larger (product) formulation. For example, Therapist: “I wonder 
whether after you have seen your children (A), you feel sad and feel no 
                                                          
18 See extended paper section 2.6 for extended information about the measures used (2.61 on 
WAI-SF, 2.62 on PROMIS Depression Measure, 2.63 on MHC-SF, 2.64 on CORE-OM) 
19  See extended paper section 2.7 for further detail on rationale for delivering process and 
product formulations. 
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motivation to do anything (C), because you think you have let them down 
and you are not a good father (B),  
 
 
ii) Product formulation 
A product formulation was delivered in a diagrammatic form, using 
the Beck longitudinal model (Beck, 1995) and was drawn out on large 
pieces of paper collaboratively during the session.  The product 
formulation was delivered twice during the intervention phase; in 
session 3 and 7. (See Appendix F for Beck longitudinal model) 
 
 
Change Interviews 
Interviews were informed by Elliott’s change interview (Elliott, Slatick, & 
Urman, 2001) and were undertaken by an independent researcher (interview 
schedule in Appendix G).  They aimed to explore participant’s experience of 
change, if any, during and after the intervention, asking whether changes were 
as a result of the formulation or any other factors, related and external to 
therapy. Participants were also asked specifically about their experiences of 
developing and receiving a formulation.  The qualitative data aimed to 
triangulate with the quantitative data and to gain participant’s accounts of 
receiving a formulation.   
 
Procedure20 
 Ethics21.  
This study was approved by a Research Ethics Committee (REC) and 
the Health Research Authority (HRA) within the NHS.  Also, the study was 
approved by the University of Lincoln, School of Psychology Research Ethics 
Committee (SOPREC).  (See Appendices H – M for ethical approval letters)  In 
summary, all participants gave informed consent, were aware that therapy 
sessions were audio recorded and understood that their participation in the 
study was entirely voluntary. (See Appendix N for consent form, O for 
information sheet and P for debrief sheet)   
 
 
                                                          
20 See extended paper section 2.8 for further information on procedure. 
21 Section extended paper section 2.8.1 for additional information about ethical considerations 
and approval.  
Page 69 of 261 
 
 Recruitment.22   
Participants were recruited from two adult CMHTs.  First contact was 
with their known clinician and if they met the inclusion/exclusion criteria, an 
information sheet and consent form was sent out.  The researcher contacted 
them after one week to obtain verbal and written consent.   
 
 Baseline23.   
Once consent was obtained, participants commenced the baseline 
phase, which consisted of weekly completion of the PROMIS depression 
measure, for three data points (Kratochwill et al., 2010). Participants were given 
the option of completing the baseline measure online (Qualtrics) or in paper 
format.  While establishing a stable baseline is the gold standard in single-case 
research, due to using a clinical sample, this was not ethically possible in this 
study.   
 Intervention24.   
Participants received eight, one-hour sessions of CBT weekly.  See 
Figure 3 for illustration of the procedure and structure of the intervention.  The 
lead researcher was the therapist for the intervention and received 90 minutes 
of clinical supervision weekly, and also kept reflective supervision notes25.  The 
Cognitive Therapy Rating Scale (CTRS) (Young & Beck, 1980) was used to rate 
CBT adherence.  The CTRS was scored for every session by the therapist and 
one full session, for each participant was second-rated by the supervisor 
(David, Szentagotai, Lupu, & Cosman, 2008; Westra, Arkowitz, & Dozois, 
2009)26.  All sessions were audio recorded so the frequency of process 
formulations could be counted using the process formulation criteria outlined 
previously27. (See Appendix Q for CTRS)  
 The intervention delivered was CBT for low mood, informed by Beck 
(Beck et al., 1979), which aimed to improve the participant’s mood, by targeting 
their cognitions and behaviour.  
 
                                                          
22 See extended paper section 2.9 for further discussion on recruitment challenges.   
23 See extended paper section 2.10 for further detail on the baseline phase, stability and number 
of data points.   
24 See extended paper section 2.11 for additional information on the CBT intervention.  
25 See extended paper section 2.12 for further details on managing the dual role as researcher 
and therapist.   
26 See extended paper section 2.5.5 for additional information on CTRS.  
27 See extended paper section 2.13 for extended detail on second coding of process 
formulations. 
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Figure 3.  Overview of Single Case Design used in the study. 
 
 
Structure of CBT Intervention:  
Sessions 1 and 2: assessment, Session 3: product formulation, Session 4: goal setting, Session 
5 and 6: cognitive and behavioural techniques (e.g., cognitive challenge, activity scheduling), 
Session 7: product formulation, Session 8: review progress, goals, relapse prevention and 
therapy endings.    
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Table 6 
Weekly measures: Characteristics and Psychometric Properties 
Measure  Aim No. of items 
and scaling 
Example item Directionality and 
Scoring 
Reliability  
(IC and TR) 
Validity 
WAI-SF; 
Client 
Version 
Tracey & 
Kokotovic 
(1989) 
 
Measures 
working alliance; 
consists of three 
subscales; task, 
goal and bond.  
12 items (3 
subscales) 
 
7-point 
Likert scale 
(1-7) 
(Researcher’s 
name) and I 
are working 
towards 
mutually 
agreed upon 
goals. 
Higher scores 
indicate a stronger 
working alliance. 
 
Range: 12-84 
IC 
α = .86-.82 
(task);  
α = .73-.82 
(goal);  
α = .80-.83 
(bond)  
α = .91-.92 
(total) (Busseri 
& Tyler, 2003) 
Good 
convergent 
validity with 
related 
measures 
(Hatcher & 
Gillaspy, 2006) 
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WAI-SF; 
Therapist 
Version 
Tracey & 
Kokotovic 
(1989) 
Measures 
working alliance; 
consists of three 
subscales; task, 
goal and bond. 
12 items (3 
subscales) 
 
7-point 
Likert scale 
(1-7) 
I believe 
(client’s 
name) likes 
me. 
Higher scores 
indicate a stronger 
working alliance. 
 
Range: 12-84 
IC 
α = .86-.90 
(task);  
α = .81-.90 
(goal);  
α = .77-.86 
(bond);  
α = .91-.96 
(total) (Busseri 
& Tyler, 2003) 
Good 
convergent 
validity with 
related 
measures 
(Hatcher & 
Gillaspy, 2006) 
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PROMIS 
Depression 
– Short 
Form (8b) 
Measure 
(Cella et al., 
2010) 
Measures 
affective and 
cognitive 
aspects of 
depression. 
8 items 
 
5-point 
Likert scale 
(1-5) 
In the past 7 
days…I felt 
worthless. 
Scores transformed 
into T-scores. 
 
Higher scores 
indicate higher 
levels of depression. 
IC 
α = .90 
(Vilagut et al., 
2015). 
Good 
convergent 
validity with 
related 
emotions.  
 
Able to 
discriminate 
between 
depression and 
other co-
morbidities. 
(Vilagut et al., 
2015). 
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MHC-SF 
(Keyes, 
2002) 
Measures 
wellbeing; 
consists of three 
dimensions; 
emotional, 
psychological 
and social 
wellbeing. 
14 items  
(3 
subscales) 
 
6-point 
Likert scale 
(0-5) 
During the 
past week, 
how often did 
you 
feel…satisfied
. 
Scores calculated 
as averages. 
Higher scores 
indicate an 
improved wellbeing. 
Range: 0-5Scoring 
categories: 
“languishing” 
(Score of 0-1 on at 
least one emotional 
and six other items) 
“flourishing” 
(Score of 4-5 on at 
least one emotional 
and six other items) 
“moderately 
mentally healthy” 
(any other 
combination) 
IC 
α = .92 
(Keyes et al., 
2012) 
 
TR 
r = .68 
(Lamers et al., 
2011) 
Good 
convergent 
validity, 
subscales 
correlate with 
related 
measures. 
 
Good 
discriminant 
validity with 
two-contina 
model of 
mental health. 
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CORE-OM 
(Evans et 
al., 2000) 
 
Measures 
therapeutic 
outcomes across 
four dimensions 
(functioning, 
problems/sympto
ms, wellbeing 
and risk)   
34 items  
(4 
subscales) 
6-point 
Likert scale 
(0-5) 
Over the last 
week, I have 
thought of 
hurting 
myself. 
Scores calculated 
as averages 
multiplied by 10. 
 
Higher scores 
indicate higher 
levels of mental 
health difficulties. 
 
Range: 0-10 
IC 
α = .91 
(Connell et al., 
2007) 
 
TR 
r = .91 (Connell 
et al., 2007) 
Good 
convergent 
validity, 
subscales 
highly 
correlated with 
related 
measures.  
 
 
Note: WAI-SF = Working Alliance Inventory – Short Form; MHC-SF = Mental Health Continuum – Short Form; PROMIS = 
Patient Reported Outcomes Measurement Information System; CORE-OM = Clinical Outcomes in Research Evaluation – 
Outcome Measurement; IC = Internal Consistency; TR = Test-Retest 
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Analysis28 
Visual analysis was used to examine trend, variability and points of interest in 
the data.  Visual analysis remains the gold standard by which single-case designs 
are most commonly analysed, however some argue that statistical methods should 
also be used alongside (Smith, 2012).  To strengthen the visual analysis, Simulation 
Modelling Analysis (SMA; Borckardt et al., 2008) was undertaken to examine the 
relationships across variables.  SMA is a bootstrapping method used to analyse auto 
correlated data, to reduce the risk of making Type-I errors. That is, SMA helps 
determine how likely it is that we would find a correlation between variables when 
there is none, by examining non concurrent relationships (Nash, Borckardt, Abbasa, 
& Gray, 2011).  In this study, SMA examined temporal relationships between two 
variables over the course of the intervention, e.g., do changes in the frequency of 
process formulations precede changes in participant ratings of alliance?  A minimum 
number of three replications, across participants was required to confirm any 
measured change reflects a relationship between variables (Kratochwill et al., 2010) 
 In order to more accurately determine whether formulation and working 
alliance impacted on depression, a baseline assessment of depression was initially 
undertaken to determine the level and trend of this variable prior to intervention. This 
was undertaken with the rationale that determining the overall trend of this variable 
would allow for a clearer assessment of the co-variation between variables 
(depression, working alliance and formulation) to be made. In order to determine 
whether any changes in secondary outcome measures were deemed reliable 
(beyond what could be accounted for due to measurement error at 95% confidence) 
and clinically significant (placing the participant in a non-clinical range.  Jacobson 
and Truax's (1991) Reliable Change Index (RCI) and Clinical Significant Change 
(CSC) scores were also calculated.   
Participant’s responses from the change interviews were tabulated and 
considered alongside the quantitative data.  This method of triangulation enabled the 
researcher to strengthen or contest inferences made regarding the effect of 
formulation on the working alliance and secondary outcomes.  
 
 
 
 
                                                          
28 See extended paper section 2.14 for extended analysis. 
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Results 
Treatment Fidelity 
 In order to assess treatment fidelity, the CTRS was completed by the therapist 
whilst listening back to audio recordings for each session.  To assess inter-rater 
reliability, an independent rater (supervisor) listened to the audio recordings of one 
full session, for each participant (12% of sessions delivered) and sessions were 
chosen randomly using an online number generator.  The independent rater scored 
the CTRS and recorded the frequency of process formulations (α = .88).  On the 
CTRS ratings differed slightly (+ or -  1 point difference on some items) and therapist 
ratings tended to be lower than the independent rater.  Product formulations were 
also discussed and checked prior to sharing with participants.   
  
This study firstly examined whether:  
(1) Formulation impacts on working alliance.   
 To examine the trend and variability of the WAI and formulations (process 
and product), visual analysis was undertaken.  Particular attention was given to 
points of interest in the data, i.e. the two data points where the product formulation 
was delivered. Graphical displays of the data are provided in Figure 4.  P2’s second 
product formulation was delayed (delivered in session 8) and as a result the 
intervention was 9 sessions long.  This was due to particularly distressing content 
shared by the participant during session 7.  
The data showed an upward trend on both participant and therapist measures 
of working alliance for all but one participant (P3).  P3 showed a flat trend on the 
participant working alliance measure.  There is little variability on the measures of 
working alliance across participants and the therapist’s measure of alliance is lower 
than all participant’s. However, P2 is the only participant where the therapist’s 
measure of working alliance is higher than the participant’s at the end of the 
intervention.  There was moderate variability in the frequency of process 
formulations delivered across participants, with the lowest total of formulations 
delivered with P3 (total = 21) and the highest total delivered with P1 (total = 45)29.  
Visual inspection of the graphs showed that there is a slight peak in the measure of 
working alliance reported by the therapist for P1, P2 and P4, at the point the second 
product formulation was delivered.  Participant’s report of working alliance showed a 
slight elevation at the first product formulation for P3 and P5 and at the second 
product formulation for P4.  The peak in working alliance, at these points of interest 
in the data is very slight and is not the only point of elevation during the intervention.   
                                                          
29 See extended paper section 3.4 for means, standard deviations and totals for all measures and 
process formulations for each participant. 
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Figure 4.  Graphs representing Working Alliance Inventory and process formulation 
frequency  
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Figure 4 continued.  Graphs representing Working Alliance Inventory and process 
formulation frequency  
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Figure 4 continued.  Graphs representing Working Alliance Inventory and process 
formulation frequency  
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SMA was undertaken to analyse the relationship, including any lagged relationship 
between the frequency of process formulations and the working alliance.  The 
analysis showed very few significant correlations between working alliance and the 
frequency of process formulations.  Two participants (P3, r = +.77; P5, r = +.79) 
showed that an improvement in participant reported working alliance preceded an 
increased frequency of process formulations delivered by the therapist in the 
following session.  However this does not meet replication criteria (minimum number 
of 3).  No statistically significant correlations were found between process 
formulations and therapist reported working alliance30.  
In summary, visual analysis and SMA suggests a slight trend between 
working alliance and formulation.  Specifically, visual analysis showed a trend 
between therapist reported working alliance and the product formulation and SMA 
suggested a trend between a higher frequency of process formulations and improved 
working alliance rated by the participant.   
 
Secondly, this study examined whether: 
(2) There is a relationship between formulation, working alliance and 
psychosocial outcomes.  
To examine trend and variability of the PROMIS depression measure, visual 
analysis was undertaken.  Changes from baseline to intervention were examined in 
order to more accurately analyse the trend and variability of depression prior to 
introducing the intervention.  Graphical displays of the data are provided in Figure 5.  
Most participants showed an improving trend in depression during the baseline 
phase (P1, P2 and P4), one participant showed a relatively stable baseline (P5) and 
one showed a worsening trend prior to commencing the intervention (P3).  There 
was little variability in participant’s depression scores throughout the intervention, 
with P2 showing most variation. Focussing on points of interest in the data, one 
participant (P1) showed highest scores of depression during sessions of highest 
frequency of process formulations, although this was not repeated with other 
participants.  
  
 
 
 
                                                          
30 See extended paper section 3.5 for SMA correlation coefficients for frequency of process 
formulations and working alliance.  
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Figure 5.  Graphs representing PROMIS Depression and process formulation 
frequency 
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Figure 5 continued.  Graphs representing PROMIS Depression and process 
formulation frequency 
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Figure 5 continued.  Graphs representing PROMIS Depression and process 
formulation frequency 
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SMA was used to analyse the relationship between the frequency of process 
formulations, depression and well-being (measured on MHC-SF).  The analysis 
showed that for participant one, a higher frequency of process formulations delivered 
by the therapist preceded a deterioration in depression in the following session (P1, r 
= +.81). However, no further statistically significant correlations were found with any 
other participant and therefore this does not meet replication criteria.  SMA also 
reported two statistically significant correlations between the frequency of process 
formulations and a deterioration in wellbeing, although the lags in which correlations 
were found were inconsistent.  For participant two, the analysis showed that an 
increase in the frequency of process formulations delivered preceded a deterioration 
in wellbeing in the following session (P2, r = -0.67).  However, for participant five, the 
analysis found that a deterioration in wellbeing preceded and increased frequency of 
process formulations delivered by the therapist in the session afterwards.   In 
summary, no consistent relationship was found between the frequency of process 
formulations, depression and well-being31. 
 Visual analysis of working alliance data and levels of depression was also 
undertaken.  Graphical displays of the data are illustrated in Figure 6.  During the 
intervention phase, two participants (P2 and P4) showed a worsening trend in levels 
of depression in parallel to an increase in working alliance, reported by the 
participant.   SMA was undertaken to analyse the relationship between participant 
and therapist reported working alliance and also participant reported working alliance 
reported and depression.  Table 7 presents correlation coefficients, reporting 
whether the correlation is statistically significant, the direction of the association      
(+ or -) and at what lag the association occurred.  
 
 
 
 
 
 
 
 
 
                                                          
31 See extended paper section 3.6 for SMA, correlation coefficients for frequency of process 
formulations, wellbeing, depression and working alliance.   
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Table 7 
Simulation Modelling Analysis: Participant and Therapist Alliance and Participant 
Alliance and Depression 
Participant Lag Participant & 
Therapist 
Alliance 
Lag Participant 
Alliance & 
Depression 
P1 +1 r = +.69* +1 r = -.49  
0 r = +.84* 0 r = -.28 
-1 r = +.48 -1 r = +.12 
P2 +1 r = +.48  +1 r = -.71* 
0 r = +.75* 0 r = -.74* 
-1 r = -+.47 -1 r = -.17 
P3 +1 r = -.03 +1 r = +.41  
0 r = -.13  0 r = +.47 
-1 r = -.63*  -1 r = +.20 
P4 +1 r = +.75* +1 r = -.61*  
0 r = +.64  0 r = -.12 
-1 r = +.22 -1 r = +.02 
P5 +1 r = +.17 +1 r = +.21  
0 r= +.82*  0 r = +.64 
-1 r = -.01 -1 r = -.08 
Note. * = p<.05.  + or – indicates direction of correlation (positive or negative).  
 
SMA analysis showed that for three participants (P1, P2 and P5), there was a 
significant correlation between participant and therapist reported alliance, at a lag of 
0 (i.e., within the same therapy session). This is repeated across three cases and 
therefore meets minimum replication criteria.  Also, two participants (P2 and P4) 
reported significant correlations between an increase in participant reported alliance 
and an improvement in depression in the following session.  However this was not 
repeated across three participants and therefore does not meet replication criteria.  
In summary, a strong relationship was found between therapist and participant 
reported working alliance and a slight relationship was found between participant 
reported working alliance and improved levels of depression29.   
SMA was undertaken on participant reported alliance and levels of wellbeing.  
Analysis reported one significant correlation (P4), which showed that an increase in 
participant reported working alliance preceded an improvement in wellbeing in the 
following session, although this was not repeated at the same lag with any other 
participant and therefore does not meet minimum replication criteria29.   
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Figure 6.  Graphs representing Working Alliance Inventory and PROMIS Depression  
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Figure 6 continued.  Graphs representing Working Alliance Inventory and PROMIS 
Depression  
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Figure 6 continued.  Graphs representing Working Alliance Inventory and PROMIS 
Depression  
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 RCI and CSC analyses were undertaken on the PROMIS depression, 
MHC and CORE measures at significant time points throughout the 
intervention, including pre (session1), post (session 8/9) and at the point the 
first and second product formulation (session 3 and 7/8) was delivered32.  This is 
presented in Table 8.   
 
Table 8 
Reliable Change Index and Clinically Significant Change Analyses  
Note. RCI and CSC calculated using clinical and non-clinical norms in published 
literature unless standardised norms are available.  PROMIS Dep – Reduction 
in score indicates improvement in depression.  Scores reported as t-scores.  
MHC-SF – Increase in score indicates improvement in wellbeing.  Scores report 
average of total score.  CORE – Reduction in score indicates improvement 
across symptom domains. * P2, product formulations delivered in session 3 and 
8 and duration of intervention was 9 sessions. R = indicates reliable change.      
C = indicates clinically significant change.  
 
Three participants (P1, P2 and P4) showed reliable change at post 
intervention on the PROMIS depression measure, although none achieved 
CSC.  On the MHC, two participants (P1 and P2) showed reliable and CSC at 
the point the second product formulation was delivered, which was further 
                                                          
32 See extended paper section 3.7 for RCI and CSC calculations. 
Participant Measure Pre 
 Session 
1 
Product 
Formulation 
Session 3 
Product 
Formulation 
Session 7/8* 
Post  
Session 
8/9* 
1 PROMIS Dep 65.4 66.4 62.5 55.3 R 
MHC-SF 0.71 0.79 1.43 RC 1.36 RC 
CORE 69 - - 46 R 
2 PROMIS Dep 66.4 64.4 55.3 R 57.1 R 
MHC-SF 0.93 0.64 2.0  RC 2.5 RC 
CORE 50 - - 35 R 
3 PROMIS Dep 69.3 74.8 71.4 69.3 
MHC-SF 1.21 1.21 1.14 1.36 
CORE 68 - - 50 R 
4 PROMIS Dep 66.4 56.2 R 61.6 54.3 R 
MHC-SF 1.64 1.43 2.07 2.07 
CORE 57 - - 43 R 
5 PROMIS Dep 74.8 77.9 77.9 81.1 
MHC-SF 0.57 0.36 0.14 0.21 
CORE 97 - - 92 R 
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improved at post intervention. Four out of five participants (P1, P2, P3 and P4) 
made reliable improvements on the CORE measure at post intervention.   
Change Interviews 
All but one participant (P4) took part in the change interviews.  
Participant’s responses are presented in Table 9 and a summary of responses, 
relevant to the research questions is provided below.  
When asked about helpful aspects of therapy, all participants 
commented on the positive therapist characteristics, although they did not 
specifically attribute this to the formulation process.  However, participants 
talked about helpful aspects of the alliance, including feeling understood (P1) 
and feeling at ease to talk about difficult topics (P2 and P3).  The majority of 
participants also referred to the approach of the therapist being helpful; non-
judgemental (P2 and P3), “gentle but direct” and not condescending (P5) were 
all highlighted.   
 All participants reported positive changes in therapy, but they did not 
make explicit links between these changes and the formulation.  Furthermore, 
participants did not attribute these changes to the CBT or to external factors 
outside of therapy either.  Three participants (P1, P2 and P5) referred to 
changes in their thinking, specifically feeling more able to challenge their 
thoughts.  Two participants described feeling different, “less guilty” (P1) and 
“more accepting…better in myself” (P3).  With regards to changes in behaviour, 
half of participants (P1 and P3) talked about engaging in more activity, although 
P1 reported that this improvement had not sustained following the end of 
therapy. Participants reported less negative changes but two participants 
reported no change, specifically in relation to their thoughts (P3) and continuing 
to experience anger (P5).  All participants referred to external factors that may 
explain any changes that have occurred in therapy.   
 When asked about their experiences of formulation, all participants 
referred to the process of drawing out the formulation (product) and all but one 
participant (P1) reported that this was a helpful to make sense of their 
experiences.  Half of participants (P1 and P2) talked about their experience of 
process formulations, although two participants were not aware of process 
formulations during therapy. 
Three participants (P2, P3 and P5) referred to a negative emotional 
response in relation to their formulation. Two participants described finding the 
product formulation “overwhelming” (P2) and “hard to look at…like having to 
relive it again” (P5), although both felt like the formulation was a helpful 
process.  P3 reported that some of the explanations of the development of her 
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depression was “not very nice” and described feeling shocked, but overall the 
formulation aided her understanding.   
Half of the participants (P2 and P5) added that they felt the product formulation 
made more sense the second time it was shared and it was therefore more 
helpful (P2), although they did not report whether this contributed to changes in 
their thoughts, feelings or behaviours.  P2 specifically felt that if the formulation 
had been shared during every session, it would not have had the same positive 
effect.    
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Table 9 
Summary of Participant’s Responses from Change Interview 
Interview 
Question 
 
Participant 1 Participant 2 Participant 3 Participant 5 
Previous 
therapy  
No previous therapy 
but watched CBT 
videos on YouTube. 
CBT 7 years ago, but totally 
different to therapy with Hannah.  
No previous therapy. Counselling. 
Influence 
expectations of 
current therapy 
Open minded as to 
whether it would help.  
Tried therapy 
because I was 
struggling and had to 
do something. 
Didn’t enjoy previous CBT and 
didn’t think current therapy 
would be any different. 
No expectations. Aware that you have to 
engage with the person 
as well as the therapy.  
Felt apprehensive, but 
willing to try anything.  
Helpful 
aspects of 
therapy 
She understood me. 
Her questions were 
accurate for my 
personal situation. 
She encouraged me 
to do more. 
Felt comfortable, she didn’t force 
information out of me, and I told 
her things I hadn’t told anyone 
before. 
She wasn’t judgemental, it felt 
like she knew me and that 
helped. 
Explanation of why my anxiety 
happens.   
She helped me to understand 
it’s okay and normal to feel like I 
do. 
Therapy hasn’t cured it, it’s 
helped me put things into 
Felt easy and I could talk 
about anything. 
Helped to understand how 
I was feeling was normal.  
Helpful to talk because 
she never judged me, it 
felt reassuring 
Hannah listened and 
helped me to see things 
from other perspectives. 
Hannah’s approach 
helped, she was gentle 
but direct and didn’t come 
across condescending.  
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perspective. 
Unhelpful 
aspects of 
therapy 
Struggled to follow 
weekly schedules 
(going to the gym and 
going out). Difficult to 
do them in between 
sessions. 
Sad therapy ended, it would 
have been nice to have longer. 
Sometimes we didn’t 
agree, but that was okay.  
I told her I didn’t agree 
and we talked about it.  
 
I wanted more time for 
therapy.  
Therapy was challenging 
and hard sometimes, but I 
needed it.  
I could have done with 
more time with Hannah. 
Any positive 
changes 
Changed how I 
thought about myself, 
feel less guilty. I 
looked at the 
evidence, it helped 
me to see I am not a 
failure. 
Understood why I felt 
depressed. 
I did more things I 
enjoyed in therapy, 
this has stopped now. 
Challenge my thoughts and I 
can have a word with myself. 
Intrusive thoughts are less 
frequent and understand 
thoughts are normal. 
 
I am more accepting of 
things. 
I do more (badminton and 
things around the house). 
I feel a bit better in myself 
and I notice my emotions 
more.  
Try to see other’s points 
of view.   
Recognise and challenge 
my black and white 
thinking.  
Can process how I feel 
and let go of bad feelings 
quicker.  
Share how I feel more 
than before.  
Any negative 
changes 
None. None. My thoughts are still the 
same. 
I still get angry and “blow 
up” like I used to.  
External 
factors to 
therapy to 
explain 
changes 
Personal difficulties 
towards end of 
therapy and ongoing 
at time of interview. 
Personal difficulties towards end 
of therapy and ongoing at time 
of interview. 
Good relationship with 
peer support worker who I 
see regularly. 
Go to meditation and 
have a good relationship 
with nurse. 
 
Ongoing difficulties with 
physical health and pain.  
Experiences of 
formulation – 
Yes No Yes  No 
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required a 
prompt 
Experiences of 
product 
formulation 
She drew something 
out with me, but can’t 
remember much. 
Writing it down helped to look at 
it all together and understand my 
depression and anxiety. 
We looked at how I was thinking 
and my beliefs.  
 
 
Hannah broke it all down.  
We looked at my past at 
what caused my 
depression. 
We drew it out; looked at 
how my thoughts work 
and how I react.  Looked 
at my past, which helped 
explain how my thoughts 
work.  
The second time, we 
changed it slightly 
because of something 
that happened.  
Experiences of 
process 
formulations 
This is what the 
therapy was all 
about, helping me to 
see how my 
behaviour, thoughts 
and feelings, how 
they are linked 
together.   
She did these most sessions. At 
first, I was a bit dubious and 
didn’t think it would be helpful. 
After a few sessions, it started to 
make sense and I thought about 
it after sessions.  
Not aware of process 
formulations. 
Not aware of process 
formulations. 
Helpful 
aspects of 
formulation  
Helped me to look at 
my thoughts, 
challenge them and 
see that I shouldn’t 
feel guilty.  
Helped to understand 
how I feel about 
myself. 
At the time, it felt 
more helpful. Now I 
Drawing it out helped to make 
sense of thoughts.   
Felt like a conversation, the 
formulation didn’t feel forced on 
me. 
Writing it down was 
helpful, seeing it all written 
down in a diagram, it 
made sense.  Helped me 
to put things in 
perspective.  
When we drew it out, it 
helped me get it.  
Helped to spot how I 
think, what I do in 
everyday life and 
understand why I do what 
I do.  
Overall a positive 
experience.   
Page 96 of 261 
 
don’t know how to 
use what I learnt in 
the formulation.  
Unhelpful 
aspects of 
formulation 
None. When it was drawn out, I felt a 
bit overwhelmed.  It wasn’t 
negative, but seeing everything 
from my past, it was a shock.  It 
made me think, no wonder I get 
depressed.   
Didn’t want to take formulation 
away, because I felt I got it out 
of my system. 
At first I thought “that’s not 
very nice”.  It was a shock 
to me, but it did help me to 
understand my 
depression. 
Sometimes it was hard to 
look at.  It was like having 
to relive it again and it felt 
hard to disengage with, 
because it was in front of 
me.  
Seeing it in black and 
white, it’s like confronting 
a lot of your demons.  
Sometimes, it felt hard to 
hear. 
It wasn’t the nicest thing 
in the world to do, but it 
wasn’t unhelpful, it was a 
positive experience. 
Anything else 
to add. 
None. Looked at formulation in a totally 
different way the second time.  
Had a better understanding and 
knew what it was trying to do 
rather than bits of information on 
a piece of paper. Made more 
sense and it was more helpful. 
If we had looked at the 
formulation every session, I 
don’t think it would have had the 
same effect.  
None. Looking at formulation the 
second time, because we 
had talked a lot, it made 
more sense.  
 
Note. Hannah = name of therapist.  
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Discussion 
 This study aimed to examine whether formulation impacts on working 
alliance and other secondary outcomes during CBT.  The study answered two 
research questions, each of which are outlined below, considering the findings 
and making links to existing literature.  Finally, a critique of this study is 
provided, offering recommendations for future research.   
 
Does Formulation Impact Working Alliance?33 
The findings showed a slight relationship between formulation and working 
alliance, although evidence was not robust enough to confirm whether 
formulation directly impacts working alliance.  
 With regards to process formulations, findings showed little evidence to 
suggest that an increased frequency in process formulations impacted the 
working alliance.  The number of process formulations delivered across 
participants varied (total ranged 21 – 45).  This variability may provide an 
internal consistency check, as the delivery rate of process formulations differed 
across participants (i.e., participants received varied doses of formulations), 
which means if there was an effect to be found it would be more easily 
detected.  Variability could be indicative of an improved working alliance, 
creating a safe space where the therapist feels better able to deliver a greater 
number of formulations.  Contrary to this, it could also be that when the 
therapist perceived the alliance was weak or the client’s understanding was 
limited, this resulted in a compensatory effort to foster engagement and 
coherence, thus the therapist delivered a higher frequency of process 
formulations.  The receptiveness of the client is also important and may 
influence the number of formulations the therapist delivers.  In this study, 
participant three was particularly talkative, allowing less room for the therapist to 
deliver process formulations (total frequency = 21).  Finally, it might be that 
supervision may increase the therapist’s confidence to deliver more 
formulations throughout therapy.  These explanations of variability are simply 
hypotheses as to why there was such variability in the frequency of process 
formulations.  As this was not measured in the current study, it may provide a 
recommendation for future research. 
Psychodynamic literature suggests that a higher frequency of 
interpretations offered in therapy improves the working alliance and importantly 
this is mediated by the client’s perceived level of accuracy (Crits-Christoph, 
                                                          
33 See extended paper section 4.1 for further discussion answering does formulation impact 
working alliance. 
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Barber, & Kurcias, 1993).  In the current study, SMA reported statistically 
significant correlations for two participants, showing that an improvement in 
participant reported working alliance preceded an increase in the frequency of 
process formulations delivered in the following session.  It is important to note 
the limitations of SMA conducted in this study when interpreting findings.  
Identifying lagged correlations between the frequency of process formulations 
and the working alliance are likely to be confounded by sessions when a 
product formulation was delivered. This is because fewer process formulations 
were offered but a formulation was delivered in a different, unmeasured form 
(i.e., sessions may inaccurately reflect the ‘dose’ of formulation delivered). As 
process formulations were delivered more subtly during therapy, it was difficult 
to obtain participant’s experiences of them during the change interviews.  The 
quality and accuracy of formulations is vital when understanding the impact 
formulation has on working alliance.  When measuring formulation using a 
bottom-up approach, it is important we consider how client’s receive the 
formulation (i.e. is the formulation helpful for them) (Kuyken, Fothergill, Musa & 
Chadwick, 2005).  This emphasises that the client’s perceived accuracy of the 
formulation is essential, as this may drive or hinder the working alliance.  For 
example, if a therapist delivers a high frequency of process formulations, which 
the client perceives as an inaccurate reflection of their experiences, this may 
rupture the alliance. The accuracy of formulations delivered was not measured 
and therefore cannot be considered when drawing conclusions, which highlights 
a potential limitation of this study. 
In relation to the product formulation, therapist’s measure of working 
alliance showed a slight peak at the point the second product formulation was 
delivered for three participants, although this was not reflected in participant’s 
responses on the WAI.  Peaks observed in working alliance reported by the 
therapist were very slight and not the only peaks noted during the intervention, 
therefore this should be interpreted tentatively.  Nevertheless, there is 
inconsistency between the therapist and participant’s reports of working alliance 
at the point the second formulation is delivered.  This supports Chadwick and 
colleagues (2003) findings that therapists report an improved alliance when 
delivering a formulation, which was not reflected in participant’s responses, 
suggesting that formulation may be more beneficial for therapists rather than 
clients.  In this study, it is not possible to attribute therapist’s responses on the 
WAI with the product formulation delivered during the session and other 
explanations must be considered.  Several studies have examined the 
development and decay of the working alliance during time-limited therapies, 
which proposed a ‘curvilinear pattern’; an initial high level, which declines during 
a conflictual period and then subsequently recovers towards the end of therapy 
(Gelso & Carter, 1994; Horvath & Marx, 1990).  However, in practice there are 
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considerable variations, for example, when working with complex clients, 
alliance ratings tend to be lower for longer throughout the initial phase of 
therapy (Kivlighan & Shaughnessy, 2000).  This hypothesis may offer one 
explanation for the peak in therapist’s reports of working alliance during the 
penultimate session of therapy (when the product formulation was delivered).  
As the study design did not include post-therapy interviews with the therapist, it 
is not possible to tease this apart further.   
Consistent with previous research (e.g., Chadwick, Williams & 
Mackenzie, 2003; Evans & Parry, 1996; Rayner, Thompson & Walsh,2011), 
participants described the formulation process as helpful, enabling them to 
“make sense” and have a “better understanding of their difficulties”, however, 
this study showed little evidence to confirm whether formulation directly impacts 
working alliance.  Teasing apart the formulation component from other aspects 
of therapy, such as the CBT intervention is a challenge.  Formulation is 
embedded into psychological interventions, such as CBT, and consequently is 
difficult to separate from other psychotherapeutic techniques.  Referring back to 
the definition of formulation, a tool which applies psychological theory to make 
sense of the development and maintenance of an individual’s difficulties (Butler, 
1998; Johnstone, 2006), it is conceptually and clinically problematic to 
disentangle this from CBT techniques, such as, a cognitive challenge or setting 
up a behavioural experiment.  Overlap in these processes creates uncertainty 
as to whether the formulation and, or the CBT intervention is driving the working 
alliance during therapy.   
 
What is the Relationship between Formulation, Working Alliance and 
Psychosocial Outcomes?34 
 Data showed mixed findings in terms of the relationship between 
formulation, working alliance, and the psychosocial outcomes measured.  
Although over half of participants showed an improvement in depression, two 
showed improvements in wellbeing and the majority improved across a range of 
symptoms on the CORE-OM, it is not possible to attribute these changes solely 
to formulation.  Factors such as the CBT intervention may have contributed to 
these improvements, although the study design did not specifically measure 
aspects of CBT that are expected to change (e.g., thinking styles), which would 
have helped to distinguish whether it was the CBT intervention, or other factors 
(e.g., non-specifics) that impacted on outcomes.  However, during the change 
interviews participants did comment on changes that are reflective of CBT, 
                                                          
34 See extended paper section 4.2 for extended discussion on answering what is the relationship 
between formulation, working alliance and psychosocial outcomes. 
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including changes in thinking (e.g., “challenge my thoughts…recognise and 
challenge my black and white thinking”), behaviour (increase in levels of 
activity) and their emotional state (e.g., “feel less guilty…more accepting”).  
Although the authors cannot be conclusive as to whether changes can be 
explained by the CBT intervention, process of formulation or the working 
alliance, it is important to highlight that the language used by participants 
mirrors that of CBT.  However, existing research suggests that the alliance is 
the strongest predictor of outcome in therapy (Duncan, Miller, Wampold & 
Humble, 2010; Horvath, Del Re, Flückiger & Symonds, 2011) and therefore 
should be considered when drawing conclusions.   
Results showed mixed findings between formulation, levels of depression 
and wellbeing.  SMA reported one significant correlation, showing that an 
increased number of process formulations delivered preceded a deterioration in 
depression in the following session, although minimum replication criteria was 
not met which limits the generalisability of this finding.  As previously discussed, 
it is difficult to ascertain whether a deterioration in depression is a result of 
process formulations delivered or other specific and non-specific factors in 
therapy.  Consistent with previous research (Chadwick et al., 2003; Evans & 
Parry, 1996; Pain, Chadwick & Abba, 2008; Rayner et al., 2011), qualitative 
data revealed three participants experienced a negative emotional response 
when provided with the product formulation.  Supporting this finding, outcome 
measures showed a worsening in depression for two of these participants (P3 
and P5) when the product formulation was delivered (on both occasions).  
Formulation is core to our clinical practice (DCP, 2010), although this finding 
along with previous research highlights that we must remain aware of potential 
negative reactions and deliver formulations sensitively.  If an effective working 
alliance is established, it should be expected that difficult emotions reported by 
clients (e.g., feeling overwhelmed, shocked, reliving) are explored using the 
safety of the client-therapist relationship.  All participants who described 
negative emotions in response to the formulation commented that this did not 
alter their views that the formulation was a helpful process.  Johnstone (2018) 
commented that previous research is unclear regarding the permanence of 
client’s negative reactions to formulation, although this study offers some 
evidence to suggest that they are followed by a more positive trajectory.  
Additionally, two participants commented that the product formulation was more 
helpful at the second point it was delivered during the intervention, although 
they did not specify how it was more helpful.  Regardless, this may offer 
valuable reflections for clinical practice and highlights that the point in which a 
formulation is delivered may alter how clients receive and utilise it.     
 Consistent with previous literature examining the trajectory of working 
alliance in therapy (Gelso & Carter, 1994), all but one participant showed an 
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upward trend on the WAI, which was supported by participant’s responses in 
the change interviews, commenting on the value and key features that the 
therapist contributed to the alliance (e.g., non-judgemental, comfortable, feeling 
listened to and understood).  The common factors model emphasises the 
importance of the alliance and suggests a relationship between a stronger 
working alliance and improved outcomes (Horvath et al., 2011; Wampold, 
2001).  SMA showed a significant correlation, at a lag of +1, between two 
participant’s measure of working alliance and improved levels of depression.  
This may reflect previous research (Horvath et al., 2011), but as minimum 
replication criteria was not met, this study cannot conclude whether there was a 
relationship between working alliance and outcomes.  Findings do provide 
evidence that the alliance was an important process for participants; however 
the results from this study have not concluded any clear relationships between 
variables.    
 
Strengths, Limitations and Future Research35 
 This study is the first attempt at measuring the impact of CBT formulation 
on working alliance and secondary outcomes, using a mixed methods, repeated 
single case design.  As outlined in previous literature and therefore expected, 
there were several challenges the researchers faced when attempting to 
answer the research questions.   
 Perhaps the most significant challenge of the study was to disentangle 
such complex process and draw conclusions as to which variables contribute to 
which changes during therapy.  As previously outlined, this study did not 
measure aspects of CBT that were expected to change, for example, 
behaviours or thinking styles, which may have aided the researcher to 
differentiate between which variables impacted on the outcomes.  Single-case 
designs allow researchers to investigate complex processes (Morgan &  
Morgan, 2008), using a systematic and scientific methodology, although 
difficulties are still faced when attempting to separate processes.  This study 
highlights overlap between the concepts of formulation, CBT and working 
alliance.  The process of formulation in therapy may enact components of the 
working alliance, for example, establishing a collaborative understanding of an 
individual’s difficulties (formulation) may replicate the development of the bond 
component of the working alliance (Bordin, 1979).  Additionally, formulation is 
embedded into psychological interventions and can be delivered subtly 
(process) as well as more explicitly (product), which often makes it difficult to 
                                                          
35 See extended paper section 4.3 for extended discussion on limitations and challenges and 
4.2 for further detail on strengths and implications for clinical practice.  
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separate out from the intervention.  As previous literature suggests (Andrusyna 
et al., 2001), conceptually CBT and working alliance share key components and 
consequently it is problematic to disentangle the two.  Introducing the product 
formulation at various time points, between different participants may have 
enabled the researcher to draw firmer conclusions as to whether the formulation 
contributed to any changes in outcome.   
Another limitation of the study was the dual role of the therapist and 
researcher, however, several methods were used to manage this, including, 
supervision, second coding, and keeping reflective notes.  Although the 
therapist was a Trainee Clinical Psychologist and acknowledges her preference 
to formulation, existing literature on formulation does not conclude any 
directional impact on outcome, therefore any bias to influence outcomes in this 
study would have been very difficult.  Considering the evidence of poor inter-
rater reliability of formulation (Flinn et al., 2015), one therapist was used 
throughout the study, to improve reliability across the CBT intervention and 
formulations.  Research proposes that different therapists may be more or less 
able to develop a working alliance, which would impact on outcomes of therapy 
(Baldwin, Wampold, & Imel, 2007).  To test this hypothesis and further examine 
the impact of working alliance, this study may have benefitted from having more 
than one therapist, however a cost of this would possibly have been reduced 
reliability of the formulation and CBT intervention. 
 Despite some of the limitations discussed here, this study provides a 
strong attempt at measuring the impact of formulation on the working alliance 
and psychosocial outcomes.  The design has considered some of the 
conceptual and measurement challenges which have been highlighted in the 
literature (BPS, 2011).  Also, the study tested formulation using scientific and 
robust methodologies, within a naturalistic setting which is most generalisable 
and useful for clinical practice.  This is a significant strength of the study, as 
there is very little published research that has attempted to do this and therefore 
offers a valuable contribution to the field of clinical psychology.   
 
 
Conclusion 
 In summary, this study contributes to a dearth in the literature 
surrounding the impact of psychological formulation on outcomes in therapy, 
specifically the working alliance.  The findings show a mixed and complex 
picture and although tentative conclusions can be made that formulation, 
particularly the product formulation, may have contributed to feeling listened to 
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and understood, it is not possible to say that this directly impacted on the 
working alliance.  This study also supports previous literature that individuals 
may have mixed emotional responses to the formulation, including feeling 
overwhelmed and shocked (Chadwick et al., 2003; Evans & Parry, 1996).  
However, in answer to Johnstone’s (2018) reflection, it does not seem that 
these negative responses are permanent and they seem to be managed and 
worked through using the vehicle of the working alliance.   
 Similarly to any area of psychotherapy research, this study highlights the 
complexity of disentangling processes to draw conclusions on what variables 
contribute to changes in outcomes, i.e. can we separate the impact of 
formulation from the specifics of the CBT intervention or the non-specifics in the 
working alliance?  Additionally, it is important to consider the overlap in the 
concepts of the working alliance, formulation and the CBT intervention.  
Considering the key components of the concept of working alliance; bond, task 
and goal (Bordin, 1979), is it possible to deliver a CBT intervention, without 
contributing to the alliance, nor is it possible to develop a formulation without 
impeding on the alliance?  Despite the complexity of this, it offers interesting 
and valuable reflections, which hopefully provides a platform for future research 
into formulation.   
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1. Extended Background 
 
1.1 Conceptualisation of Psychological Formulation 
The definition of psychological formulation varies across professions, the 
therapeutic modality used and how a therapist delivers a formulation during 
therapy (BPS, 2011).  The literature often defines formulation as a hypothesis, 
developed using psychological theory, which provides an explanation of an 
individual’s difficulties (BPS, 2011; Johnstone & Dallos, 2006).  Additional 
commonly referenced definitions include; “a process of ongoing collaborative 
sense-making” (Harper & Moss, 2003, p. 8), “a way of summarising meanings, 
and of negotiating for shared ways of understanding and communicating about 
them” (Butler, 1998, p. 4).  Dependant on the therapeutic model, the label used 
and delivery of the psychological formulation differs.  For example, in CBT, the 
term psychological or case formulation is used, in Cognitive Analytic Therapy 
(CAT) the process is referred to as reformulation and in psychoanalytic therapy, 
formulations are delivered as an interpretation.  For consistency, this study uses 
the terms psychological formulation or formulation for short.   
 
1.2 Background and Context of Psychological Formulation in Clinical 
Psychology 
The origins of psychological formulation as a core skill of the profession 
can be traced back to the 1950s (BPS, 2011).  However, prior to this Freud’s 
writing discusses the process of constructing personal meaning out of mental 
distress, for example, “case histories I write should read like short stories…case 
studies of this kind have, however, one advantage…namely an intimate 
connection between the story of the patient’s sufferings and the symptoms of 
his illness” (Freud & Breuer, 1974, p.231).  Influential clinicians including Hans 
Eysenck and Monte Shapiro used key components of operant and classical 
conditioning to develop individualised alternatives to using psychiatric 
diagnoses (BPS, 2011).   
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The term ‘formulation’ was first referenced in clinical psychology 
guidelines in 1969 (Crellin, 1998) and is now a familiar term, not only within 
clinical psychology but across psychiatric settings (Johnstone, 2018).  
Formulation has been referred to as the cornerstone of clinical psychology and 
is one of nine core competencies, outlined by the British Psychological Society 
(BPS, 2010) which must be evidenced throughout training and clinical practice.  
Formulation is a core competency in clinical psychology training and practice 
and also features in the curriculum for psychiatry training and has recently been 
introduced into the Core Mental Health Skills Education and Training 
Framework, which is applicable to all mental health professionals in England.   
The BPS and DCP have promoted formulation as an alternative to 
diagnosis for some time (Johnstone, 2018)  Several documents published by 
the BPS and DCP discuss the significant limitations of diagnosis and highlight 
the value of using formulation to develop a holistic, non-medicalised 
understanding of mental health difficulties.  Key documents include; the Power 
Threat Meaning Framework (BPS, 2018), DCP position statement on 
psychiatric diagnoses (DCP, 2013) and Good Practice Guidelines on the use of 
Psychological Formulation (BPS, 2011).  Some of the limitations of diagnosis 
and the alternative of psychological formulation are discussed below.   
 
1.3 Psychological Formulation as an Alternative to Diagnosis  
Formulation offers one possible alternative to the criticisms that 
psychiatric diagnostic classification systems have received over many years.  
Psychiatric diagnoses have been criticised for lacking reliability, validity, 
contributing to stigma and excluding the consideration of social and cultural 
contexts (Bentall, 2009; Boyle, 2002; Kirk & Kutchins, 1997).  Psychiatry 
considers mental health as a branch of medicine and understands the concept 
of human distress using a disease model (Boyle & Johnstone, 2014).  As a 
result, psychiatric diagnoses have been criticised for the negative impact they 
can have on the individual as they can turn “people with problems” into “patients 
with illnesses” (Johnstone, 2018).  It is suggested that diagnosis can contribute 
to a “loss of meaning” within an individual’s experiences, as the personal, social 
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and cultural context are overshadowed by the diagnostic label (Johnstone, 
2014).  Although diagnoses can be helpful for individual’s to name their distress, 
this is unsupported by empirical evidence and the majority describe feelings of 
shame, worthlessness and hopelessness (Johnstone, 2014).  It is unclear how 
researchers have been able to isolate variables associated with mental ill-health 
from the awarding of a diagnosis.  Given that shame, hopelessness and 
worthlessness are already key characteristics of many conditions, such as 
depression, it is uncertain how this is separated from the individual’s experience 
of receiving a diagnosis.   
In comparison to diagnosis, formulation pays less attention to the 
individual’s deficits and focuses on their strengths and resilience during times of 
extreme challenges.  Also, formulation approaches any form of psychological 
distress on the premise that “at some level it all makes sense” (Butler, 1998, p. 
2).  Johnstone (2006) argues that formulation provides meaning to the content 
of an individual’s distress; whereas diagnosis removes the meaning behind the 
distress.   
Scott and Sembi (2006) propose that the process of formulation and 
diagnosis do not need to be mutually exclusive of each other, suggesting that 
diagnosis helps focus and informs the material that is considered in the 
formulation.  This notion is also supported by Eells (2002), who advocates that 
formulation provides a link between diagnosis and treatment and therefore 
rather than being two separate processes, they should support each other.  The 
idea of compatibility between formulation and diagnosis is disputed and many 
argue that formulation provides an alternative to diagnosis, rather than an 
addition that should be used concurrently (Carey & Pilgrim, 2010).  Despite the 
ongoing debate between formulation and diagnosis, it is clear that both 
approaches have strengths and limitations which should be considered when 
delivering them with clients.  Within clinical psychology, there has been a clear 
shift away from diagnosis and the focus has been placed on the value 
psychological formulation has in the profession.  Despite the enthusiasm for 
formulation, the evidence for its reliability, validity and utility is lacking.   
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1.4 Research on Formulation  
 
1.4.1 Formulation and Psychosocial Outcomes.  
 A small number of studies (Chadwick, Williams & Mackenzie,  2003; 
Evans & Parry, 1996; Thew & Krohnert, 2015) which have measured the impact 
formulation has on psychosocial outcomes in therapy have shown very little 
evidence to support a relationship between variables.  Chadwick et al. (2003) 
found no significant difference in participant’s anxiety and depression after 
sharing a CBT formulation over two sessions.   In a second experiment, 
Chadwick and colleagues used a single case series design which found that 
when the formulation was delivered over four separate sessions, the results 
showed no significant impact on the strength of delusions or negative self-
evaluations.   
 Evans and Parry (1996) used a multiple baseline across subjects design 
to examine the short-term impact of reformulation in CAT with four participants.  
Similarly to Chadwick and colleagues, results showed that the reformulation had 
no impact on outcomes (participant’s perceived helpfulness of sessions, 
therapeutic alliance and individual problems).  One limitation highlighted by 
Evans and Parry (1996) was that the study focussed on sessions immediately 
following the reformulation and therefore failed to consider that the process of 
reformulation may have started as early as session one, when the therapist 
started collecting information.  This raises a challenge when measuring 
formulation, as to specifying when the formulation process begins, which 
emphasises the importance of clearly operationalising formulation and how it 
will be measured during therapy.   
 Thew and Krohnert (2015) presented a single case report, which used 
three outcome measures pre and post the delivery of a diagrammatic CBT 
formulation.  Results showed that there were no significant differences in 
outcomes following the formulation; however the methodology was unclear as 
to when the measures were administered.  A major limitation of this study was 
the lack of a rigorous design and methodology which meant that little 
conclusions could be made.    
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 As discussed, each of the studies reported here attempted to measure 
whether delivering a psychological formulation during therapy impacted on 
psychosocial outcomes.  A limitation which these studies share is the difficulty 
in separating the formulation from other processes, such as the intervention or 
the alliance between the client and therapist during the intervention.  
Additionally, identifying when the process of formulation begins and ends is 
essential when measuring the impact formulation has on outcomes.  This 
highlights the importance of ensuring a robust, systematic and scientific 
methodology so that where possible, some of these processes can be 
separated.   
 
1.4.2 Formulation and the Therapeutic Relationship.  
Four published studies (Chadwick et al., 2003; Crits-Christoph, Jacques, 
& Kurcias, 1993; Evans & Parry, 1996; Shine & Westacott, 2010) have also 
measured the impact formulation has on the therapeutic relationship, all of 
which show little evidence to support a relationship between the process of 
formulation and the therapeutic relationship.   
 As previously discussed, Chadwick et al. (2003) investigated the impact 
formulation has on psychosocial outcomes and they also measured client and 
therapists’ ratings of the therapeutic alliance two sessions before and two 
sessions after a CBT formulation was delivered.  Results showed that although 
clients’ ratings of the alliance increased over the course of therapy, this was 
probably attributable to a general increase in therapeutic alliance expected 
during therapy and could not be attributed to the formulation.  However, 
therapists rated the therapeutic alliance as higher than participants between 
time points when the formulation was delivered, although it was uncertain as to 
whether this was as a result of the delivery of the formulation or other specific 
and non-specific factors.  The authors highlight that the formulation had an 
impact on therapist’s alliance ratings and therapist’s comments confirmed that 
the formulation could be a “validating experience”, although this was not 
supported by participant responses.  This raises the idea that the delivery of 
formulation during therapy may have more of an impact on the alliance for 
Page 118 of 261 
 
therapists rather than clients, which questions who benefits from the process of 
delivering a formulation.  It could be that formulation is a clinical tool which 
builds confidence for the therapist and therefore from the therapist’s perspective 
improves the alliance, although this hypothesis has not yet been researched.   
 Evans and Parry (1996) and (Shine & Westacott, 2010) both used a 
single-case series design and measured the impact of reformulation on the 
therapeutic alliance during CAT.  Both studies used visual analysis, although 
little detail of the analysis and interpretation is provided to support their 
conclusions that there was no change in therapeutic alliance after the 
formulation was delivered.  Crits-Christoph et al. (1993) also found that an 
increased level of perceived accuracy was correlated with improved alliance, 
however, due to limitations in the design of the study, no causal links could be 
established.   
 Each of the studies discussed here share a similar limitation when 
attempting to disentangle the alliance from other specific and non-specific 
processes during therapy.  Limitations such as this and the small sample sizes 
used means that existing literature cannot conclude whether delivering 
psychological formulation impacts the alliance.   
 
1.4.3 Client’s Experiences of Formulation.   
Eight studies have explored client’s experiences of formulation, which 
overall show mixed results (Chadwick et al., 2003; Evans & Parry, 1996; 
Kahlon, Neal, & Patterson, 2014; Rayner, Thompson & Walsh., 2011; Pain, 
Chadwick, & Abba, 2008; Redhead, Johnstone, & Nightingale, 2015; Shine & 
Westacott, 2010; Thew & Krohnert, 2015).  Of these studies, four used a 
qualitative methodology (Kahlon et al.,  2014; Rayner et al., 2011; Redhead et 
al., 2015; Pain et al., 2008) and four included semi-structured interviews within 
a mixed methods design (Chadwick et al., 2003; Evans & Parry, 1996; Shine & 
Westacott, 2010; Thew & Krohnert, 2015).  All studies reported that participants 
described formulation as a positive experience, particularly contributing to 
feelings of optimism and a sense of relief.  For some participants, this was as a 
result of receiving an explanation of their difficulties which was pertinent to 
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feeling understood (Kahlon et al., 2014; Redhead et al., 2015; Shine & 
Westacott, 2010).  In comparison, all but one study (Thew & Krohnert, 2015) 
also discussed the negative experiences of formulation, which detailed a range 
of negative emotional reactions experienced by participants when receiving a 
formulation.  These included feelings of ‘sadness’ (Chadwick et al., 2003; 
Rayner et al., 2011), ‘overwhelmed’ (Evans & Parry, 1996), ‘a bit daunting’ 
(Pain et al., 2008) and ‘worried’ (Chadwick et al., 2003).   
Negative emotional experiences seemed to be as a result of a process of 
realisation, an increased awareness of difficulties that had been supressed or 
actively avoided by the participant (Kahlon et al., 2014; Redhead et al., 2015).  
This process of realisation supports the idea initially suggested by Eells (2007), 
that formulation may hinder a client’s engagement due to a conflict between 
hearing or seeing the content of the formulation delivered and a supressed 
understanding into their difficulties.  Although this discomfort might be a 
necessary transition to move through in order to progress through recovery, 
without further research it is impossible to draw any firm conclusions.   
 
1.5 Reliability and Quality of Formulation  
Research investigating the reliability of formulation can be dated back to 
1966, when Philip Seitz studied the reliability of psychoanalytic formulations.  
His study found that there was little agreement across formulations and that 
therapists were inclined to rely on their intuitive impression without checking the 
accuracy of these.  In a major review, Bieling and Kuyken (2003) found that 
research has predominately focussed on the inter-rater reliability of formulations 
and less attention has been given to test-retest reliability to assess whether 
formulations remain stable over time.  In a recent review of the literature 
conducted by Flinn, Braham and das Nair (2015) found that the reliability of 
case formulations varied from ‘slight to substantial’ (.1 - .4 and .81 – 1.0) and 
reported that studies have shown that reliability in formulations can be achieved 
across a range of therapeutic models.  This review highlighted the varied 
reliability of formulation across studies and also raised several challenges, 
including the variation in how formulation is defined and delivered (depending 
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on the theoretical orientation and the preference of the clinician) and a diverse 
range of methodologies used across studies, which generates difficulties when 
drawing conclusions. 
There is little clarity of how to assess the quality of formulation (i.e., 
minimal guidance and a lack of quality assessment tools) and therefore there is 
disagreement over what constitutes a good quality formulation (Flitcroft, James, 
Freeston, & Wood-Mitchell, 2007).  When scientifically measuring the impact of 
formulation, both reliability and quality of the formulation are essential 
considerations (Bieling & Kuyken, 2003).  In a review undertaken by Kuyken et 
al. (2005), they comment that although research has predominately focussed on 
the reliability of formulation, this may have little value if the quality of the 
formulation is poor.  For example, a formulation might be replicable, but this 
may have little significance if it is theoretically incoherent or it is unhelpful for the 
client.   
There are very few published tools to assess the quality of formulation.  
Perhaps the most utilised is the ‘checklist of good practice in the use of 
formulation’, published by the BPS (2011).  Although this checklist is accessible 
to researchers and clinicians, it is unclear how the checklist was developed and 
there is little detail to support its utility, which may result in subjective scoring.  
Prior to this, Eells, Kendjelic, and Lucas (1998) developed the Case 
Formulation Content Coding Method (CFCCM), a cross-theoretical tool, which 
assessed quality by categorising the information a clinician used when 
developing a case formulation.  The CCFM has been used in several studies 
(Eells et al., 1998; Kendjelic & Eells, 2007) and has shown to be a reliable and 
clinically useful tool (.60 - 1.0) (Eells et al., 2011).  The Quality of Cognitive 
Case Formulation Rating Scale (Fothergill & Kuyken, 2002) is also referenced 
in the literature (Kuyken et al., 2005), although the scale remains unpublished 
and is therefore inaccessible to clinicians and researchers.    
 
1.6 Evidence Based Practice and Practice Based Evidence  
It is well established in the literature, that the evidence to support the use 
of formulation as an intervention is lacking (Aston, 2009) and therefore it has a 
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minimal evidence-base.  However, psychological formulation is frequently used 
within the National Health Service (NHS) and psychologists are at the forefront 
of promoting its utility.  Amongst other healthcare professionals, clinical 
psychologists hold Evidence Based Practice (EBP) in high regard and are 
committed to delivering practice which is grounded in the best evidence.  There 
is a clear discrepancy between psychologists using formulation, which has a 
minimal evidence-base and placing value on EBP, which raises the question as 
to why psychologists use formulation in practice.  As previously discussed (in 
section 1.4.2, Formulation and the Therapeutic Relationship), it could be that 
psychologists find that formulation improves their confidence in their practice or 
they feel it has value to establish the working alliance (i.e. Practice Based 
Evidence; PBE), although there is little evidence to support this. The economic 
climate of the NHS is placing ongoing pressure on professionals to sell 
themselves and prove their worth.  Clinical psychologists brand the skill of 
formulation as unique and core to the profession, which emphasises the need to 
prove what they are doing is effective, for example, that formulation is 
contributing to positive outcomes.   As outlined as a recommendation by the 
BPS (2011), further research into formulation is required.   
 
1.7 Common Factors Approach 
Given that this study aims to examine the impact of formulation on working 
alliance and the relationship between formulation, working alliance and 
psychosocial outcomes, it is important to consider the literature surrounding 
common factors, specific factors and Empirically Supported Treatments (ESTs).   
How the term ‘common factor’ is currently used in the literature is 
inconsistent and therefore confusing (Lampropoulos, 2000).  The ‘common 
factors approach’ focuses on factors that are required and sufficient for change 
to occur in therapy.  Wampold (2001) outlines five common factors, which are 
all necessary ingredients for efficacious interventions (see Table 2).  In 
comparison, specific factors solely focus on the technical components of the 
therapeutic process (i.e., psychotherapeutic techniques).  For example, in CBT, 
specific factors refer to techniques such as, socratic questioning, guided 
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discovery and thought challenge.  In summary, common and specific factors 
focus on different aspects and levels of the therapeutic process. 
 The discussion about common factors in psychotherapy was initiated 
after an article published by Saul Rosenzweig (1936) suggested that all 
psychotherapies are equally effective and referred to this notion as the ‘Dodo 
bird verdict’.  The phrase referred to a famous quote taken from Alice’s 
Adventures in Wonderland, when the Dodo declares “Everybody has won and 
all must have prizes”, implying that if psychotherapies produce similar outcomes 
they “all must have prizes”.  In the 1970s, the role of common factors in therapy 
became a popular discussion and consequently this resulted in a surge of 
research studies which aimed to examine how they impacted on outcomes 
(Laska, Gurman, & Wampold, 2014). 
Evidence published mainly from comparative treatment studies suggest 
that diverse psychological therapies produce largely equivalent results (Laska et 
al., 2014; Lubrosky et al., 2002; Wampold et al., 1997).  Studies investigating 
which variables are accountable for the most variance in therapeutic outcomes 
show that in addition to the client-therapist relationship (Flückiger, Del Re, 
Wampold, & Horvath, 2018; Wampold, 2001), client’s expectations of therapy 
also correlate with improved outcomes (Greenberg, Constantino, & Bruce, 
2006).  Lambert (1992) conducted one of the first meta-analyses of correlational 
studies in the area of common factors research.  To provide a clearer 
understanding of the sources of variation in therapeutic outcomes, the authors 
categorised common factors, which are illustrated in Figure 7.  The analysis 
showed that ‘common techniques’ accounted for almost a third of improvement 
in outcomes.   
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Figure 7.  Factors contributing to the effectiveness of psychotherapy (Lambert, 
1992) 
 
A recent factor analysis by Tschacher, Junghan and Pfammatter (2014) 
of 22 common factors identified in the literature found that patient engagement, 
affective experiencing and the therapeutic  alliance were judged most relevant 
in the therapeutic process.  Despite variation in how common factors are used 
and categorised, correlational studies consistently report the working alliance as 
an important variable when predicting the effectiveness of interventions.  
Relationship factors, such as goal agreement, collaboration, empathy and 
positive regard are proposed to improve the outcome of therapy (Hatcher & 
Gillaspy, 2006).  This suggests that there will be differences between therapists 
(i.e., some might be more skilful at developing an alliance than others and 
therefore will produce more effective outcomes).  Multilevel analyses have 
shown that the therapists’ contributions to the alliance are key in predicting 
outcome in comparison to the clients’ (Baldwin, Wampold, & Imel, 2007).   
Despite persuasive evidence to support the role of common factors in 
psychotherapies, the findings have been criticised for being misrepresentative 
due to averaging outcomes across primary and secondary outcome measures 
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(Crits-Christoph, 1997).  Also, Beutler (2002) critiqued the common factors 
model and cautioned against assuming client and therapist homogeneity.  
Laska et al. (2014) highlight that there are several misunderstandings about 
common factors, one being that merely the therapeutic relationship is sufficient 
for change.  To clarify, research has shown a relationship between an improved 
alliance and outcomes (Flückiger et al., 2018; Horvath, Del Re, Flückiger, & 
Symonds, 2011) but the alliance is only one factor that is necessary from the 
common factors model.  The debate surrounding which factors are responsible 
for change in therapy is very complex and studies have questioned whether it is 
possible to dichotomise common and specific factors (Tschacher et al., 2014). 
 
1.8 Specific Factors and Empirically Supported Treatments (ESTs) 
 Specific factors focus on technical components of the treatment model 
being used.  The literature has suggested that specific factors are not critical to 
improve outcomes in therapy but the development of practice guidelines and 
Empirically Supported Treatments (ESTs) suggests otherwise (Chambless & 
Ollendick, 2001).   
The literature suggests that some specific models and techniques show 
superior outcomes (Mayo-Wilson et al., 2014; Siev, Huppert, & Chambless, 
2009; Tolin, 2010).  Evidence has suggested superiority of particular 
treatments, including CBT for depression (Tolin, 2010), although some 
therapeutic models may be better suited to controlled evaluations and therefore 
have an advantage in producing positive results.  For example, CBT is 
considered more structured in comparison to less explicitly directive therapies, 
such as, psychodynamic therapy, making it easier to measure and 
consequently might possibly skew the outcomes literature favourably to CBT.   
 Research has shown minimal evidence to support the utility of 
formulation as an intervention or a clinical tool in its own right.  For example, if 
formulation was not used in therapy, would this have any effect on outcomes?  
Although this was not explicitly measured in this study (i.e., no participants 
received an intervention without a formulation), it is an interesting question to 
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hold in mind when interpreting findings and attempting to disentangle non-
specific and specific factors that occur during therapy.   
 
1.9 Development of the Concept of Alliance 
The therapeutic alliance is one of the most intensely researched 
concepts in psychotherapy research (Castonguay, Constantino, & Holtforth, 
2006).  The term therapeutic alliance refers to a number of interpersonal 
processes which occur between the client and therapist (Elvins & Green, 2008) 
and is thought to act in parallel to the implementation of specific treatment 
techniques (Green, 2006).  The concept of the alliance can be traced back to 
Freud’s (1913) writings, where he acknowledged the client’s conscious 
attachment to the therapist.  The work of Rogers (1965) further developed the 
concept of alliance and operationalised the working alliance as a conscious 
process, involving the collaboration between the client and therapist (Greenson, 
1965).  Orlinsky and Howard (1975) synthesised ideas proposed from previous 
research and suggested three dimensions of alliance: working alliance 
(investment of client and therapist in the process of therapy), empathic 
resonance and mutual affirmation.    
 Bordin (1979) further developed the alliance concept and proposed that 
the alliance is achieved through collaboration and involves three key processes; 
an agreement on therapeutic goals, a consensus on tasks which are 
undertaken during therapy and the bond between the client and therapist.  
Bordin’s model of alliance offers a pan-theoretical framework which can be 
applied to different therapeutic modalities, although he argues that different 
therapies may place emphasis on different aspects of the alliance (Bordin, 
1994).  This suggests that therapists using different therapeutic models may 
wish to place more focus on particular components of the working alliance.   
There is no generally agreed definition of the alliance, although this has 
enabled clinicians and researchers from diverse theoretical backgrounds to 
utilise the concept within their specific understanding of the therapeutic process 
(Horvath et al., 2011).  However, the detriment to not having a uniform definition 
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of the alliance concept has meant that the development of research to inform 
the literature has been ambiguous and complex (Horvath et al., 2011). 
In this study the rationale for using Bordin’s conceptualisation of working 
alliance was that it fits CBT well (Andrusyna, Tang, DeRubeis, & Luborsky, 
2001).  Andrusyna et al. (2001) conducted an exploratory factor analysis of the 
working alliance (measured on the WAI) and CBT.  The analysis showed that 
the goal and task components of the working alliance are not distinct concepts 
and both covary with CBT.  For example, in CBT a client’s goal might be to 
change their negative thoughts (goal) and this might be achieved using a 
thought challenge (task).  Findings also showed that each component of the 
working alliance (bond, task and goal) fit closely with CBT (Andrusyna et al., 
2001), which supports that establishing jointly agreed goals, discussing ways to 
achieve goals and the importance of genuine therapeutic bond are fundamental 
to CBT (Beck , Rush, Shaw, & Emery, 1979).   
 
1.10 Working Alliance and Outcomes: Overview of Evidence 
 Research has shown that the alliance accounts for a greater proportion 
of the outcome than the specific model of therapy (Duncan, Miller, Wampold, & 
Hubble, 2010).  Also, evidence has shown that the alliance is especially 
predictive of therapeutic outcomes when it is established early in treatment and 
has been identified as a predictor of client dropout (Constantino & Wilson, 
2002).  This provides valuable clinical implications and suggests that therapists 
should focus on developing an alliance within the first moments of therapy and 
working through ruptures as they occur (Castonguay et al., 2006).  Although 
research has established a correlation between the working alliance and 
improved outcomes (i.e., symptom change), we do not yet have a clear 
understanding of how this occurs within therapy.  
 Researchers have made a considerable effort to investigate the 
importance of the alliance within psychotherapies.  For example, a task force 
set up in 1999 (Division of Psychotherapy’s Task Force on Empirically 
Supported Therapy Relationships) aimed to identify components of effective 
therapy relationships and to define methods of tailoring therapy to the individual 
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(Norcross, 2001; later updated Norcross, 2011).  Constantino and Wilson 
(2002) investigated which client characteristics and behaviours correlate 
positively and negatively with the alliance.  Findings showed that psychological 
mindedness and hope for change positively correlated and avoidance and 
interpersonal difficulties negatively correlated with the alliance.  Studies have 
also examined therapist’s characteristics which are conducive of a positive 
working alliance.  A review of therapist attributes and associated techniques 
identified; warmth facilitated by the therapist’s understanding, flexibility which 
occurs through exploration and confidence demonstrated by accurate 
interpretations correlated with an improved working alliance (Ackerman & 
Hilsenroth, 2003).  Studies have shown correlational evidence between some of 
the variables discussed here and an improved alliance, although clarity on how 
these processes occur and a firmer understanding of how they mediate the 
alliance is lacking.   
 
1.11 Psychological Formulation and Working Alliance 
 A challenge of measuring formulation within a naturalistic setting is the 
complexity of disentangling processes which occur during therapy.  There is 
clear overlaps in the conceptualisation of psychological formulation and the 
working alliance.  For example, formulation involves developing a collaborative 
understanding of an individual’s difficulties, which may also overlap with or 
contribute to the bond component of the working alliance (as defined by Bordin, 
1979).  Additionally, drawing out a diagrammatic formulation during a session 
may also correspond with the task component of the working alliance.  As 
discussed in Section 1.10, studies have shown therapist characteristics and 
techniques that are particularly conducive of developing an effective alliance 
(e.g., understanding, exploration, accurate interpretations), all of which 
conceptually share aspects of the formulation process.  Taking this into 
account, it may not be feasible to separate the process of formulation in practice 
from the working alliance, which creates a significant challenge when drawing 
conclusions about which variables correlate with each other.  
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1.12 Clinical Relevance and Study Rationale 
Although formulation is commonly used and a core skill that is central to 
clinical psychology training and practice, there is currently little evidence to 
support the utility of it.  Literature reviews have highlighted a distinct gap in the 
evidence-base, which has been further reiterated by the BPS and DCP 
recommending the need for further research.  Aside from formulation, the 
literature has emphasised the importance of common factors, identifying key 
ingredients that are necessary for an effective psychotherapeutic intervention.  
As part of this, research has established a correlational but not causal 
relationship between the working alliance and improved outcomes across 
psychotherapeutic models.  Currently, little is understood about whether 
formulation impacts on the working alliance within CBT and the relationship 
between formulation, working alliance and other psychosocial outcomes.   
Margison et al. (2000) advised that evidence for the effectiveness of 
therapeutic interventions, including formulation, should be developed from 
practice-based evidence along with evidence-based practice.  Therefore 
measuring formulation within clinical practice draws on the scientist-practitioner 
model and is most generalisable to clinical practice.  In the current economic 
context of the NHS, there is increasing pressure for clinical psychologists, along 
with other healthcare professionals to ‘prove their worth’ (i.e., demonstrate what 
is practiced is also efficacious).  Furthermore, the drive to deliver empirically 
supported treatments may shape how funding is provided in healthcare; as 
funding may go to therapies that have been able to demonstrate an evidence-
base (Winter, 2006).  Using methodologies such as single-case designs, allows 
researchers or clinicians to investigate complex processes (such as those that 
occur in psychotherapy) in a scientific and systematic way.   
 
1.13 Research Aims and Questions: Defining Impact 
The primary aim of this study was to examine whether formulation impacts 
on working alliance.  Impact will be defined as the interaction of one variable 
(formulation; process and product) with another variable (working alliance).  To 
measure impact, the researcher will focus on changes in the working alliance 
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(i.e., improve, decline or remain stable) at points when formulations are 
delivered during the intervention (i.e., when the product formulations are 
delivered or there is an increased frequency of process formulations).  
 
2.  Extended Method 
2.1  Epistemology 
 This study was designed, conducted and findings were interpreted from a 
critical realist position.  Critical realism is a philosophical stance established in 
response to the debate between positivism/empiricism and 
interpretivist/relativism (Houston, 2001).  Whilst a critical realist accepts that 
there is a reality to be tested, they remain critical of the reality observed, with 
the aim of developing a deeper understanding of the phenomena (McEvoy & 
Richards, 2006).  Critical realists move away from purist positivist assumptions, 
which are said to rely on observations of facts (Bechtel, 2009), independent 
from the researcher’s frame of reference (Pring, 2000).    
Critical realism lends itself to using multiple methods and triangulation, 
recognising the strengths of both quantitative and qualitative approaches to 
obtain reliable results and investigate complex concepts (McEvoy & Richards, 
2006).  Although some researchers have argued that quantitative and 
qualitative research approaches cannot be appropriately combined, due to 
differing assumptions about reality (Teddlie & Tashakkori, 2003), critical realism 
opposes this.  Critical realism allows for quantitative and qualitative approaches 
to be combined to explore individual experiences, whilst using formal measures 
of underlying processes (Liscomb, 2011).  Critical realism is well suited for case 
study research as it enables the researcher to study any phenomena, with the 
aim of understanding the processes and mechanisms in psychological 
interventions.  
Given the complexity and challenges of researching formulation, 
adopting the position of critical realism seems appropriate, as it allows the 
researcher to maintain a critical stance and investigate the research aims using 
a multi-dimensional approach.  Using a mixed methods approach will develop a 
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more comprehensive understanding of the processes that occur when 
delivering formulation during therapy (Rogers & Nicolaas, 1998). 
 
2.2 Rationale for Study Design and Critique of Single Case Design 
Approach 
The BPS (2011) outline a number of conceptual and methodological 
challenges which must be carefully considered and planned for when 
researching formulation.  Some of these include, defining formulation (i.e., 
‘process vs event’) and also separating the effects of the formulation from other 
variables occurring during therapy.  Margison et al. (2000) advised that 
evidence for the effectiveness of therapeutic interventions, including 
formulation, should be developed from practice-based evidence along with 
evidence-based practice.   
Taking these challenges into account, single case designs (SCDs) are 
particularly helpful when answering research questions about mechanisms of 
therapeutic change and the effectiveness of interventions.  These designs can 
provide rich data and enable the discipline to translate empirical approaches 
into naturalistic clinical settings (Nash, Borckardt, Abbasa & Gray, 2011).  The 
American Psychological Association’s (APA’s) Division 12 Task Force on 
Promotion and Dissemination of Psychological Procedures (DIV 12) outline that 
single case designs allow for systematic manipulation of independent variables 
(IVs) which can fairly test effectiveness of psychological interventions.  Despite 
the appealing characteristics of SCDs, their popularity has diminished due to 
the increased use of group methodologies in the last 50 years (Borckardt et al., 
2008).  Randomised Controlled Trials (RCTs) and large N experimental studies 
have increased in status, particularly in large organisations such as the NHS, 
which are aiming to deliver the most effective.  Nevertheless, SCDs capability to 
track individual outcome measures across multiple time points means that it is 
particularly suited for addressing the aims of this study. 
The A-B SCD used in this study shares similarities with Single Case 
Experimental Designs (SCEDs), as it involves systematic and repeated 
measurement of Dependant Variables (DVs; working alliance, depression, 
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wellbeing) and the Independent Variables (IVs; formulation (product and 
process) and CBT) are manipulated by the researcher.  Typically causal 
relationships are investigated using an A-B-A design, which involves a non-
treatment phase (baseline) (A), followed by an intervention phase (B) followed 
by another non-treatment phase where the intervention is withdrawn (A).  
Applying an A-B-A design to psychotherapeutic treatments can be difficult as 
treatment effects cannot be “unlearnt” and it is therefore not possible to return to 
the non-treatment baseline phase.  Additionally, such designs have ethical 
limitations as withdrawing an efficacious treatment could be deemed unethical 
(Rassafiani & Sahaf, 2010).  
 The multiple-baseline A-B design allows the researcher to investigate a 
causal relationship between variables, without removing the treatment 
(Rassafiani & Sahaf, 2010). A multiple-baseline design involves the introduction 
of the intervention phase (B) at different time points, across participants creating 
a staggered baseline (e.g., delivering the product formulation at different time 
points across participants).  This enables the researcher to make stronger 
conclusions about treatment effectiveness, particularly if the same change is 
observed across multiple subjects.  A limitation of the A-B-A design, a major 
drawback of multiple baseline A-B designs is that it excludes participants from 
receiving the intervention, for different lengths of time (Barger-Anderson, 
Domaracki, Kearny-Vakulick, & Kubina, 2004).  As this study uses a clinical 
sample from an NHS setting, implementing a multiple-baseline presents 
significant ethical challenges and was therefore deemed unsuitable.  Also, this 
study is primarily focussed on investigating the impact of formulation on working 
alliance and is therefore less interested in overall treatment effectiveness (i.e., 
effectiveness of CBT).     
 The repeated single case AB design used in this study was considered to 
be the most ethically sound and appropriate design to answer the research 
questions.  In view of the methodological and conceptual challenges of 
researching formulation, using a repeated single case, naturalistic design has 
enabled the researcher to use a scientific methodology within clinical practice, 
increasing clinical relevance.    
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2.3 Justification for sample size 
 Consistent with the study design, a total number of five participants was 
deemed to be sufficient.  The sample size was informed by guidance published 
by the What Works Clearinghouse (Kratochwill et al., 2010), which recommends 
a minimum of three replications for SCDs (at least three cases) to achieve 
sufficient data.  Due to the small number of participants in SCDs, replication 
with the same subject and across multiple subjects improves external validity of 
the study (Morgan & Morgan, 2008).  A sample size of five was considered 
reasonable within the time frame of the study and would also allow for 
replication of any effects measured.  Initially recruiting seven participants 
allowed for attrition, which was considered likely given the complexity of the 
client group and the intensive nature of the study (eight week intervention and 
completion of weekly measures). 
2.4 Participants 
 All participants who took part in the study reported symptoms of low mood 
and depression, although depression was not any participant’s primary 
diagnosis.  See Table 10 for participant’s primary diagnoses.   
 
Table 10 
Participant’s primary diagnoses 
Participant Number Pseudonym   Primary Diagnosis 
1 Luke First Episode Psychosis 
2 Louise Borderline Personality Disorder 
3 Julie Bipolar Disorder 
4 Heather Paranoid Schizophrenia 
5 Amy Borderline Personality Disorder 
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2.5 Inclusion Criteria 
To ensure participant’s suitability for the study, eligibility was assessed using 
inclusion and exclusion criteria.  Criteria and the rationale are outlined in Table 
11.  
 
Table 11 
Outline and Rationale for Inclusion Criteria 
Inclusion Criteria Rationale 
Accessing the CMHT Met the standard service protocol. 
Between the ages of 18 and 65 Part of the standard service protocol. 
Present with symptoms of 
depression. 
To ensure that an evidence-based 
treatment (CBT) was provided.  
Be able to give informed consent. To ensure participant has the 
capacity to decide on their 
involvement. 
Be able to understand and speak 
English. 
To be able to engage with CBT 
delivered in English.  
As the study is measuring working 
alliance, using an interpreter was not 
deemed appropriate due to the 
addition of a confounding variable. 
 
2.6 Overview, Rationale and Critique of Measures 
 An overview and critique of each measure is provided here, outlining a 
rationale for why it was chosen for this study.   
2.6.1 Working Alliance Inventory- Short Form (WAI-SF).   
There is considerable variability in the conceptualisation and terminology 
used for the working alliance, which has resulted in numerous published 
outcome measures accessible to researchers and clinicians.  A recent meta-
analysis (Horvath et al., 2011) found that in the 201 studies reviewed, over 30 
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different alliance measures had been used.  Four “core measures” were used in 
two thirds of the studies, which included the: California Psychotherapy Alliance 
Scale (CALPAS), Helping Alliance Questionnaires (HAQ), Vanderbilt 
Psychotherapy Process Scale (VPPS) and WAI.  Measures focus on different 
components of the alliance, which ultimately creates difficulties when comparing 
results across studies.   Elvins and Green (2008) provide a diagrammatic 
illustration of the development of the working alliance concept and commonly 
used alliance measures. 
The WAI is theoretically underpinned by Bordin’s (1979) 
conceptualisation of working alliance and therefore measures three key 
components of bond, task and goal. Horvath and Greenberg (1989) developed 
the 36-item WAI scales, which include both client and therapist versions.  A 12-
item short-form of the WAI was developed by Tracey and  Kokotovic (1989), 
which examined the four highest loaded items from each of the three 
dimensions to develop the short-form measure.    The WAI-SF comprises of 12 
items rated on a 7 point scale (never = 1 to always = 7) and has demonstrated a 
high correlation with the full 36-item version (.95) (Hatcher & Gillaspy, 2006). 
(See Appendix A and B). 
Although numerous alliance measures have been developed (Muran & 
Barber, 2010) the 36-item WAI is the most commonly used measure in research 
(Smits, Luyckx, Smits, Stinckens, & Claes, 2015).  There is less published data 
on the psychometric properties of the short-form but studies so far have 
evidenced that the WAI-SF has high internal-consistency on the therapist (.91-
.96) and client measure (.91-.92).  Test-retest has not been calculated for the 
WAI-SF, however is good for the full 36 item version (.73; Martin, Garske, & 
Davis, 2000).  Also, convergent validity with other commonly used measures is 
good; CALPAS (.80) and HAQ (.74).   
 In summary, the rationale for using the WAI-SF in this study was that it 
measured aspects of the working alliance which are consistent with Bordin’s 
(1979) conceptualisation.  Also, the measure is widely used in psychotherapy 
literature and has demonstrated good reliability and validity.  Using a short-form 
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version also allows for consideration of participant fatigue, which is particularly 
important in this study given that measures are administered weekly. 
2.6.2 Patient Reported Outcomes Measurement Information 
System (PROMIS) Depression – Short Form Measure.   
The Patient Reported Outcomes Measurement Information System 
(PROMIS) is an initiative developed by the National Institute of Health (NIH), 
which was designed to improve self-reported outcome measures. Applying 
models from Item Response Theory (IRT), PROMIS uses a rigorous multi-step, 
mixed methods approach to develop a range of health-related measures, which 
include mental, physical and social health (Cella et al., 2010).  The approach to 
developing PROMIS measures involves an iterative process of literature 
searches, item pooling, the development of conceptual frameworks, qualitative 
assessment of items using focus groups, expert reviews, cognitive interviewing 
and quantitative evaluation of items (Pilkonis et al., 2011).   Figure 8 illustrates a 
flowchart outlining the PROMIS measure methodology.   
The PROMIS depression measure specifically focuses on affective and 
cognitive manifestations of depression (Schalet et al., 2016).  PROMIS have 
developed several versions of the depression measure, which include the full 
28-item measure and four short forms ranging from four to eight items 
(Versions, 4a, 6a, 8a and 8b).  The 8b short form measure (version used for 
current study – see Appendix B), specifically focuses on representing the range 
of the state (depression) and this is represented in the item bank.  This 8 item 
short form was used in the Diagnostic and Statistical Manual of Mental 
Disorders – 5 (DSM-5) field trials, where it demonstrated its feasibility as a 
robust measure (Narrow et al., 2013).  The 8 item short form has demonstrated 
a high correlation (.96) with the full 28 item depression bank (Cella et al., 2010).   
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Figure 8: Flowchart of PROMIS methodology (Taken from, Pilkonis et al., 2011) 
 
The 8-item short form shows strong convergent validity with other 
commonly used measures of depression, including, the Centre for 
Epidemiological studies depression scale (CED; .83) and the mood and anxiety 
symptom questionnaire (.72) (Cella et al., 2010).  Less research has focussed 
on the psychometric properties of the short form version, however given the 
strong correlation between the 8 and 28-item version, consideration should also 
be given to these findings.  The 28-item has shown strong convergent validity 
with the Patient Health Questionnaire - 9 (r = .84) and the Beck Depression 
Inventory –II (r = .89) (Choi, Schalet, Cook, & Cella, 2014). 
Although other widely used measures of depression have good reliability 
and validity (e.g., BDI-II, PHQ-9) these are required to be administered every 
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two weeks and were therefore not appropriate for this study (i.e., measures 
administered following weekly therapy session).  The PROMIS depression 
measure has demonstrated equally good internal consistency (α = .90;  (Vilagut 
et al., 2015) and convergent validity.  Using a short-from version also 
considered the possibility of participant fatigue, which is particularly relevant as 
measures were administered weekly during the baseline phase and after 
therapy sessions.   
 
2.6.3 Mental Health Continuum – Short Form (MHC-SF).   
 The MHC-SF measures subjective well-being across three subscales of 
emotional, psychological and social well-being (see Appendix C).  The 
conceptualisation of well-being shifts away from understanding mental health 
using a medical model and focuses on the presence or absence of positive 
functioning (Keyes, 2002).  Keyes (2005) highlights that the two-continua model 
of mental health states that wellbeing is linked with but is also different from 
mental illness.  For example, an individual who has a diagnosis of depression is 
likely to experience a reduction in social functioning and life satisfaction, but this 
is not perfectly correlated.   
The MHC-SF was developed by Keyes (2002) with the aim of developing 
a brief measure of subjective wellbeing.  The short-form measure is 14-items 
long and was developed from a number of instruments measuring wellbeing 
used in the Survery on Midlife Development in the United States (Keyes, 2002).  
The subscales of wellbeing used in the MHC-SF are defined as; 
- Emotional Wellbeing:  refers to the presence or absence of positive 
feelings about life, evidenced by the presence of positive affect and 
perceived satisfaction with life. 
- Psychological Wellbeing: refers to more personal and private criteria for 
evaluation of an individual’s functioning in life. 
- Social Wellbeing: refers to more public and social criteria in which an 
individual would evaluate their functioning in life. 
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 The measure categories scores on the MHC-SF into the following 
(Keyes, 2002); 
- Languishing: respondents are described as having an ‘incomplete mental 
health’ and report feelings of emptiness and stagnation in their life.   
- Flourishing: respondents are described as ‘flourishing’ in life and have high 
levels of wellbeing, including positive emotions and are functioning well 
psychologically and socially.   
- Moderately Mentally Healthy: respondents are considered to neither be 
languishing nor flourishing  
 
The first evaluation of the MHC-SF was conducted with four communities 
in South Africa and showed good reliability and validity (Keyes et al., 2008).  A 
further study conducted by Lamers et al. (2011) examined the psychometric 
properties of the MHC-SF in an adult Dutch sample and showed good test-
retest reliability (.68).  The MHC-SF also demonstrated good convergent validity 
with related outcome measures, including the Positive and Negative Affect 
Scale (PANAS) and Rosenberg Self-Esteem Scale (RSE) and good 
discriminant validity, showing a good fit with the two-continua model of mental 
health (Lamers et al., 2011).   
The MHC-SF was used in this study as the conceptualisation of well-
being is closely related to psychological formulation (i.e., understanding mental 
health with less focus on diagnostic labels and illness).  Keyes (2002) 
understands wellbeing and mental health as closely linked concepts, but 
highlights that both do not always occur together (e.g., if someone has a 
diagnosis of a mental illness, this does not necessarily mean they are 
dissatisfied with life).  Therefore measuring wellbeing is equally important to 
measuring symptoms of mental ill-health (e.g., symptoms of depression) as it 
reduces the risk of not capturing an individual’s experience of distress.  The 
MHC-SF is short in comparison to other measures of wellbeing and therefore 
considers participant fatigue, which is particularly relevant for this study.   
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2.6.4 Clinical Outcomes in Research Evaluation – Outcome 
Measure (CORE-OM). 
The service where participants were recruited administered the CORE- 
OM (Evans et al., 2000) as a standard at pre and post interventions (See 
Appendix D).  With consent from participants, the data from the CORE-OM was 
used for RCI and CSC analyses and pre and post intervention.   
 The CORE-OM has demonstrated good internal and test-retest reliability 
(Connell et al., 2007).  The measure also shows good convergent validity and 
correlates with associated measures such as the Clinical Interview Schedule – 
Revised (CIS-R) and subscales with the BDI-II, Beck Anxiety Inventory (BAI), 
Brief Symptom Inventory (BSI) and Symptom Checklist – 90 (SCL-90) (Connell 
et al., 2007; Evans et al., 2002). 
 
2.6.5 Cognitive Therapy Rating Scale (CTRS).   
The Cognitive Therapy Rating Scale (CTRS; Young & Beck, 1980) 
(Appendix Q) is a tool developed to evaluate therapist’s competence in 
cognitive therapy for depression (Beck et al., 1979).  The scale is an observer-
rated scale, which consists of 11 items across three subscales (general skills, 
interpersonal skills and specific cognitive therapy skills).  Each item is rated on 
a seven point Likert scale and the CTRS manual provides behavioural 
descriptors to guide ratings.  
 The CTRS has demonstrated varied inter-rater reliability for single items, 
ranging from 0.54 (feedback) to 0.87 (application of cognitive-behavioural skills; 
Vallis, Shaw, & Dobson, 1986), although this is consistent with other 
psychotherapy rating scales (Lahey, Downey, & Saal, 1983).  Although the 
CTRS is widely used in research and clinical practice, it has been critiqued for 
its lack of practical utility (Blackburn et al., 2001).  Also, the scores on the CTRS 
do not differentiate well between different levels of therapist competence 
(Blackburn et al., 2001).  The points on the scale are unclear, as only alternate 
points are defined, which results in varied degrees of interpretation from the 
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raters (Blackburn et al., 2001).  Young and Beck (1988) superseded the original 
11-item version (Young and Beck, 1980) with a 13-item version (Cognitive 
Therapy Scale – Revised, CTS-R).  However, there are very few published 
studies using the CTS-R and more published research outlining the 
psychometric properties of the original CTRS, providing a rationale for using the 
CTRS in this study. 
 To ensure treatment fidelity, the CTRS was rated and recorded by the 
researcher whilst listening to audio recordings of therapy sessions.  In addition 
to using the CTRS in supervision meetings, ratings were also seconded rated 
by the field supervisor for one full therapy session, for each participant (12% of 
sessions delivered).  The literature suggests varied percentages for second 
coding, including 15% (David, Szentagotai, Lupu, & Cosman, 2008) and 20% 
(Westra, Arkowitz, & Dozois, 2009) of the full data set.  Whilst it was important 
to ensure reliability of the data this was balanced with practicality (time 
pressures and availability of the second coder). Therefore, second coding 12% 
of the data, in addition to weekly supervision (where product and process 
formulations were discussed) was deemed sufficient. 
Table 12 illustrates the frequency and time points of when measures 
were administered.   
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Table 12 
Frequency and Time Points of Measures Administered 
 Time Point 
Measure B1 B2 B3 S1 S2 S3 S4 S5 S6 S7 S8 
PROMIS Depression            
WAI-SF Therapist            
WAI-SF Client            
MHC-SF            
CORE-OM            
CTRS            
Note. B = Baseline. S = Session.  = indicates measure was administered.  
WAI-SF = Working Alliance Inventory – Short Form.  MHC-SF = Mental Health 
Continuum – Short Form.  CORE = Clinical Outcomes in Research Evaluation – 
Outcome Measure. 
 
2.7 Rationale for Delivering ‘Product’ and ‘Process’ Formulations 
 Clearly defining formulation must be carefully considered when designing 
research studies (BPS, 2011).  The BPS (2011) comment on the variation in 
which formulations are delivered during therapy and refer to this as ‘process vs 
event’.  Practically, formulation may occur more commonly as a ‘process’, 
through a recurrent process of assessment, intervention, discussions, 
summaries and revisions between the client and therapist.  In comparison, 
formulations that are presented diagrammatically or in written form, possibly 
occur less frequently in practice and understand formulation as a tangible 
process, e.g., as a ‘product’.    
With this in mind, in this study, ‘formulations as a process’ have been 
referred to as ‘process formulations’ and ‘formulations as an event’ have been 
referred to as ‘product formulations’.  In line with the theoretical concepts of 
CBT, it was agreed during discussions within the supervisory team that a 
process formulation would consist of three components, including an 
Antecedent (A), Belief/Cognition (B) and Consequence (C), which could be 
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delivered in any sequence, for example, A-C-B or A-B-C.  An example of a 
process formulation may look like: 
Therapist: I wonder whether when your husband talks to you like that (A), you 
feel sad and avoid speaking to him (C), because you think you are not good 
enough for him (B).  
Therapist: When you are in physical pain (A), it seems that you think if I do not 
put a front on, then people will think you are an unfit mother (B) and that makes 
you feel very anxious (C).   
Process formulations were delivered verbally by the therapist throughout 
the intervention, at points when they felt it was appropriate or beneficial for the 
participant.  A product formulation was delivered twice during the intervention, 
during session three and seven.  The product formulation was drawn out 
diagrammatically using the Beck (1995) longitudinal model (Appendix F).   
 
2.8 Procedure 
2.8.1 Ethical issues and ethical approval.   
Ethical issues were considered and discussed within the research team 
prior to applying for and gaining ethical approval for the study.  Ethical approval 
was granted from the East Midlands – Nottingham 1 Research Ethics 
Committee (Appendices H - K), the Health Research Authority (Appendix M) 
and the University of Lincoln ethics committee (Appendix M).  The study 
obtained favourable opinion on 7th March 2017 and three further amendments 
were submitted and approved on 14th July 2017, 12th September 2017 and 26th 
February 2018. 
 
2.8.1.1 Informed consent.   
 Using the eligibility criteria, Community Psychiatric Nurses (CPNs) 
identified potential participants on their caseloads and after giving them an 
overview of the study they gained verbal consent from participants for the 
researcher to contact them.  The researcher then contacted potential 
participants via telephone and posted them an information sheet (Appendix O) 
and consent form and they were given one week to consider their participation 
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in the study.  After one week, the researcher telephoned participants back to 
provide them with an opportunity to ask any questions, seek clarification on 
anything they wished and ensured that the participant understood what was 
required of them during the study, i.e. audio recording sessions and completing 
weekly measures.  During the telephone call, the researcher arranged baseline 
measures and their first therapy appointment. 
 
2.8.1.2 Withdrawal from the study.  
 At their request, participants were able to withdraw from the study at any 
point, including during and within two weeks of completion of the study.  If 
participants wished for the data collected to be erased this would be done if 
requested within two weeks after the date of withdrawal.  All participants were 
made of their rights to withdraw, without penalty and this information was 
detailed on the information sheet (Appendix O) and consent form (Appendix N).  
If a participant wished to withdraw from the study but not from the therapy they 
were receiving, the participant would have been able to continue with their 
therapy with no penalty, i.e. participants would continue with treatment as usual.  
Although it was felt that the risk of participants losing capacity during their 
participation was low, guidance was outlined from the outset in the event this 
occurred.  If a participant lost capacity to consent during their participation, they 
were withdrawn from the study.  Data already collected was retained and 
adhered to confidentiality and anonymity.  
 
2.8.1.3 Confidentiality and anonymity.   
 The Confidentiality NHS Code of Practice (Department of Health, 2003) 
was followed to ensure that participant information was processed and 
managed fairly, lawfully and transparently.  Confidentiality was clearly explained 
to all participants recruited in the study, including the parameters of 
confidentiality during therapy sessions.  This included that the content of 
sessions would be discussed in supervision with the researcher’s field 
supervisor (a member of the direct care team).  Also, if a participant was to 
disclose information that raised concerns about their safety or the safety of 
others, this may be discussed with third parties if further action was required.  
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To protect participant’s identity, all participants were given an individual 
participant number and pseudonym.    
 
2.8.1.4 Data storage and security.   
 All digital recordings were transferred and saved onto an encrypted USB 
stick and erased from the audio recorder. Consent forms, which include full 
names and signatures of participants were kept in a locked filing cabinet on 
LPFT premises and then uploaded onto Silverlink (secure patient administration 
system).  All contact details for participants were also kept on Silverlink and 
clinical notes following each therapy session were uploaded onto Silverlink and 
supervision records were stored in a locked filing cabinet or destroyed in 
confidential waste.  All hard copies of the research data will be stored at the 
University of Lincoln and adhering to the university storage policy; data will be 
securely stored for seven years and then destroyed.   
If participants give consent, anonymised data will be used for future 
research studies.  However, if consent is not obtained, data will be destroyed as 
outlined above.  
 
2.8.1.5 Protection of research participants.  
 As participants received psychological therapy, it was possible they may 
have found some topics of discussion distressing.  As the researcher was the 
therapist and is also a Trainee Clinical Psychologist with substantial clinical 
experience, it was expected that they would be able to contain and manage any 
distress that occurred.  If the researcher felt that the participant required further 
support or if the participant requested it, the researcher utilised supervision from 
the field supervisor and also considered appropriate referrals or signposting to 
further support, e.g. their CPN/key worker, crisis team.     
 
2.8.1.6 Debriefing of participants.   
 At the end of therapy, all participants were debriefed by the researcher.  
Participants were provided with a debrief sheet, which gave them contact 
details for the researcher, research supervisors and other helpful organisations, 
e.g. the Samaritans.  Participants were also given the opportunity to ask any 
Page 145 of 261 
 
questions and were also offered the option to have a summary of the results 
from the study to be sent to them in the post. 
   
2.8.1.7 Risk for researcher.   
 As the researcher was also the therapist, they received weekly 
supervision from the field supervisor.  This ensured that the researcher had time 
to reflect on anything they wished and to also raise any concerns that they 
needed support with.  In addition to providing support to the researcher, 
supervision ensured that the researcher delivered safe and effective practice to 
each participant.  The researcher was also required to see one participant in 
their home (a standard service offered by the CMHT).  The researcher ensured 
that she adhered to the Lincolnshire Partnership Foundation Trust lone working 
policy.   
 
2.9  Recruitment Challenges 
The researcher faced several challenges recruiting to the study, which 
required a substantial amendment to REC and a further research site was 
added.  Initially the researcher intended to recruit from the adult psychology and 
psychotherapy service, although there were very few clients on the waiting list 
who had been recommended CBT following their initial assessment.  Most 
service users on the waiting list had been recommended more lengthy (16 
weeks) and alternative interventions, such as, CAT.  With this in mind, it was 
agreed that the CMHTs may have more suitable service users for the study and 
an amendment was submitted to the relevant ethics committees.  The 
researcher met with the CMHTs and service managers on several occasions to 
discuss the study and attended a couple of team meetings.  Another CMHT was 
added as an additional research site in order to recruit a sufficient number of 
participants.   
 
2.10  Baseline Phase: Stability and Number of Data Points  
 Until relatively recently, there were no published standards for single-
case research, although several professional groups and task forces have since 
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proposed guidelines. The What Works Clearinghouse (WWC; Kratochwill et al., 
2010) present the most detailed guidelines and standards. 
 The minimum number of data points in the baseline phase remains a 
disputed area of single-case research (Center, Skiba, & Casey, 1986; Huitema, 
1985; Sharpley, 1987).  In intervention research, researchers have suggested a 
typical baseline phase to range from 3 to 12 data points (Center et al., 1986; 
Sharpley, 1987).  A review of 881 experiments suggested a modal number of 
three to four baseline data points (Huitema, 1985).  However, longer baseline 
periods have been suggested to increase the validity of observations and 
reduce bias (Huitema & McKean, 1994).  In conclusion, the WWC, DIV12 and 
DIV16 agree that a minimum number of three data points during the baseline 
phase is required.  The literature also suggests the baseline must be relatively 
stable, free of significant trend and have marginal overlap with data in 
subsequent phases (Franklin, Allison, & Gorman, 1997).  Visual analysis is 
most commonly used to assess the stability of the baseline (Smith, 2012).   
As the current study uses a naturalistic design, waiting to achieve a 
stable baseline prior to introducing the intervention (IV) presented ethical 
challenges.  As participants were recruited from the NHS it would have been 
unethical to wait until participant’s baseline data stabilised (measure of 
depression), which would have required the researcher to delay access to the 
psychological intervention.  Also, this study primarily focuses on the impact of 
formulation on working alliance and the relationship between formulation and 
psychosocial outcomes and is less interested in the impact of the CBT 
intervention on outcomes.  To allow for a more accurate examination of whether 
working alliance and formulation impacted on depression, baseline data 
measuring depression was collected to determine the level and trend prior to 
intervention.  With this in mind, based on the literature discussed and 
considering ethical implications, the current study used three data points and all 
participants started the intervention after this time period, whether their baseline 
data was stable or not. 
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2.11 CBT Intervention 
 The CBT intervention was informed by Beck et al. (1979) and primarily 
focussed on participant’s experiences of low mood.  In addition to the 
assessment and formulation, cognitive (e.g., cognitive restructuring) and 
behavioural (e.g., behavioural activation) techniques were used with the aim to 
improve participant’s mood.  National Institute of Health and Care Excellence 
(2009) recommend 16-20 sessions of a high intensity psychological therapy, 
such as CBT for adults with moderate to severe depression, which means that 
the intervention delivered in this study was outside of NICE guidance.  
However, this study was undertaken as part of a doctoral thesis and therefore 
time constraints limited the researcher’s capacity to deliver a longer 
intervention.   
 
2.12  Managing Dual Role as Researcher and Therapist 
 As already mentioned in the journal article, the researcher had a dual 
role in the study and she was also the therapist.  There were several reasons 
for this and procedures were implemented to ensure the dual role was managed 
carefully.   
 Research has shown that formulation has poor inter-reliability (Flinn et 
al., 2015), therefore having one therapist, with a dual role of both researcher 
and therapist aimed to improve reliability of formulations delivered across 
participants.  Also, it was expected that recruiting therapists from the CMHT 
service to undertake the research would have resulted in recruitment difficulties 
due to high workloads and a lack of resources within the service.  It was 
therefore felt that the researcher conducting the therapy would be most 
appropriate.   
However, the literature highlights the importance of considering 
researcher allegiance, referred to as the researcher’s “belief in the superiority of 
a treatment…the superior validity of the theory of change that it associated with 
the treatment” (Leykin & DeRubeis, 2009, pp. 55).  Researcher allegiance is an 
important factor to consider in this study and although the researcher took 
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significant steps to reducing the threat this may have had to the reliability and 
validity of the study, it is impossible to eliminate this entirely.  Although studies 
that use a naturalistic methodology may be more prone to researcher 
allegiance, empirical evidence shows that methodologies such as gold standard 
RCTs are not entirely immune from bias (Kaptchuk, 2001).  Furthermore, it has 
been highlighted that researcher allegiance may be an accurate reflection of 
true differences that occur during psychotherapy interventions, which are 
gained through intensive researcher and clinical involvement (Munder, Brütsch, 
Leonhart, Gerger, & Barth, 2013) Although this hypothesis might make 
theoretical sense, there is little empirical evidence to support it, therefore 
researcher allegiance and how it is managed must be considered, particularly in 
psychotherapeutic research (Munder, Gerger, Trelle, & Barth, 2011). 
 The researcher received 90 minutes of weekly supervision, which 
involved listening to audio recordings of therapy sessions and using the CTRS 
to ensure fidelity to the CBT model.  The researcher also kept reflective 
supervision notes following therapy sessions and did not look at participant 
ratings on outcome measures until the study had ended.   
 
2.13 Second Coding Process Formulations 
The frequency of process formulations were coded for each session and 
each participant by the researcher.  In addition to listening to audio recordings 
during supervision, one full session for each participant was coded by a second 
rater (supervisor).  Sessions were randomly selected using an online number 
generator.  Once second coded, any discrepancies were discussed and if 
required sections of audio recordings were listened back to, so that a decision 
could be made as to whether criteria had been met for a process formulation to 
be coded. 
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2.14 Extended Analysis 
Additional detail of the analyses used have been provided here.  Also, 
the rationale for not undertaking further analyses of the effects of the 
intervention (CBT) are also outlined. 
 
2.14.1 Visual Analysis.  
Visual analysis is the hallmark method of interpreting intervention effects 
in SCDs (Lane & Gast, 2014; Smith, 2012) and is considered to be a reliable 
method (Baer, 1977).  There have been several attempts to clearly define how 
visual analysis should be conducted (Smith, 2012) and researchers are advised 
to assess trend, level, variability, patterns of data points across phases 
(Kratochwill et al., 2010).  Visual analysis has been criticised for being highly 
subjective and susceptible to individual interpretation and consequently error 
(Furlong & Wampold, 1982).  When intervention effects are subtle, this reduces 
the reliability of visual analysis as there is often disagreement between judges 
(Lenz, 2013).     
Visual inspection can be improved by using trendlines, which can show 
moment-to-moment changes of DVs alongside the IVs (Morgan & Morgan, 
2008).  Also, a trendline of the baseline phase can be superimposed over the 
intervention phase, to evaluate how the intervention data points deviate from 
this line.  Other common analyses used in SCDs include the percentage of non-
overlapping data statistic (PND), dual-criteria (DC) analyses and statistical 
process charts. 
In this study, visual analysis was the main method used on graphical 
displays, focusing on trend, variability and patterns of data points at significant 
points in the intervention.  No further analyses were undertaken to analyse the 
effect size of the intervention (CBT) as this was not an aim of the study.  
Although undertaking further analyses (such as, PND or DC analyses) may 
have calculated the effect size of the intervention, this extends to a different 
research aim (i.e. examining the effectiveness of CBT) and was therefore not 
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deemed appropriate.  Trend lines were used to aid the visual analysis rather 
than examining the number of data points that fell above or below the trend line.   
 
2.14.2 Simulation Modelling Analysis (SMA). 
To strengthen the visual analysis, SMA was undertaken to examine the 
relationships across variables (Borckardt et al., 2008).  SMA is a bootstrapping 
method which is used to analyse the correlation between two variables, 
adjusting for autocorrelation and reducing the risk of making Type I errors (the 
incorrect rejection of a null hypothesis).  A series of observations (e.g., ratings 
of working alliance) is thought to be autocorrelated if the value of one 
observation depends on the value of the immediately preceding observations 
(e.g., frequency of process formulations) (Nash et al., 2011).  That is, SMA 
examines non-concurrent or lagged relationships between variables across the 
course of therapy (i.e, does change in one variable (frequency of process 
formulations) precede change in another variable (working alliance)) from lag -1 
to lag +1.  A positive lag suggests change in variable one (e.g., frequency of 
process formulations) precedes change in variable two (e.g. working alliance 
ratings), whereas a negative lag suggests change in variable two (e.g., working 
alliance ratings) precedes change in variable one (frequency of process 
formulations).  Results are reported as an R statistic which can be understood 
as a correlation, although it specifies temporal precedence (Borckardt et al., 
2008).   
In this study, SMA examined temporal relationships between the following pairs 
of variables, over the course of the intervention: 
- Frequency of process formulations and working alliance (participant and 
therapist). 
- Participant working alliance and therapist working alliance. 
- Frequency of process formulations and depression. 
- Frequency of process formulations well-being.  
- Participant working alliance and depression. 
- Participant working alliance wellbeing.   
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2.14.3 Determining Reliable and Significant Change.   
Measurement is not always reliable and the difference between two 
scores, e.g. pre and post scores, could be due to measurement error (Morley, 
2018).  Jacobson and Truax (1991) suggest two methods to evaluate change in 
psychological treatments, in order to answer the following: 1) is the change 
reliable (Reliable Change Index; RCI) and 2) is the change clinically significant 
(Clinically Significant Change; CSC).  RCI and CSC criteria were used when 
assessing outcomes at important points of the intervention (e.g., when the 
product formulation was delivered).  If a measure had pre-established values for 
determining RC and CSC, these were used.  For measures that did not, the 
following calculations were used.   
 
2.14.3.1 Reliable Change Index (RCI).   
Jacobson used classical test theory to determine confidence intervals 
around the pre-treatment score, which is referred to as the Reliable Change 
Index (RCI).  The value of +1.96 was set to compare the RCI value, which is 
equivalent to the 95% confidence interval around the pre-treatment score.   
 
To calculate the RCI value, the individual’s pre-treatment score is 
subtracted from the post-treatment score and then divided by the standard error 
of the difference (SEdiff).  The SEdiff is calculated using the Standard Error of 
Measurement of the test used.  These calculations are outlined below: 
RCI = (pre-treatment score – post-treatment score) 
           SEdiff  
Figure 9.   RCI Calculation  
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To calculate the SEdiff, the Standard Error of Measurement (SEM) is required for 
the following calculation (Figure 10). 
 
SEdiff =  
Figure 10: Standard Error of the Difference Calculation  
 
The SEM is calculated by multiplying the Standard Deviation (SD) by the 
square root of 1 minus the coefficient reliability (r) (Figure 11).  The coefficient 
reliability used in this study was the Internal Consistency (IC).  The rationale for 
choosing the IC is that firstly, it is nearest to the conceptual basis for reliability 
and secondly, the SEM is smaller than the test-retest reliability and will 
therefore give a tighter estimate of the RCI (Morley, 2018).   
 
SEM = SD  
Figure 11: Standard Error of Measurement Calculation  
 
Once the RCI value has been calculated, one can determine whether the 
difference between the pre and post scores is reliable or not.  If the value of the 
RCI exceeded 1.96, the change measured was deemed ‘reliable change’ at 
95% confidence and is not due to measurement error.   
  
2.14.3.2 Clinically Significant Change (CSC). 
 To determine whether RC is clinically significant, Jacobson and Truax 
(1991) proposed three statistically derived criteria; criterion a, b and c, outlined 
in Table 13 and cut-off points illustrated in Figure 12. 
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Table 13. 
Definition of Criterion 
Criterion Definition When to Use 
Criterion a Participant’s post-
treatment score falls 
more than two standard 
deviations from the 
mean of the clinical 
group, in the direction of 
the non-clinical group. 
If normative data for a 
non-clinical population is 
not available. 
Criterion b Participant’s post-
treatment score falls 
within two standard 
deviations of the mean 
of the non-clinical group. 
If the normative data for 
a non-clinical and 
clinical populations are 
available and the scores 
from both populations 
do not overlap. 
Criterion c Participant’s post-
treatment score falls 
closer to the mean of 
the non-clinical group 
than the clinical group. 
If the normative data for 
a non-clinical and 
clinical populations are 
available and the scores 
from both populations 
overlap.   
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Figure 12.  Illustration of the three cut points for criterion a, b and c (Jacobson & 
Truax, 1991). 
 
3. Extended Results 
The journal paper provides an overview of the key findings of this study 
and additional information is provided here; such as, supplementary participant 
demographics, T-score transformation, rationale for the norms used for the RCI 
and CSC calculations.  Also sections of the extended results provide additional 
data and show calculations/workings out, therefore there are occasions where 
the extended results does not follow the narrative of the journal paper.   The 
extended results have not been presented according to the research questions, 
however, where relevant this is highlighted for the reader.   
 
3.1 Participant Demographics 
 
 Table 14 presents demographic information for the five participants who 
completed the study.  Ages ranged from 35 to 60 (mean age 44.8 years), one 
participant was employed, one retired and three were unemployed.  
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Table 14 
Participant demographics 
Participant 
Number 
Pseudonym Age Marital Status Occupation 
1 Luke 38 Divorced Employed 
2 Louise 35 Married Unemployed 
3 Julie 60 Married Retired 
4 Heather 52 Married Unemployed 
5 Amy 39 Separated Unemployed 
 
3.2 Participants Who Did Not Complete 
Two additional participants begun the study, although withdrew after 
session two.  For the purpose of discussion here, they will be referred to as P6 
and P7.  During the first two sessions with P6, it was apparent that she was 
very unwell and concerns were raised with regards to risk to herself and others.  
It was agreed with her care team that P6 would be withdrawn from the study as 
it was unclear whether she had the capacity to consent for the study.  P7 also 
withdrew after two sessions, as she was offered a different psychological 
intervention that was more appropriate to her treatment needs.  It was agreed 
with P7 that it would not be feasible or beneficial for her to undertake two pieces 
of psychological therapy in parallel, therefore she decided to withdraw from the 
study.  Due to the small amount of data collected, which had mainly focussed 
on the assessment, it was agreed amongst the supervisory team to not report 
the data in either the journal or extended paper.  As seven participants were 
recruited for the study, this allowed for the attrition and meant that the 
recommendation for a minimum of three replications took place (Kratochwill et 
al., 2010). 
 
 
 
Page 156 of 261 
 
3.3 PROMIS Depression T-Score Transformation  
 This study has followed guidance from the PROMIS depression scoring 
manual which advises users to translate raw scores into a T-score for each 
participant.  The T-score rescales the raw score into a standardised score, with 
a mean of 50 and a SD of 10 (i.e., a participant with a T-score of 60 is one SD 
above the mean).     
 
3.4 Means, Standard Deviations and Totals of Measures and Process 
Formulations 
Table 15 outlines the means and standard deviations for each 
participant, on each measure and the total and mean frequency of process 
formulations delivered with each participant. 
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Table 15 
Means, Standard Deviations and Totals for all Measures and Frequency of Process Formulations 
 
 
 
 
 
 
 
 
 
Note. M = Mean. SD = Standard Deviation. * P2 had 9 sessions. ** Missing data point.  PROMIS Depression – higher scores 
indicate higher levels of depression.  Working Alliance Inventory – higher scores indicate a stronger working alliance. Mental 
Health Continuum – higher scores indicate  
 
 
Participant PROMIS 
Depression 
Baseline 
M (SD) 
PROMIS 
Depression 
Intervention 
M (SD) 
Working 
Alliance 
Inventory  
Participant 
M (SD) 
Working 
Alliance 
Inventory 
Therapist 
M (SD) 
Mental 
Health 
Continuum  
M (SD) 
Process 
Formulation 
Frequency  
Total (M)  
P1 64.47 (2.07) 64.75 (4.09) 80.5 (3.24) 62.13 (7.08) 1.23 (.58) 45 (5.63) 
P2 67.77 (3.45) 60.46 (4.51) 60.44 (4.55) 59.22 (10.13) 1.40 (.59) 29 (3.22)* 
P3 72.57 (2.35) 71.63 (2.55) 78.5 (2.5) 57.38 (6.12) 1.22 (.27) 21 (2.63) 
P4 65.77 (2.97) 61.91 (4.23) 53.75 (5.61) 52.75 (6.98) 1.46 (.46) 29 (3.63) 
P5 76.77 (.27) 78.33 (2.46) 80.86 (4.19)** 51.38 (6.48) 0.42 (.22) 32 (4) 
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3.5 Simulation Modelling Analysis (SMA) for Research Question One 
SMA was undertaken to analyse the temporal relationship, between 
participant and therapist working alliance ratings and the frequency of process 
formulations.  Table 16 provides correlational data, reporting whether the 
correlation is statistically significant, the direction of the association (+ or -) and 
at what lag the association occurred..   
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Table 16.  
SMA Correlation Coefficients for Frequency of Process Formulations and 
Working Alliance 
 Note. * = p<.05.  + or – indicates direction of correlation (positive or negative). 
 
 
 
Participant Lag Process Formulations and 
Participant Alliance 
Lag Process Formulations and 
Therapist Alliance 
1 +1 r = -.13 +1 r = -.44 
0 r = -.48 0 r = -.24 
-1 r = -.58 -1 r = -.34 
2 +1 r = +.29 +1 r = -.12 
0 r = -.04 0 r = -.02 
-1 r = -.51 -1 r = -.42 
3 +1 r = -.40 +1 r = -.41 
0 r = -.21 0 r = -.04 
-1 r = +.77* -1 r = -.35 
4 +1 r =+.26 +1 r = +.34 
0 r =+.46 0 r = +.02 
-1 r = -.24 -1 r = -.18 
5 +1 r = -.02 +1 r = +.44 
0 r = +.13 0 r = +.56 
-1 r = +.79* -1 r = +.44 
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3.6 Simulation Modelling Analysis (SMA) for Research Question Two 
SMA was also undertaken to analyse the temporal relationship, between 
the frequency of process formulations, participant reported working alliance, 
depression and wellbeing (measured on the MHC-SF).  Table 17 provides 
correlational data for the frequency of process formulations, wellbeing and 
depression, reporting the direction of association (+ or -), whether the 
correlation is statistically significant and at what lag the association occurred. 
 
Table 17. 
SMA Correlation Coefficients for Frequency of Process Formulations, Wellbeing 
and Depression 
Note. * = p<.05.  + or – indicates direction of correlation (positive or negative). 
 
 
Participant Lag Process Formulations and 
Wellbeing 
Lag Process Formulations and 
Depression  
1 +1 r = -.15 +1 r = +.81* 
0 r = -.32 0 r = +.18 
-1 r = -.27 -1 r = -.13  
2 +1 r = -.67* +1 r = -.07 
0 r = -.15 0 r = +.27 
-1 r = -.18 -1 r = +.19 
3 +1 r = -.10 +1 r = +.26 
0 r = -.16 0 r = +.36 
-1 r = +.13 -1 r = +.47 
4 +1 r = +.54 +1 r = -.15 
0 r = -.47 0 r = +.31 
-1 r = +.19 -1 r = +.17 
5 +1 r = -.41 +1 r = +.15 
0 r = -.12 0 r = +.41 
-1 r = -.76* -1 r = +.38 
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Table 18 provides correlational data between participants’ reported working 
alliance and wellbeing, outlining the direction of association (+ or -), whether the 
correlation is statistically significant and at what lag the association occurred.   
 
Table 18. 
SMA Correlation Coefficients for Working Alliance and Wellbeing 
Participant Lag Participant Alliance and 
Wellbeing 
1 +1 r = +.35 
 0 r = -.06 
 -1 r = -.48 
2 +1 r = +.20 
 0 r = +.34 
 -1 r = -.06 
3 +1 r = -.33 
 0 r = -.02 
 -1 r = -.62* 
4 +1 r = +.94* 
 0 r = +.16 
 -1 r = +.25 
5 +1 r = +.01 
 0 r = -.73* 
 -1 r = -.06 
Note. * = p<.05.  + or – indicates direction of correlation (positive or negative). 
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3.7 RCI and CSC Calculations.   
 As outlined in the extended method, the RCI value was calculated to 
measure RC on the PROMIS depression, MHC and CORE measures at key 
points of the intervention (i.e., when the first and second product formulations 
were delivered and at post-intervention).  Table 19 provides clinical and non-
clinical normative data used for RCI calculations.   
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Table 19. 
Comparison Data for Outcome Measures  
Measure Sample Population N Mean (SD) 
PROMIS Depression Clinical (Vilagut et al., 2015) Spanish adults experiencing a Major 
Depressive Episode in the community 
and inpatient settings. 
65 54.3 (not 
reported) 
 Non-Clinical (Liu et al., 2010) Adults from the USA general population, 
in the 2000 general USA census.  
5239 50 (10) 
MHC-SF Clinical (Fledderus, Oude Voshaar, 
ten Klooster, & Bohlmeijer, 2012) 
Dutch adults experiencing mild to 
moderate symptoms of depression and 
anxiety, living in the community.   
362 2.13* (.76) 
 Non-Clinical (Corey L. M. Keyes et 
al., 2012) 
Adult college/university students from 
across the USA. 
5689 3.39 (.76) 
CORE-OM Clinical (Connell et al., 2007) Adults from primary care counselling, 
clinical psychology and psychotherapy 
services in secondary care and generic 
outpatient and community mental health 
services. 
10,761 18.3 (7.1) 
 Non-Clinical (Connell et al., 2007) General UK population. 535 4.8 (4.3) 
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 Note. * Due to inconsistency in scoring (items scored 0-6 rather than 0-5), the mean has been adjusted accordingly to 
enable consistent comparisons (original reported mean = 3.13).  N = number. SD = standard deviation 
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3.7.1 PROMIS Depression.   
The PROMIS depression measure is a standardised measure and 
outlines a mean score of 50 and SD of 10, which was used to calculate the RCI 
and CSC (Liu et al., 2010).  Informed by Jacobson’s method, Revicki and 
colleagues (2008) propose that if the participant’s score moves more than 2 
SDs away from the mean, clinical significance has been achieved (Criterion a).   
3.7.2 MHC-SF. 
Clinical normative data outlined in Table 17 was used to calculate the 
RCI.  Change was deemed CSC if the participant’s score was greater than the 
RCI value (outlined in Table 18) and moved category (e.g., languishing to 
moderately mentally healthy).   
3.7.3 CORE-OM.   
The CORE-OM has published standardised RCI and CSC values, which 
were used in this study.  If a participant’s score moves by + or – 5 points, this 
indicates reliable change.  If a participant’s score is < 10, this indicates CSC 
(Connell et al., 2007).   
Table 20 provides RCI values, indicating whether RC was achieved by 
exceeding the value of 1.96.  For example, if the RCI value (calculated using 
the formulae in Extended Method) exceeded 1.96, one can be 95% confident 
that reliable change has occurred.  
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Table 20. 
RCI Values Used to Determine Reliable Change 
Participant Measure Product 
Formulation 
Session 3 
Product 
Formulation 
Session 7/8* 
Post 
Session 
8/9* 
1 PROMIS Depression -0.22 0.65 2.26R 
 MHC -0.26 -2.37R -2.14 R 
 CORE - - - 
2 PROMIS Depression 0.45 2.48 R 2.08R 
 MHC 0.95 -3.52 R -5.16R 
 CORE - - - 
3 PROMIS Depression -1.23 -0.47 0 
 MHC 0 0.23 -0.49 
 CORE - - - 
4 PROMIS Depression 2.28R 1.07 2.71R 
 MHC 0.69 -1.41 -1.41 
 CORE - -  
5 PROMIS Depression -0.69 -0.69 -1.41 
 MHC 0.69 1.41 1.18 
 CORE - - - 
Note. * P2, product formulations delivered in session 3 and 8 and duration of 
intervention was 9 sessions.  R = indicates reliable change SEM calculated 
using clinical normative data (See Table 17).  PROMIS Depression SEM = 3.16. 
MHC SEM = 0.21. CORE SEM = 2.13. CORE uses standardised value of + or – 
5 points to indicate reliable change. 
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3.8 Overall Synthesis of Results 
The results showed inconsistency across participants which meant that 
that little evidence was found to show that psychological formulation directly 
impacts working alliance.  Visual analysis of data presented in graphs (Figure 4) 
showed slight peaks in working alliance (reported by the therapist) at the point 
the second product formulation was delivered for thee participants (P1, P2 and 
P4), although this was not consistent with participant measures.  Visual analysis 
showed a peak in participant’s measure of working alliance for two participants 
(P3 and P5) at the point the first product formulation was delivered, although 
this was not repeated with other participants.  SMA showed just two statistically 
significant correlations between participant reported working alliance and the 
frequency of process formulations at a lag of -1 (P3 and P5).  This suggests that 
an improvement in participant working alliance rating preceded an increased 
frequency of process formulations delivered in the following session.  However, 
this finding did not meet the minimum number of replications and therefore 
cannot be generalised.  In the change interviews, all participants commented on 
the therapist’s characteristic and approach which they identified as helpful and 
could be linked with the working alliance.  However, although all participants 
spoke about the formulation process and working alliance separately, they did 
not make a connection between the two variables.   
 The results also showed inconsistent and therefore limited evidence to 
suggest a relationship between psychological formulation, working alliance and 
psychosocial outcomes.  Visual analyses examining formulation, working 
alliance and depression (Figures 2 and 3) showed a minimal trend between the 
two variables.  SMA found several statistically significant lagged correlations 
between variables, however none met minimum replication criteria, therefore 
limited conclusions could be made.  SMA reported a statistically significant 
correlation with two participants (P2 and P4), showing an increase in participant 
reported working alliance preceded an improvement in depression in the 
following session.  RCI and CSC analyses showed one participant’s (P4) 
depression reliably improved when the first product formulation was delivered 
and another participant’s (P2) depression reliably improved at the second 
product formulation.  Two participant’s (P1 and P2) wellbeing scores reliably 
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improve and met criteria for clinical significant when the second product 
formulation was delivered.  In the change interviews the majority of participants 
reported improvements in their cognitions, behaviour and/or mood, although 
they did not make links between changes and the formulation or working 
alliance.   
 
3.9 Summary of Results for each Participant 
To capture the idiosyncrasies of each participant, the following section 
provides a narrative of the findings for each participant, making reference to 
analysis of the measures conducted and responses on the change interview 
(refer to journal paper for tabulated/graphed results).  Using supervision notes 
and the therapist’s reflective log, additional information about the participant’s 
journey through therapy is provided, commenting on general observations of 
their engagement during therapy and also any external factors outside of 
therapy that may provide evidence for and against change.  
 
3.9.1 Participant 1: Luke.   
Visual analysis showed a generally increasing trend in alliance over the 
course of the intervention.  In comparison to other participants, Luke received 
the highest number of process formulations by a large margin (n = 45) and he 
also reported the second highest average working alliance score (M = 80.5), 
although no significant correlations (including lagged correlations) were found 
between process formulations and alliance.   
 Luke’s data showed a slightly improving trend in depression during 
baseline and an improving trend from session 4 during the intervention.  Results 
showed that Luke improved across all secondary outcome measures at post 
intervention. His scores on the depression measure and CORE-OM reliably 
improved at the end of his final therapy session and scores on the MHC-SF 
reliably improved and were also clinically significant at post-intervention.  Luke’s 
reported scores on the MHC-SF showed a reliable and clinically significant 
improvement at the end of session 7, when the product formulation was 
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delivered for a second time.  The SMA showed one significant correlation at a 
lag of +1 between the frequency of process formulations and a deterioration in 
Luke’s depression, which indicates that an increase in process formulations 
delivered by the therapist preceded a deterioration in depression in the following 
session.  No other significant correlations were found across other variables. 
During the change interview, due to difficulties mentioned below, Luke 
was tearful and quite withdrawn throughout.  Luke was the only participant who 
talked about the accuracy of the therapist’s questions, which he alluded to him 
feeling understood.  He was also the only participant who could not remember 
much detail about the product formulations but recalled the process 
formulations, describing that the process formulations were “what the therapy 
was all about”.  It is unclear from Luke’s responses whether he fully understood 
what a process formulation was (from the definition provided by the interviewer), 
as later he talks about “challenging his thoughts” as a helpful aspect of the 
formulation which could also overlap with cognitive techniques used in the CBT 
formulation. 
Prior to starting therapy, Luke had recently finalised a divorce from his 
ex-wife and throughout therapy he was living separately from his children.  At 
the end of therapy and at the time of the change interview, Luke decided that he 
was going to return back home (abroad) away from his ex-wife and children.  
This had a significant impact for Luke, as the decision was understandably very 
difficult for him and resulted in him feeling very emotional.   
 Throughout the CBT, Luke engaged well with both cognitive and 
behavioural tasks.  On occasions he found it difficult to understand some of the 
concepts of more cognitively focussed tasks, e.g., undertaking a thought 
challenge, although after further explanation was provided, this aided his 
understanding and engagement.  Although in the change interview Luke 
reported that he found the behavioural homework tasks difficult, e.g., activity 
scheduling, he persisted with these throughout.  In a couple of sessions, Luke 
brought some of his achievements with him to share, including positive 
photographs he had taken throughout the week.  
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 During the product formulation sessions, Luke seemed to be attentive 
throughout and was actively involved drawing out the diagram.  The first 
occasion the product formulation was shared, Luke became quite tearful when 
discussing his core beliefs.  He made several changes to elements of the 
formulation which he disagreed with and these were explored collaboratively.  
When the product formulation was shared a second time, Luke made less 
changes and generally agreed with the contents.  He also presented less 
emotional than when the formulation was shared on the initial occasion and the 
content seemed to make more sense to him, likely due to his improved 
understanding of cognitive and behavioural concepts.  
 
3.9.2 Participant 2: Louise.   
Visual analysis of the alliance showed a generally increasing trend 
throughout the intervention, although there was a noticeable dip in Louise’s 
report of alliance at session six.  During this session, Louise reported having a 
particularly difficult week and the session focussed on encouraging Louise to 
challenge her thoughts using factual evidence.  SMA showed no significant 
correlations (including lagged correlations) between the frequency of process 
formulations and the working alliance.  
 Louise’s depression scores showed an improving trend during baseline 
and continued throughout the intervention, with an observable improvement in 
depression at session five.  During session five, Louise had reported having a 
positive week as she had felt that she had been able to cope with difficult 
circumstances.  She had also completed homework tasks during the week prior 
to the session and shared some of these achievements with the therapist, which 
were positively reinforced.  SMA showed a significant correlation between the 
frequency of process formulations and a deterioration in well-being scores at a 
lag of +1.  This suggests that there was a statistically significant relationship 
between the frequency of process formulations delivered with Louise and a 
deterioration in her well-being in the following session.  Additionally, the SMA 
showed a significant correlation between the working alliance and improved 
levels of depression and a lag of +1.  This indicates that an increase in Louise’s 
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ratings of working alliance preceded an improvement in reported levels of 
depression in the following session.  
 The data showed that at the point the second product formulation was 
delivered and maintained at the end of the final session, Louise’s depression 
had reliably improved.  Additionally, when the second product formulation was 
shared and at the end of the final session, Louise’s well-being scores were 
deemed reliable and clinically significant and her scores on the CORE-OM had 
also reliably improved.     
 During the change interview, similarly to other participants, Louise talked 
about positive therapist characteristics when she was asked about helpful 
aspects of therapy.  Although Louise had some ongoing difficult personal 
circumstances (expanded below) during the course of therapy, she reported no 
negative changes and commented on only positive changes.  Louise was the 
only participant who shared that she felt “dubious” about the process 
formulations and was also the only participant who described thinking about the 
formulations in-between sessions.  When discussing the product formulation, 
Louise reported that she did not want to take away the formulation, as she felt 
“she had got it out of her system”, although she also described some negative 
emotional reactions to the formulation which might also explain her reluctance 
to want to take a copy home with her.  Louise was also the only participant to 
comment that if the formulation (product) had been shared during every session 
of the intervention, it would not have had the same effect, although she does 
not explicitly state whether she means a positive of negative effect.  
 Throughout the intervention, Louise described a high demanding life at 
home as she was a stay at home mother of seven children, which often resulted 
in her feeling exhausted, isolated and she had little time for herself.  During 
session seven, Louise disclosed a significant safeguarding concern during the 
session, which resulted in this being the focus of the session and the product 
formulation was not delivered.  It was agreed with Louise that due to this, we 
would extend the intervention to nine sessions and deliver the product 
formulation in session eight.  This safeguarding concern was ongoing for Louise 
throughout the last three sessions and also at the time of the change interview, 
Page 172 of 261 
 
which was understandably very difficult for her although she commented on 
how surprised she was that she had coped as well as she did.  
 Throughout the CBT intervention Louise engaged well, particularly with 
in-session tasks such as, the continuum exercise, psychoeducation of cognitive-
behavioural principles.  When we shared the first product formulation, Louise 
was not tearful but it was clear from her observable presentation that she found 
the formulation difficult to process and she commented that she felt shocked 
seeing it written down.  In the session Louise described a moment of realisation 
of what she had been through, which had mixed consequences of feeling 
shocked but also she reported that it helped her to make sense and normalise 
why she experiences depression.  
 
3.9.3 Participant 3: Julie.   
Julie was the only participant who showed a flat trend on participant 
reported alliance throughout the intervention.  Additionally, the lowest frequency 
of process formulations were delivered with Julie (n = 21).  Visual analysis 
showed a slight peak in the participant reported alliance when the second 
formulation was delivered, however this was not the only peak during the 
intervention.  SMA showed a positive significant correlation between process 
formulations and participant reported alliance at a lag of -1, which means that 
an increase in Julie’s working alliance ratings correlated with an increased 
frequency of process formulations delivered in the following session. 
 Julie was also the only participant who showed a worsening trend in 
depression scores during the baseline phase.  SMA showed no significant 
correlations between process formulations and depression or wellbeing.  Also, 
SMA showed no significant correlations between working alliance and 
depression, although a negative significant correlation was found between 
Julie’s working alliance ratings and wellbeing at a lag of -1.  This indicates that a 
deterioration in Julie’s wellbeing preceded a change in Julie’s ratings of the 
working alliance.  Although depression scores improved at the point the first and 
second product formulations were delivered, these improvements were not 
deemed reliable.  The data showed no improvement in Julie’s depression at 
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post-intervention.  Julie’s scores on the MHC-SF generally remained the same 
when both product formulations were delivered and although there was an 
improvement in Julie’s wellbeing at post-intervention, this was also not 
classified as reliable.  Julie showed a reliable improvement on the CORE-OM at 
post-intervention.   
 Throughout the majority of the intervention, Julie had a lot of input from 
other professionals which included weekly visits from her peer support worker 
and CPN.  During the last couple of weeks of therapy, her peer support worker 
was off work on sick leave and she had also not been seen by her CPN for 
several weeks. This became a focal point for the last couple of sessions with 
Julie as she was unhappy about the prospect of therapy ending and not having 
received as much professional involvement as she had previously in the 
intervention.   
In the change interview, Julie talked about the therapist’s characteristics 
as being helpful during her experiences of therapy.  Julie was the only 
participant who shared that she did not always agree with the therapist’s 
suggestions but implied that the positive alliance enabled these disagreements 
to be discussed.  During the change interview Julie described that she felt 
shocked and thought “that’s not very nice” when initially seeing her product 
formulation, however she did not share this with the therapist during the session 
but raised some disagreements in the following session. 
 Throughout the intervention Julie was very talkative and she would often 
dominate sessions and her conversation would veer off on tangents which were 
difficult to refocus.  The therapist reflected that this resulted in less space for 
process formulations to be delivered and CBT tasks to be undertaken.  Julie 
engaged relatively well with in-session tasks but less well with homework, 
particularly if she was required to do tasks independently.  Julie’s peer support 
worker would encourage her to participate with activities, e.g., badminton, going 
for walks or a coffee, which supported Julie with homework tasks that focused 
on behavioural activation principles.   
 During the first product formulation, Julie engaged very well and 
described that the content “made sense” and it provided her with information 
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that she had not considered previously.  However, in the following session Julie 
raised that she had thought about the formulation between sessions and she 
disagreed with some of the contents.   
 
3.9.4 Participant 4: Heather.   
Data shows an increasing trend in working alliance throughout the 
intervention with a slight peak at the point of the second formulation, however 
this peak follows an increasing trajectory of working alliance throughout therapy.  
Heather reported the lowest average working alliance score (M = 53.75) which 
was also consistent with the therapist’s measure of alliance, reporting the 
second lowest average score (M = 52.75).  SMA showed no statistically 
significant correlations between the frequency of process formulations and 
working alliance.   
 Heather’s depression scores showed an improving trend during the 
baseline phase and an improving trend from session four of the intervention.  
SMA showed no statistically significant correlations between the frequency of 
process formulations and depression or wellbeing.  However, SMA did show a 
significant correlation between working alliance and wellbeing at a +1 lag, which 
suggests that an increase in working alliance correlated with an improvement in 
wellbeing in the following session.  Additionally, SMA found a statistically 
significant correlation at a +1 lag between working alliance and depression, 
which indicates that  an increase in Heather’s working alliance ratings preceded 
an improvement in depression reported in the following session.   
 Heather’s reported levels of depression reliably improved at the point the 
first product formulation was delivered, which further improved at post-
intervention.  Heather’s well-being scores initially deteriorated when the first 
product formulation was delivered, but then improved following the second 
product formulation and at post-intervention, although these improvements were 
not deemed reliable.  Heather’s scores on the CORE-OM show a reliable 
improvement at post-intervention.    
 Heather declined to take part in the change interview, therefore there is 
no qualitative interview data to report. 
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 Although the focus of the intervention was on Heather’s low mood, her 
primary diagnosis was Paranoid Schizophrenia.  Heather reported experiencing 
symptoms associated with her diagnosis of Schizophrenia, which included 
paranoid thoughts resulting in her feeling very anxious.  During sessions, 
Heather’s experiences of paranoia frequently impacted on her ability to engage 
with therapy, for example, she described feeling anxious about opening up 
during therapy due to her fear that something bad would happen to her or the 
therapist.  As a result Heather was often reluctant to share any of her cognitions 
which created barriers when developing her product formulations or engaging in 
cognitive-behavioural techniques.  From the therapist’s perspective, due to 
Heather’s paranoia it felt more difficult to develop a working alliance, particularly 
in such a short space of time (8 sessions). 
 
3.9.5 Participant 5: Amy.   
Similarly to other participants, the working alliance showed an increasing 
trend throughout the intervention, with a slight peak at the point the second 
formulation was delivered.  Amy reported the highest average working alliance 
(M = 80.86) but the therapist scored the lowest average (M = 51.38).  SMA 
showed a statistically significant correlation at a -1 lag between the frequency of 
process formulations and an increase in working alliance.  This means a 
relationship was found between an increase in Amy’s working alliance ratings 
and an increased in the frequency of process formulations delivered in the 
following session.  
 Amy was the only participant who showed stable depression scores 
throughout the baseline phase.  During the intervention, Amy reported little 
variation in depression scores, although there was a slight improvement 
between sessions two and four.  On average, Amy reported the highest (worse) 
depression score and the lowest (worse) wellbeing score during the 
intervention.  SMA showed a statistically significant correlation between the 
frequency of process formulations and a deterioration in wellbeing scores at a 
lag of -1.  This suggests that a deterioration in Amy’s reported wellbeing 
preceded an increased frequency of process formulations delivered by the 
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therapist in the following session.  SMA also found a significant negative 
correlation between working alliance and wellbeing (0 lag), which suggests a 
relationship between working alliance a deterioration in wellbeing at the end of 
the session delivered.   
 Amy’s reported levels of depression deteriorated at the point the first 
product formulation was delivered, which remained stable at the second product 
formulation and then further deteriorated at post-intervention. Amy’s wellbeing 
scores also deteriorated during the session the first product formulation was 
delivered, then further deteriorated when the second formulation was shared 
and slightly improved at the end of the final session but did not improve overall.  
Amy’s ratings on the CORE-OM showed a slight improvement at post-
intervention which was classified as a reliable change.    
 During the change interview, similarly to other participants Amy talked 
about the therapist’s characteristics and approach which she found helpful.  
Amy was the only participant who made any reference to the therapy being 
challenging but commented that although it was sometimes difficult, she felt as 
though she needed it.  Specifically to the product formulation, although Amy 
described it as overall a positive experience, it was difficult seeing the 
formulation written down, likening it to “confronting her demons”.  In addition to 
another participant, Amy also commented that she found the formulation made 
more sense the second time it was shared with her.   
 External to therapy, Amy had several ongoing stressful circumstances 
which she would often talk about during sessions.  Amy had a diagnosis of 
Fibromyalgia and as a result she would often experience significant pain which 
she linked to her low mood and intolerance for others.  During sessions, Amy 
would sometimes be in physical pain which would impact her ability to engage, 
e.g., sit comfortably for the duration of the session.  Although Amy had ongoing 
stressful circumstances she had a lot of positive support from friends, which 
encouraged her to have an active social life.  Also, Amy had a good relationship 
with her CPN who she was in contact with on a regular basis.  
 Throughout sessions, Amy was often very emotional and her mood 
would fluctuate from being quiet and withdrawn to tearful and also very angry 
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and frustrated.  From the therapist’s perspective, at times this was difficult to 
manage and on reflection this may have impacted the therapist’s ability to 
develop a working alliance.  Amy engaged relatively well with CBT, although 
she would often challenge some of the in-session tasks and she was reluctant 
to undertake any homework.  When developing the product formulations, Amy 
was very tearful throughout, particularly during the first product formulation.  
Although Amy was very emotional, as previously commented, this was not 
unusual to her presentation during other sessions.   
 
4. Extended Discussion 
The extended discussion will further expand on ideas explored in the 
journal paper, making reference to psychological theory and existing research.  
Additionally, it will further discuss the implications of findings for the profession 
considering the study’s limitations and recommendations for future research. 
 Psychological formulation is a core skill of clinical psychology practice 
and training and is considered a central component of the majority of 
psychological therapies (DCP, 2010).  Despite the emphasis placed on the 
utility of psychological formulation, there is a limited evidence-base to suggest 
that it improves outcomes and the working alliance (Bieling & Kuyken, 2003).  
An overarching aim of this study was to contribute to the dearth of research 
examining whether CBT formulation impacts outcomes in therapy.  In summary, 
the findings of this study found limited evidence to confirm whether formulation 
impacts working alliance and little or no relationship between formulation, 
working alliance and secondary outcomes (depression and wellbeing).   
 
4.1  Does Formulation Impact Working Alliance? 
Although the study found a slight trend between formulation and working 
alliance, the results were not able to confirm whether formulation directly 
impacts working alliance during therapy.    Results showed little consistency 
and repetition across participants which meant that minimum replication criteria 
(three replications) was often not met, which limited the generalisability of 
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findings.  The majority of participant’s data showed an increasing trend in 
working alliance over the course of the intervention.  This was further supported 
in the SMA, which showed a strong statistically significant correlation between 
participant and therapist reported working alliance (at lag 0), which was 
repeated with three participants.  This does not offer a unique finding to the 
literature, but supports previous research that shows that although the alliance 
reported by therapists and clients typically follows a U-shaped curve (high-low-
high), the alliance follows a steadily increases trend over the course of therapy 
(Gelso & Carter, 1994). 
Visual analysis showed some elevations in working alliance at significant 
points in the intervention when product formulation/s were shared or when a 
higher frequency of process formulations were delivered.  However participant 
and therapist reports of working alliance were not consistent, i.e., peaks did not 
occur at the same points, which suggests that the visual analysis did not find 
that formulation impacts working alliance.  In addition to this, SMA found two 
statistically significant, positive correlations at a lag of -1, which suggests a 
slight relationship between an increase in working alliance (reported by the 
participant) and an increase in process formulations delivered by the therapist in 
the following session.  Although this finding shows a slight relationship between 
these two variables and suggests that working alliance may have a lagged 
correlation with the frequency of process formulations delivered, this was not 
repeated across three subjects and is therefore limited.  No studies have 
examined the relationship between CBT formulation and working alliance using 
SMA, therefore it is difficult to link this finding to pre-existing literature (Aston, 
2009; Bieling & Kuyken, 2003).  Research has shown that the accuracy of 
therapist’s interpretations in psychodynamic therapy are positively correlated to 
an improvement in therapeutic alliance in proceeding sessions (Crits-Christoph, 
Barber, & Kurcias, 1993).  Although this study suggests that the accuracy of 
formulations might act as a mediating factor of the working alliance, it is 
important to consider how accuracy is defined and measured.  The current 
study did not measure the accuracy of formulations delivered, therefore it was 
not possible to further explore whether the accuracy of CBT formulations 
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mediated working alliance during therapy, potentially highlighting an area for 
future research.   
Participant findings from the visual analysis were not consistent with 
therapist reported working alliance.  The discrepancy between participant and 
therapist findings supports previous literature published by Chadwick and 
colleagues (2003), which found that although therapist’s reported that 
formulation contributed to the therapeutic alliance and was a validating process 
for the client, this was not supported by participant’s responses.  This may 
indicate that the benefits of formulation may be for the therapist rather than the 
client.  If so, this may have implications for the profession and raises the 
question whether formulation should be used as a clinical tool directly with 
clients or indirectly during supervision or independent study.   
During the change interviews, all participants talked about therapist 
characteristics when asked about helpful aspects of the therapy.  This finding 
supports previous research which has shown that clients often attribute positive 
experiences or outcomes of therapy to therapist’s personal attributes (Sloane, 
Staples, Cristol, Yorkston, & Whipple, 1976).  Participants in the current study 
described that the therapist had contributed to them feeling “understood”, 
“comfortable”, “never judged” and “listened to”.  These are consistent with 
previous findings from Ackerman and Hilsenroth's (2003) study, which 
demonstrated a positive correlation between similar therapist attributes and 
positive outcomes in therapy. Additionally, a study conducted by Lazarus (1971) 
found that clients reported that personal qualities of the therapist were more 
important than specific technical components of therapy, which supports the 
common factors model which proposes that common factors account for 30% of 
improvement in therapy outcomes (Lambert, 1992). Baldwin et al. (2007) 
suggested that the therapist’s contribution to the development of the alliance is 
essential to producing improved outcomes.  This may suggest that some 
therapists are more skilled at establishing more effective alliances than others.  
In the current study, the same therapist was used across participants, therefore 
we were unable to measure whether variation in therapists would mediate 
outcomes, including the working alliance.   
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In the change interview, participants commented on aspects of or 
positive changes associated with formulation and CBT, although they did not 
make specific links between them.  For example, some participants commented 
on changes in their thoughts (e.g., “recognise and challenge my black and white 
thinking”), behaviours (increased levels of activity) and emotions (e.g., feel less 
guilty, more accepting, can process how I feel and let go of bad feelings 
quicker).  Although a key goal in CBT is to alter cognitions and behaviours, with 
the aim of improving an individual’s emotional state, it cannot be entirely 
conclusive that these changes reported by participants were solely a result of 
CBT, the working alliance or formulation.  However, it should be highlighted that 
participants did report improvements which are reflective of the CBT model. 
When asked about helpful aspects of the formulation, participants generally 
talked about feeling understood, for example, “seeing it all written down in a 
diagram, it made sense”, “when we drew it out, it helped me to get it”.  
Needleman (1999) proposed that if the formulation contributes to clients feeling 
understood by the therapist, this may indicate that formulation has a role in the 
development of the therapeutic alliance.  Although Needleman’s idea makes 
logical sense, considering the findings from this study and existing research, 
there is little empirical evidence to support that if formulation contributes to 
these experiences for the client, this results in an improvement in the working 
alliance.    
 
4.2 What is the Relationship between Formulation, Working Alliance 
and Psychosocial Outcomes? 
 The study showed mixed findings in the relationship between formulation 
working alliance and psychosocial outcomes measures.  Although the majority 
of participants showed an improvement in depression, wellbeing and across a 
range of symptoms on the CORE, it is not possible to attribute these changes 
specifically to the formulation, CBT or working alliance.   
 SMA showed inconsistent correlations between the frequency of process 
formulations and psychosocial outcomes (depression and wellbeing), which 
suggests no relationship between formulation and outcomes.  SMA also 
showed mixed results in the relationship between the working alliance, 
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wellbeing and depression.  Although two statistically significant correlations 
were found between an improvement in working alliance and a reduction in 
levels of depression in the following session, although minimum replication 
criteria was not met. This supports existing literature which found that the 
working alliance is positively correlated with improved outcomes (Horvath et al., 
2011), although the findings from this study cannot conclude any clear 
relationships between variables.  Figure 13 illustrates statistically significant 
correlation coefficients found between variables, indicating the direction of the 
correlation (+ or -) and at which lag the association occurred (-1, 0 or +1 lag).  
This figure highlights the level of inconsistency and lack of repetition in 
relationships found between variables.   
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Figure 13.  Statistically Significant Correlation Coefficients between Variables 
Note. P = Participant; p< .05. + or – indicates direction of correlation (positive or negative) 
 
 
Frequency of 
Formulation 
 
Depression 
 
Wellbeing 
 
Working Alliance 
P1 r = +.81 
(+1) 
P2 r = -.67 (+1);   P5 r = -.76 (-1) 
P2 r = -.71 (+1); P4 r = -.61 
(+1) 
P3 r = -.62 (-1); P4 r = +.94 (+1);  
P5 r = -.73 (0) 
P3 r = +.77 (-1); P5  r = +.79 
(-1) 
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 Results showed some evidence to suggest that delivering a product 
formulation might be a distressing experience for clients.  Data showed a 
deterioration in depression scores (for two participants) when the product 
formulation was delivered (See Table 6 – RCI and CSC).  Also, during the 
change interviews three participants reported that receiving the product 
formulation resulted in negative emotional reactions, for example, “I felt a bit 
overwhelmed…seeing everything from my past, it was a shock”, “at first I 
thought ‘that’s not very nice’”, “it was hard to look at…it was like having to relive 
it again…like confronting a lot of your demons”.  All participants who described 
a negative emotional reaction also commented that the product formulation had 
also been helpful in developing insight into their difficulties.  This finding 
supports existing literature that whilst the majority of clients describe formulation 
as overall being a helpful tool in therapy, clients can also experience some level 
of distress when receiving a formulation (Kahlon et al., 2014; Redhead et al., 
2015). In Brown (2008) unpublished doctoral thesis, grounded theory was used 
to develop a theoretical understanding and model of client and therapist’s 
experience of formulation (Figure 14).  Brown highlights client’s experience of 
initial doubt, which progresses to an ‘awareness of the process’.  She suggests 
that increased awareness resulted in client’s being more consciously aware of 
complex personal information, contributing to feeling frightened, exposed and 
overwhelmed adding to clients’ distress.   Brown suggests that ultimately clients 
were able to move away from their initial doubt, through a process of increased 
awareness and associated distress to feeling the formulation encouraged a 
sense of empowerment.  Although this model has not been published and the 
generalisability has not yet been tested, the qualitative findings of the current 
study offer some support to Brown’s model, as although some participants 
reported some level of distress when receiving the product formulation, overall 
they generally described the formulation as a positive and helpful experience.   
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Figure 14.  Theoretical Diagram – Clients’ View of Clients’ Experience of Formulation (taken from (Brown, 2008)
Initial Doubt 
Responsive 
Client Ownership 
Awareness of the Process 
Connection with Information 
Empowering 
Journey of Growth 
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4.3 Limitations and Challenges 
The limitations and challenges of the study have been referred to 
throughout the extended and journal discussion. The most significant challenge 
of this study was disentangling formulation from other processes occurring in 
therapy and will therefore be the main focus of this section.   
 
4.3.1 Disentangling Formulation from Specific and Non-Specific 
Factors.  
 Separating the formulation out from other processes in therapy resulted 
in difficulties when attempting to conclude which variables contributed to which 
outcomes measured in therapy.  There are clear overlaps in the 
conceptualisation of delivering a psychological formulation, components of CBT 
and establishing a working alliance, which must be considered when attempting 
to unravel such complex processes.  As discussed in the journal paper, 
delivering a psychological formulation may contribute to or enact elements of 
the working alliance (e.g., bond) and the working alliance might also be difficult 
to separate from components of CBT (e.g. homework tasks, goal setting).  
Table 21 provides a visual representation of some of the potential overlap 
between these variables.   
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Table 21. 
Visual Representation of the Overlap between Working Alliance, Psychological 
Formulation and CBT. 
 Working Alliance 
 Task Bond Goal 
Psychological 
Formulation 
Delivering a 
formulation, e.g., 
drawing out 
diagrammatically. 
Collaborative 
process. 
A shared 
understanding. 
Informs 
intervention, 
guided by 
mutually agreed 
goals. 
Cognitive 
Behavioural 
Therapy  
In-session and 
homework tasks. 
Collaborative 
therapy. 
An effective 
alliance is central 
to the therapy. 
Setting and 
working towards 
measurable goals.  
 
This overlap may have contributed to measurement difficulties, 
highlighting whether you can measure each process separately or are there 
occasions when you are measuring aspects of the same process.  This is a 
potential challenge of psychotherapy research when measuring processes that 
occur within naturalistic settings (i.e., therapy) and with human subjects which 
introduces variables that cannot be controlled or measured.  However, research 
such as the current study that examine processes and outcomes within 
naturalistic settings with ‘real life’ participants (i.e., patients in the NHS) have 
strong ecological validity and are arguably most useful for clinical practice.   
Using a repeated single-case design and data analysis such as SMA allowed 
the researcher to measure complex processes within therapy.  A strength of the 
design is the multiple points and levels of measurement allowing rich data to be 
collected, enabling the researcher to apply an empirical and robust 
methodology to a clinical practice setting (Borckardt et al., 2008). 
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4.3.2 Problems with Measuring Working Alliance.  
 In this study, working alliance was measured using participant and 
therapist versions of the WAI-SF.  As with many standardised self-report 
measures there are limitations that must be considered.  One of the key 
theoretical critiques of the working alliance concept is the emphasis on 
collaboration and consensus ( Doran, 2016).  Bordin’s (1979) definition 
highlights the degree of agreement between client and therapist on the goals 
and tasks during therapy.  Theorists have raised concerns that not enough 
attention is given to potential conflict or negative feelings in the alliance 
(Brenner, 1979).  Cushman and Gilford (2000) also argue that the working 
alliance construct as become conflated with the idea of agreement and does not 
give necessary consideration to the alliance developing through conflict and 
confrontation, consequently mistaking client compliance for an authentic 
working alliance.  The WAI-SF measures the three components of Bordin’s 
conceptualisation of working alliance (bond, task and goal) and therefore does 
not give consideration to some of the factors discussed here.  This may result in 
measurement error and researchers have noted that the way clients perceive 
the therapy relationship is not accurately captured by existing measures, such 
as the WAI-SF (Owen, Reese, Quirk, & Rodolfa, 2013).  Doran, Safran, 
Waizmann and Muran (2012) highlight that whilst the WAI-SF has some 
negatively worded items, there are a lack of items that focus on the degree of 
tension or conflict in the therapy relationship.  Some of the limitations of the 
WAI-SF must be considered when drawing conclusions from the results of this 
study.  Also, as presented in the working alliance data in the current study, 
there is a lack of variability in the reporting of working alliance.  Furthermore, 
ratings are often high from the first therapy session (prior to formulations being 
introduced) and are generally maintained at similar levels throughout the 
intervention.  Consequently, this creates difficulties when trying to detect any 
changes in the alliance when formulations are delivered (i.e., working alliance is 
reported high during early assessment sessions when the formulation frequency 
is low or even absent).     
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4.4 Strengths and Implications for Clinical Practice 
 Reviews of existing literature surrounding formulation (Aston, 2009; 
Bieling & Kuyken, 2003), would suggest that the current study is the first to 
measure the impact of CBT formulation on working alliance and secondary 
outcomes using a single-case design and analyses such as SMA.  
Consequently, this study offers a valuable contribution to the dearth of 
published research and can offer several implications for clinical practice.   
 As previously discussed, formulation is a competency central to clinical 
psychology training and practice (DCP, 2010).  The findings of this study are 
complex and in summary there was no conclusive evidence to suggest that the 
utility of formulation in CBT impacts on or correlates with outcomes.  There are 
limitations to the generalisability of findings (i.e., small sample size, difficulty 
controlling confounding variables), however the results may encourage Clinical 
Psychologists to reflect on why we deliver psychological formulation when there 
is such a limited evidence-base and whether the benefits of formulation lie with 
the client, the therapist or both.  The findings of this study supports existing 
research that shows clients have mixed emotional responses to the formulation 
process.  This offers an important clinical implication and suggests that 
clinicians should be attuned to the potentially distressing experience of 
receiving a formulation.  Additionally, the findings suggest that the distress 
associated with receiving a formulation is not permanent and can be worked 
through using the containment of an effective working alliance.  This further 
emphasises the importance of establishing a positive alliance within therapy 
and clinicians should possibly measure the working alliance to ensure that one 
is established prior to delivering a formulation.   
 Despite the complexity of findings in this study, it encourages a critical 
discussion and reflections surrounding the utility of psychological formulation in 
practice.  It also highlights the complexity of psychotherapy research and the 
challenge of separating out processes which potentially overlap with each other.  
Clinical psychologists may want to consider whether it is possible to deliver CBT 
without sharing a formulation (process or product) or whether when delivering a 
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formulation is this also contributing to the working alliance.  A significant 
strength of this study is that it opens up new ideas and opportunities for future 
research which will hopefully continue to develop our understanding of the 
mechanisms and impact of psychological formulation in practice.  
 
4.5   Future Research  
The current study contributes to a paucity in the literature surrounding the 
impact of psychological formulation on working alliance and psychosocial 
outcomes.  The findings discussed here provide a strong platform for future 
research into formulation.   
An area of interest that the current study did not investigate was measuring 
the accuracy of psychological formulations delivered and whether this had any 
impact on outcomes measured.  Future studies should consider how accuracy 
is defined and whether a top down or bottom up approach is taken to examine 
this.  For example, accuracy could be defined as the coherence to the 
theoretical model or it may also be defined as the perceived level of accuracy of 
the formulation from the participant’s perspective (i.e., does it accurately reflect 
their experiences).  Future research may wish to consider participant’s 
behavioural responses following a process or product formulation, for example, 
verbal indicators which may suggest that the participant agrees or disagrees 
with the formulation shared.  Measuring the accuracy of formulations delivered 
alongside outcome measures, such as, working alliance, measure of distress 
may provide the opportunity to investigate whether accuracy co-varies with 
these variables (i.e., formulation and outcomes such as, working alliance, low 
mood, wellbeing).  As discussed previously, there are limitations to measuring 
the working alliance using alliance measures, such as the WAI-SF.  Future 
researchers may wish to consider additional methods of measurement, for 
example, an observational schedule.   
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5.  Critical Reflections 
This section offers my clinical reflections on the research process, 
focussing on the development and refinement of the study, how the scientist 
practitioner model shaped my decisions on the study design and a reflection on 
some of the challenges I faced.  Also, I will present my reflections on the 
theoretical and clinical contributions I believe this study offers, providing a 
platform for future research into psychological formulation.   
 
5.1  Development of Study Ideas and Motivation for Area of Research 
 I initially felt overwhelmed with the vast choice of research topics and it 
took me some time to narrow down my interests.  Something that was 
particularly important to me was to ensure that I picked a research area that 
was clinically relevant and also something that I felt passionate about, that I 
would be able to take forward after clinical training.   In my clinical experience 
prior to training and during the teaching on the course, I noticed that 
psychological formulation was a core area of my practice and also central to the 
teaching we received.  As a clinician, personally I thought that the process of 
formulation was helpful for me to organise my theoretical and clinical 
understanding of the clients I worked with but also (possibly naively) I assumed 
that formulation was also beneficial for my clients.  After reading more around 
the literature and guidelines, I was astounded by the lack of evidence to support 
the utility of formulation, particularly as we align ourselves with the scientist-
practitioner model.  There is a clear need for further research into formulation in 
order to ensure that we are delivering evidence-based practice.  
 The complexity of researching psychological formulation was something I 
underestimated and a great deal of time and thought was given to design a 
study that considered some of the challenges faced in previous studies.  I 
initially intended to undertake a qualitative study exploring the value of 
psychological formulation for clients and therapists, however after considering 
some of the methodological and conceptual challenges of researching 
formulation, I decided that the study would benefit from being more specific and 
a qualitative study would have possibly been too open and broad.  I went 
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through a long process of refining and narrowing my research question/s to 
ensure it was clear what I was measuring and how I would measure it.  For 
example, initial questions I considered were; ‘is sharing a formulation helpful?’, 
‘does formulation work?’ and ‘how and why is formulation helpful?’.  I decided 
that assuming that formulation is helpful without the literature to support this 
would result in a researcher bias and I needed to be clear on how I would 
measure a formulation if it ‘worked’.  Moving forward with these initial ideas, I 
spent a long time considering how I would define formulation, how does 
formulation occur in clinical practice and how would I know when a formulation 
is being delivered, what dependant variables I would measure and how I could 
ensure reliability and ecological validity in the study.  I gave a lot of thought to 
how formulation is truly delivered in clinical practice, in busy services where 
clinical psychologists have less time to develop formulations in accordance with 
good practice guidelines (BPS, 2011).  During my first year placement, in an 
adult psychology service, I spoke to clinical psychologists about how they 
deliver psychological formulations in practice.  Most said that they often did not 
deliver formulation in a ‘formal way’ (unless delivering Cognitive Analytic 
Therapy) but they weaved the formulation throughout their psychotherapeutic 
intervention.  Some of these preliminary discussions encouraged me to think 
about how I could design a study that could measure formulation within therapy 
and further highlighted the importance of clearly defining how formulation will be 
delivered (e.g., as a process and/or product).   
Researching psychological formulation within therapy is very interesting and 
complex, although at times I felt perplexed.  A challenge I faced was ensuring 
that I did not design a study that was beyond a realistic timeframe of the clinical 
doctorate.  I found that remaining focused on the research aims and questions 
of this study was occasionally very difficult, as further questions occurred 
throughout.  For example, does the accuracy of process formulations impact on 
outcome?  Supervision meetings had a tendency to go off on tangents, often 
due to the excitement and enthusiasm about the study and the opportunity for 
future research.   
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5.2 Reflection on the Study Design 
The more literature I read on formulation, I became increasingly aware of 
the conceptual and methodological challenges of measuring formulation within 
psychotherapy.  I found that using a SCD was ideal to measure such complex 
processes in a scientific and systematic way.  I enjoy undertaking the role of a 
scientist-practitioner and I feel that my experience of using a SCD in this study 
allowed me to bridge the gap between research and clinical practice.  Choosing 
a study design that enabled me to translate research into something that is 
clinically relevant was very important to me and I feel that this was one factor 
that maintained my interest throughout the research process.  
However, this was my first experience of conducting a SCD and prior to 
clinical training, the majority of my research experience was using qualitative 
methodologies and I initially felt overwhelmed by all the different components of 
the design.  Using a SCD fitted well with my epistemological position (critical 
realism) and also with the area of research, particularly as it encourages the 
researcher to remain critical of the variables being tested.   
 
5.3 Refection on the Process of Data Collection and Therapy 
When designing the study, I spent some time thinking about whether I 
should deliver the therapy myself (giving myself a dual role of researcher and 
therapist) or whether I should attempt to recruit clinical psychologists who would 
be willing to following my study procedure.  Due to concerns that recruiting 
psychologists who have the time and capacity to do this might be very difficult, I 
agreed with my supervisors that I would take on the role as therapist.   
On reflection, I think I underestimated the demand of delivering the therapy 
myself, alongside other commitments, such as placement and academic 
deadlines.  This was compounded by recruitment difficulties and I was 
significantly behind schedule, only finishing data collection in December 2017.  
Juggling these demands along with delivering therapy for the research and 
receiving 90 minutes of additional CBT supervision was extremely stressful and 
resulted in periods where I felt burnt out.  However, after having some time to 
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reflect, I don’t think that I would have changed my decision.  I feel that being the 
therapist provided me with a unique insight and understanding of my 
participants and I was able to discuss and reflect on some of the idiosyncrasies 
in the data.  Also, I think being the sole therapist meant that factors such as 
therapist effects, were able to be controlled for.   
 
5.4 Reflection on Data Analysis and Interpretation 
As previously commented on, I initially felt overwhelmed with the sheer 
amount of data collected.  An arduous task was coding the frequency of 
process formulations throughout sessions.  This involved me listening back to 
audio recordings of every session, with each participant and coding the time 
and number of process formulations.  Similarly to delivering the therapy, on 
reflection I think I underestimated how tiring and lengthy this process would be 
(i.e., 41 hours of data coding).  Although criteria of how process formulations 
would be coded was clearly defined from the outset, at times it was difficult to 
ascertain whether I had included the three components and therefore required 
me to playback sections multiple times.   
In addition to coding the frequency of process formulations, I completed the 
CTRS for every session with each participant.  I found the CTRS difficult to use 
as items on the rating scale were not clearly defined and at times, some items 
were not relevant for that particular session and therefore a score of zero would 
be given for the item, pulling down the total rating for the session.  For example, 
during initial sessions, items such as ‘application of cognitive behavioural 
techniques’  were not relevant but the CTRS does not exclude them from the 
administration.   
I found the interpretation of results an interesting but very challenging 
process.  The results of the study showed very little consistency across 
participants and I found it very difficult to understand and synthesise my results 
in relation to the research questions.  In the midst of data analysis and 
interpretation I found that I was so immersed in the data that I struggled to see 
beyond the subtle nuances of the data.  I noticed that I was trying to search for 
findings or the meaning behind findings, when potentially there was none, which 
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resulted in lengthy discussions in supervision meetings.  Disentangling 
formulation from specific and non-specific processes at times felt an impossible 
task.  Not having concrete or conclusive results felt anxiety provoking and I was 
overwhelmed with the possible explanations as to why variables may have or 
may not have correlated. 
 
5.5 Reflection on CBT Supervision and Delivering CBT 
I received 90 minutes of weekly CBT focussed supervision, which was a 
really valuable learning process.  Initially supervision sessions felt quite intense 
as listening back to audio recordings (using a stop/start method) felt exposing.  I 
reflected feeling anxious that my supervisor would think that I was incompetent 
and at times I felt compelled to avoid listening to audio recordings with him.  I 
applied the CBT model to formulate my response and identified that early 
supervision meetings seemed to trigger my core belief that “I am not good 
enough”, which resulted in feeling anxious.  However, as time passed, my 
anxiety reduced and my learning experiences excelled.  In my reflective logs, I 
commented on feeling more confident in my ability to apply cognitive 
behavioural theory and I think this translated into my clinical practice; not just 
with research participants but also with clients on placement.  As my confidence 
progressed, I recall delivering more process formulations during sessions and 
listening back to the audio recordings, the formulations seemed to flow more 
naturally.  Although this study has not measured the confidence of the therapist, 
I wondered whether an improvement in confidence correlated with an increased 
frequency of process formulations.  Also, I would be interested to investigate 
whether the accuracy of process formulations correlated with an increase or 
decrease in engagement with the client or correlated with outcomes. 
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Appendix A:  Working Alliance Inventory – Short Form  
 
 
 
 
Working Alliance Inventory 
 
Short Form (Participant Version) 
 
Instructions 
 
 On the following pages there are sentences that describe some of the different ways a person might think or feel about 
his or her therapist (counsellor).  As you read the sentences mentally insert the name of your therapist (counsellor) in place of 
_____________in the text. 
Below each statement inside there is a seven point scale: 
 
 ___________________________________________________________________________________________________  
 1 2 3 4 5 6 7 
 Never Rarely Occasionally Sometimes Often Very Often Always 
 ___________________________________________________________________________________________________  
If the statement describes the way you always feel (or think) circle the number 7; if it never applies to you circle the number 1.  
Use the numbers in between to describe the variations between these extremes. 
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1. _______________ and I agree about the things I will need to do in therapy to help improve my situation. 
 
1 2 3 4 5 6 7 
Never Rarely                  Occasionally    Sometimes      Often Very Often     Always 
  
2.  What I am doing in therapy gives me new ways of looking at my problem. 
 
1 2 3 4 5 6 7 
Never Rarely Occasionally Sometimes      Often Very Often      Always 
 
3.  I believe _______________ likes me. 
 
1 2 3 4 5 6 7 
Never Rarely Occasionally   Sometimes       Often Very Often     Always 
 
4._______________ does not understand what I am trying to accomplish in therapy. 
1 2 3 4 5 6 7 
Never Rarely Occasionally   Sometimes       Often Very Often     Always 
 
5.  I am confident in _______________ 's ability to help me. 
1 2 3 4 5 6 7 
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Never Rarely Occasionally Sometimes       Often Very Often     Always 
 
6._______________ and I are working towards mutually agreed upon goals. 
1 2 3 4 5 6 7 
Never Rarely Occasionally Sometimes       Often Very Often     Always 
 
7.  I feel that _______________ appreciates me. 
1 2 3 4 5 6 7 
Never Rarely Occasionally  Sometimes      Often Very Often     Always 
 
8.  We agree on what is important for me to work on. 
1 2 3 4 5 6 7 
Never Rarely Occasionally   Sometimes      Often Very Often     Always 
 
9._______________ and I trust one another. 
1 2 3 4 5 6 7 
Never Rarely Occasionally   Sometimes      Often Very Often     Always 
 
10._______________ and I have different ideas on what my problems are. 
1 2 3 4 5 6 7 
Never Rarely Occasionally   Sometimes     Often Very Often     Always 
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11. We have established a good understanding of the kind of changes that would be good for me. 
1 2 3 4 5 6 7 
Never  Rarely Occasionally   Sometimes     Often Very Often     Always 
 
12. I believe the way we are working with my problem is correct. 
1 2 3 4 5 6 7 
Never Rarely Occasionally    Sometimes     Often Very Often     Always 
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Working Alliance Inventory 
 
Short Form (Therapist Version) 
 
Instructions 
 
 On the following pages there are sentences that describe some of the different ways a person might think or feel about his 
or her client.  As you read the sentences mentally insert the name of your client in place of _____________in the text. 
 
Below each statement inside there is a seven point scale: 
 
  ________________________________________________________________________________________________  
  1 2 3 4 5 6 7 
  Never Rarely Occasionally Sometimes Often Very Often Always 
  ________________________________________________________________________________________________  
 
  If the statement describes the way you always feel (or think) circle the number 7; if it never applies to you circle the 
number 1.  Use the numbers in between to describe the variations between these extremes. 
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1._______________ and I agree about the steps to be taken to improve his/her situation. 
1 2 3 4 5 6 7 
Never Rarely Occasionally   Sometimes      Often Very Often     Always 
 
2.  My client and I both feel confident about the usefulness of our current activity in therapy. 
1 2 3 4 5 6 7 
Never Rarely Occasionally  Sometimes     Often Very Often     Always 
 
3.  I believe _______________ likes me. 
1 2 3 4 5 6 7 
Never Rarely Occasionally  Sometimes     Often Very Often     Always 
 
4.  I have doubts about what we are trying to accomplish in therapy. 
1 2 3 4 5 6 7 
Never Rarely Occasionally  Sometimes     Often Very Often     Always 
 
5.  I am confident in my ability to help _______________. 
1 2 3 4 5 6 7 
Never Rarely Occasionally  Sometimes     Often Very Often     Always 
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6.  We are working towards mutually agreed upon goals. 
1 2 3 4 5 6 7 
Never Rarely Occasionally  Sometimes      Often Very Often    Always 
 
7.  I appreciate _______________ as a person. 
1 2 3 4 5 6 7 
Never Rarely Occasionally Sometimes      Often Very Often    Always 
 
8.  We agree on what is important for _______________ to work on. 
1 2 3 4 5 6 7 
Never Rarely Occasionally    Sometimes      Often Very Often     Always 
 
9._______________ and I have built a mutual trust. 
1 2 3 4 5 6 7 
Never Rarely Occasionally   Sometimes      Often Very Often     Always 
 
10._______________ and I have different ideas on what his/her real problems are. 
1 2 3 4 5 6 7 
Never Rarely Occasionally   Sometimes     Often Very Often     Always 
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11.  We have established a good understanding between us of the kind of changes that would be good for _______________. 
1 2 3 4 5 6 7 
Never Rarely Occasionally Sometimes     Often Very Often     Always 
 
12._______________ believes the way we are working with her/his problem is correct. 
1 2 3 4 5 6 7 
Never Rarely Occasionally Sometimes     Often Very Often    Always 
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Appendix B: PROMIS Depression Measure  
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Appendix C: Mental Health Continuum – Short Form 
 
 
Please answer the following questions are about how you have been feeling during the 
past week and check mark in the box that best represents how often you have 
experienced or felt the following: 
 
 
 
During the past week, 
how often did you feel  
 
Never 
 
 
 Once 
or 
Twice 
 
 
About 
Once a 
Week 
 
 
About 2 
or 3 
Times a 
Week 
 
 
Almost 
Every 
Day 
 
 
Every 
Day 
 
 
1. happy 
 
      
 
2. interested in life 
 
      
 
3. satisfied 
 
      
4. that you had something 
important to contribute to 
society 
 
      
5. that you belonged to a 
community (like a social 
group, or your 
neighborhood). 
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6. that our society is 
becoming a better place 
for people like you. 
  
      
7. that people are 
basically good. 
 
      
8. that the way our society 
works makes sense to 
you 
      
 
9. that you liked most 
parts of your personality. 
 
      
10. good at managing the 
responsibilities of your 
daily life 
      
11. that you had warm 
and trusting relationships 
with others. 
 
      
12. that you had 
experiences that 
challenged you to grow 
and become a better 
person. 
 
      
13. confident to think or 
express your own ideas 
and opinions. 
 
      
14. that your life has a 
sense of direction or 
meaning to it 
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Appendix D: CORE-OM 
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Appendix E: Process Formulation Record Sheet 
 
 
A process formulation will be coded if: All three components Antecedent (A), Belief (B) and Consequence (C) are present, 
occurring in any order. 
Participant 
Number 
Session 
Number & 
Date 
Frequency and timing of 
Process Formulations 
Cognitive Therapy Rating Scale 
Items 1-9 
Rating 
(0-6) 
   Time: 
 Time: 
 Time: 
 Time: 
 Time: 
 Time: 
 Time: 
 Time: 
 Time: 
 Time: 
 Time:  
 
 
 
 
 
 
 
 
 
 
 
Total Count:   
 
1. Agenda  
2. Feedback  
3. Understanding  
4. Interpersonal Effectiveness  
5. Collaboration  
6. Pacing and Efficient Use of Time  
7. Guided Discovery  
8. Focusing on Key Cognitions or Behaviours  
9. Strategy for Change  
10. Application of Cognitive-Behavioral 
Techniques 
 
11. Homework  
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Appendix F: Product Formulation – Longitudinal CBT Model (Beck, 1979) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Early Life Experiences 
Dysfunctional Assumptions / Rules for Living 
Core Beliefs (Self / World (Others) / Future) 
Critical Incidents 
Specific Trigger Automatic 
Thoughts 
Emotion Behaviours 
Specific Trigger Automatic 
Thoughts 
Emotion Behaviours 
Depression Symptoms 
Behavioural, Motivation, Affective, Cognitive and Somatic 
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Appendix G: Change Interview Schedule 
 
Introduction 
The interviewer will thank the participant for their time and taking part in the 
study. The interviewer will explain the aims of this interview, which are to 
gain an understanding of the participant’s experience of therapy and the 
process of formulation, considering helpful and unhelpful aspects.    
 
 Part One: Experiences of Therapy 
1. Have you had therapy previously to seeing Hannah? 
Prompts: If so, what type of therapy? 
Do you think the therapy influenced your expectations of therapy? 
  
2. Tell me about your experiences of the therapy you have received 
from Hannah. 
 
Prompts:  Were there any aspects that you found helpful/positive or 
unhelpful/negative? Why did you find these helpful/positive or 
unhelpful/negative? 
 
3. Have you noticed any changes (better or worse) in yourself 
since you started and ended therapy?  
Prompts: Any changes in thoughts, feelings, behaviours and circumstances? 
What do you think has contributed to your changes (inside and outside of 
therapy)? 
 
Part Two: Experiences of Formulation 
4.  Tell me about your understanding/experiences of formulation 
 
Prompts:  
Have you had a formulation? If they say no, say: Psychologists often 
make links between past experiences and how these have shaped 
thoughts/beliefs, feelings and behaviours.  This aims to explain how your 
main problems have developed and how they are being maintained.   
 
Tell me about your experiences of the formulation that Hannah drew out with 
you. (Product Formulation) 
 
Tell me about your experiences of aspects of your formulation that Hannah has 
discussed verbally with you. (Process ABCs) 
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5.  Were there any aspects of your formulation that you found helpful 
or unhelpful?  If so, what were they? 
 
Prompts: Was it helpful/unhelpful with your difficulties? Why were they 
helpful/unhelpful? 
 
Ending 
Thank the participant for their time and ask whether there is anything they 
would like to ask.  
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Appendix H: REC Approval Letter, 7th March 2017  
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Appendix I: REC Substantial Approval Letter, 14th July 2017 
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Appendix J: REC Substantial Approval Letter, 12th September 2017 
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Appendix K: REC Substantial Approval Letter, 26th February 2018 
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Appendix L: Health Research Authority Approval 
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Appendix M: School of Psychology Ethics Committee, University of Lincoln 
Approval 
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Appendix N: Participant Consent Form 
 
Title of Study: Exploring the impact of psychological formulation on working 
alliance: a mixed methods, repeated single case investigation   
 
REC Ref: 221260 
 
Name of Researcher:  Hannah Daniels 
 
Name of Participant: 
 
I confirm that I have read and understand the information sheet version number 2 
dated 01.03.2017 for the above study and have had the opportunity to ask 
questions. 
 
I understand that my participation is voluntary and that I am free to withdraw, 
without giving any reason, and without my medical care or legal rights being 
affected. I understand that should I withdraw then the information collected so far 
can be erased if I request this within two weeks after I withdraw from the study.  I 
also understand that if I wish to withdraw after I have completed the study, I have 
two weeks from completion to request this 
 
I understand that data collected in the study may be looked at by authorised 
individuals from the University of Lincoln, the research team and regulatory 
authorities where it is relevant to my taking part in this study. I give permission for 
these individuals to have access to these records and to collect, store, analyse 
and publish information obtained from my participation in this study. I understand 
that my personal details will be kept confidential. 
 
I understand that if I lose the capacity to consent at any point, I will be withdrawn 
from the study.  Data that has already been collected will be retained and no 
further data will be collected. 
 
I understand that my therapist will discuss the content of therapy sessions, during 
supervision, with her supervisor, who is a member of the direct care team.  
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I understand that if I disclose information that raises concern that I am a risk of 
harm to myself, to others or from other, my therapist may need to discuss this with 
third parties, such as, her supervisor, safeguarding team, police.  
 
As part of the study, I agree to have my therapy sessions audio recorded for the 
purpose of data analysis. 
 
 
I understand that a professional transcriber will listen to and transcribe the end of 
therapy interviews.  The transcriber will sign a confidentiality agreement.   
 
 
I agree to take part in the above study.  
 
………………………….               ……………..                ……………………….. 
    Name of Participant                     Date                                  Signature 
 
…………………………                ……………..                ……………………… 
Name of Person Taking Consent    Date                                   Signature 
 
 
When completed, copies for: 1 for participant; 1 for researcher site file; 1 to be 
kept in medical notes 
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Appendix O:  Participant Information Sheet 
 
IRAS ID Number: 221260 
 
Title of Study:  
Exploring the impact of psychological formulation on working alliance: a mixed methods, 
repeated single case investigation. 
 
Name of Researcher:  Hannah Daniels 
 
Name of Research Supervisors:  
Dr Mark Gresswell, Dr Dave Dawson and Dr Louise Braham 
 
I would like to invite you to take part in my research study. Before you decide I would 
like you to understand why the research is being done and what it would involve for you. 
I will go through the information sheet with you and answer any questions you have. 
Feel free to talk to others about the study if you wish and ask me if there is anything that 
is not clear. 
 
What is the purpose of the study? 
The main purpose of this study is to investigate whether formulation impacts on the 
working alliance between the therapist and client.  The study will also investigate 
whether formulation impacts other outcomes, such as the intensity of depression 
experienced by the client and overall general well-being.   
 
Formulation is a skill used by Clinical Psychologists and it aims to provide an 
explanation or ideas about how an individual’s difficulties have developed and how they 
are being maintained.  The formulation is developed together with your therapist and it 
might change over the course of therapy, if it is updated with new information.  The 
psychologist will also use their skills to draw on psychological theory to help develop the 
formulation and will also use it to guide treatment.   
 
Working alliance refers to the relationship between the therapist and the client.  This is a 
two way process and is made up of several components, 1) the agreement on therapy 
goals, 2) the agreement on the target of the treatment and 3) the quality of the bond 
between the client and the therapist. 
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Why have I been invited? 
You are being invited to take part because you are currently accessing the Community 
Mental Health Team (CMHT) and your care team have identified that psychological 
therapy might be beneficial for your treatment.  You will be offered a well-known and 
evidence-based treatment called Cognitive Behaviour Therapy (CBT), which is 
commonly used for treating a range of mental health problems, including low mood and 
depression.  CBT consists of psychological assessment, formulation and intervention 
and this study is particularly interested in how formulation impacts on outcomes, such as 
working alliance and symptoms of low mood.     
 
This means that if you take part in the study, you will not be receiving a treatment that is 
different or new but the study will be measuring what processes are helpful in the 
treatment that you receive. We are inviting six participants who are receiving treatment 
in the CMHT.  
 
Do I have to take part? 
It is up to you to decide whether or not to take part.  If you do decide to take part you will 
be given this information sheet to keep and be asked to sign a consent form.  If you 
decide to take part you are still free to withdraw at any time and without giving a reason. 
This would not affect your legal rights. 
 
 
What will happen to me if I take part? 
This study will be investigating the impact formulation has during your therapy that you 
will be receiving in the Community Mental Health Team.  Your sessions will be delivered 
by the researcher, who is a Trainee Clinical Psychologist at the University of Lincoln.  
Your sessions will take place on a weekly basis, lasting for one hour and will held at the 
(enter clinic base name – dependant on which CMHT the participant is recruited from) or 
the researcher can facilitate a home visit, if you are unable to travel to the clinic base. As 
mentioned previously, the treatment you receive will be orientated around CBT, which 
has a strong evidence base and is recommended in published guidelines.  This study 
will be investigating the processes that occur during CBT, one of these is formulation.  
To investigate this, we will be offering eight sessions of assessment, formulation and 
CBT.  Your sessions will be audio-recorded so that the researchers can listen back to 
them and count the number of times a formulation is delivered.  
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We are asking for your consent for the following: 
 To audio-record your psychology sessions 
 To complete one questionnaire, three times, prior to beginning therapy. 
 To complete three questionnaires at the end of each session 
 
 
 To take part in an interview after your therapy.   
 
Audio-recording sessions will allow the researcher to measure how often formulations 
are delivered during therapy and how it effects the outcomes of your therapy.  The 
audio-recordings will be listened to by your therapist and her supervisor who works in 
the NHS.   
 
After each session, you will be asked to complete three questionnaires, which should 
take you between five and ten minutes to complete.  You will also be asked to complete 
1 questionnaire at your first and last session, this is a service-standard measure.  
 
Once you have completed your eight sessions of therapy, the researcher will ask you to 
take part in an end of therapy interview.  This will take between 40 - 60 minutes and you 
will be given the opportunity to share your experiences of receiving a formulation. This 
will be with someone external to the research team, such as another Trainee Clinical 
Psychologist.   
 
 
Expenses and payments 
Participants will not be paid to participate in the study.  Travel expenses will be offered 
for participants to attend the (enter clinic base name) for the end of therapy interview 
only because the therapy you receive is the treatment as usual offered to you in the 
psychology service.   
 
What are the possible disadvantages and risks of taking part?  
On occasions psychological therapy may require you to talk about some of your 
difficulties and topics that may be sensitive and personal.  Your therapist is trained to 
support you and guide you through therapy and also receives weekly supervision to 
discuss any difficulties if they arise. 
 
What are the possible benefits of taking part? 
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We cannot promise the study itself will help you but the information we get from this 
study may help contribute to the evidence on whether formulation has any benefits for 
clients.  It may also contribute to the training that Clinical Psychologist’s receive, which  
 
 
is particularly important to ensure that psychologists are developing skills that are helpful 
for clients that they work with. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions.  The researchers contact 
details are given at the end of this information sheet. If you remain unhappy and wish to 
complain formally, you can do this by contacting: 
 
School of Psychology Research Ethics Committee (SOPREC) 
College of Social Science 
University of Lincoln 
Brayford Pool 
Lincoln 
Lincolnshire 
LN6 7TS 
 
Email: soprec@lincoln.ac.uk  
Patient Advice and Liaison Service (PALS)  
Tel: 01529 222265 
Email: PALS@lpft.nhs.uk  
 
Will my taking part in the study be kept confidential? 
All data that is collected during this study will be anonymised and kept confidential.  
Access to the data will be kept to a minimum and will be seen only by a small number of 
people, including the researcher, research supervisors and authorised individuals at the 
University of Lincoln.   
 
We will follow ethical and legal practice and all information about you will be handled in 
confidence. 
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If you join the study, some parts of the data collected for the study will be looked at by 
authorised persons from the University of Lincoln who are organising the research. They 
may also be looked at by authorised people to check that the study is being carried out 
correctly. All will have a duty of confidentiality to you as a research participant and we 
will do our best to meet this duty.  A professional transcriber will be used to transcribe  
 
 
the end of therapy interviews.  They will also have a duty of confidentiality and will sign a 
confidentiality agreement with the lead researcher. 
 
All information which is collected about you during the course of the research will be 
kept strictly confidential, stored in a secure and locked office, and on a password 
protected database.  Any information about you which leaves the clinic will have your 
name and address removed (anonymised) and a unique code will be used so that you 
cannot be recognised from it.   
 
Your personal data (address, telephone number) will be kept on the secure patient 
administration system in Lincolnshire Partnership Foundation NHS Trust.  At the end of 
the study, we will obtain these so that we are able to contact you about the findings of 
the study.  All other data (research data) will be kept securely for 7 years.  After this time 
your data will be disposed of securely.  During this time all precautions will be taken by 
all those involved to maintain your confidentiality, only members of the research team 
will have access to your personal data. 
 
Although what you say in your psychology sessions and in the end of therapy interview 
is confidential, should you disclose anything to us which we feel puts you or anyone else 
at any risk, we may feel it necessary to report this to the appropriate persons.  This will 
include the therapist discussing her concerns with their supervisor and may also be 
taken forward to third parties, such as the safeguarding team, crisis team or the police.  
The therapist will also discuss some of the content of your sessions during weekly 
supervision, with her supervisor, who is a member of the direct care team.   
 
What will happen if I don’t want to carry on with the study?  
Your participation is voluntary and you are free to withdraw at any time, without giving 
any reason, and without your care being affected.  If you wish to withdraw after the study 
has finished, you can do this within two weeks of completing. If you withdraw during or 
after the study, you can request that information collected so far to be erased, if you 
request this within two weeks after withdrawing.  
 
You can withdraw from the study in two ways; firstly by requesting this through the lead 
researcher (Hannah Daniels) or secondly through the School of Psychology Ethics 
Committee (SOPREC).  You can contact SOPEC on soprec@lincoln.ac.uk and you 
must provide them with your participant ID code and the name of the study.  SOPREC 
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will then arrange with the researcher that you wish to withdraw and data will be erased if 
this is requested within two weeks from withdrawal. 
 
It is unlikely that you will lose capacity during the study, however if it is deemed that you 
lose capacity, at any point, you will be withdrawn from the study.  Data that has already 
been collected will be retained, however no further data will be collected. 
 
 
 
What will happen to the results of the research study? 
A summary of the results of the study will be sent to you via the post if you wish to read 
them.  The study will be written up as part of the researcher’s Doctorate in Clinical 
Psychology qualification.  It is also expected that the study will be published in an 
academic journal and may also be presented at conferences.  All identifiable information 
will be removed in any reports, publications and presentations. 
 
Who is organising and funding the research? 
This research is being organised and funded by the University of Lincoln. 
 
Who has reviewed the study? 
All research in the NHS is looked at by independent group of people, called a Research 
Ethics Committee, to protect your interests. This study has been reviewed and given 
favourable opinion by [please add name of committee submitting to] Research Ethics 
Committee. 
 
Further information and contact details 
Chief Researcher:  Hannah Daniels 
Work Telephone: xxxx 
Email: hannah.daniels@lpft.nhs.uk  
 
Research Supervisor: Dr Mark Gresswell  Research Supervisor: Dr David 
Dawson 
Work Telephone: xxxxx    Work Telephone: xxxxx 
Email: mgresswell@lincoln.ac.uk   Email: ddawson@lincoln.ac.uk 
 
Research Supervisor: Dr Louise Braham 
Work Telephone: xxxxx 
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Appendix P:  Participant Debrief Sheet 
 
Thank you for participating in this study which has investigated whether psychological 
formulation impacts on working alliance and other outcomes, e.g. severity of depression, 
general wellbeing.  We appreciate your time and effort participating in the study and hope 
that the results will be useful for future clinical practice, treatment and training of Clinical 
Psychologists.  Once the data has been analysed and interpreted, if you wish, we will send 
you the results of the study in the post. 
 
Any personal information you have provided will remain confidential and all data analysed in 
the study will be anonymous, to ensure that you are unidentifiable.  Following the end of the 
study, if you change your mind and wish to withdraw, please contact the lead researcher 
(details provided below).  All data collected from you will be destroyed if you request this 
within two weeks of withdrawal.  
 
If you have any further questions that you would wish to discuss, please feel free to contact 
the lead researcher or supervisors on the contact details provided.  If you have experienced 
any distress during the study that you do not wish to discuss with us, please use the advice 
helplines outlined below.  
 
Thank you once again for your time,  
 
Hannah Daniels      Dr Mark Gresswell 
 
Lead Researcher      Research Supervisor   
Work Telephone: 07376 557784    
Email: hannah.daniels@lpft.nhs.uk   Email: mark.gresswell@lpft.nhs.uk 
 
 
Dr David Dawson      
 
Research Supervisor     
 
Email: ddawson@lincoln.ac.uk    
 
Advice Helplines and Useful Links 
 
Crisis Team:  0303 123 4000 
 
Samaritans: 116123 or jo@samaritans.org or www.samaritans.org  
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Appendix Q: Cognitive Therapy Rating Scale 
 
Cognitive Therapy Rating Scale (CTRS) 
 
Directions: For each time, assess the therapist on a scale from 0 to 6, and record the 
rating on the line next to the item number. Descriptions are provided for even-numbered 
scale points. If you believe the therapist falls between two of the descriptors, select the 
intervening odd number (1, 3, 5). For example, if the therapist set a very good agenda 
but did not establish priorities, assign a rating of a 5 rather than a 4 or 6. 
 
If the descriptions for a given item occasionally do not seem to apply to the session you 
are rating, feel free to disregard them and use the more general scale below: 
 
 
0 – Poor 
1 – Barely Adequate 
2 – Mediocre 
3 – Satisfactory 
4 – Good 
5 – Very Good 
6 – Excellent  
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Please do not leave any item blank. For all items, focus on the skill of the 
therapist, taking into account how difficult the patient seems to be. 
 
Part I. GENERAL THERAPEUTIC SKILLS 
 
1 AGENDA 
0 Therapist did not set agenda. 
2 Therapist set agenda that was vague or incomplete. 
4 
Therapist worked with patient to set a mutually satisfactory agenda that included 
specific 
 target  problems (e.g., anxiety at work, dissatisfaction with marriage.) 
 
6 Therapist worked with patient to set an appropriate agenda with target 
problems, suitable for the available time. Established priorities and then 
followed agenda. 
 
2. FEEDBACK 
 
0 Therapist did not ask for feedback to determine patient’s understanding 
of, or response to, the session. 
 
2 Therapist elicited some feedback from the patient, but did not ask 
enough questions to be sure the patient understood the therapist’s line of 
reasoning during the session or to ascertain whether the patient was 
satisfied with the session. 
 
4 Therapist asked enough questions to be sure that the patient 
understood the therapist’s line of reasoning throughout the session and to 
determine the patient’s reactions to the session. The therapist adjusted 
his/her behavior in response to the feedback, when appropriate. 
 
6 Therapist was especially adept at eliciting and responding to verbal and 
non-verbal feedback throughout the session (e.g., elicited reactions to 
session, regularly checked for understanding, helped summarize main points 
at end of session. 
 
3. UNDERSTANDING 
 
0 Therapist repeatedly failed to understand what the patient explicitly said 
and thus consistently missed the point. Poor empathic skills. 
 
2 Therapist was usually able to reflect or rephrase what the patient 
explicitly said, but repeatedly failed to respond to more subtle communication. 
Limited ability to listen and empathize. 
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4 Therapist generally seemed to grasp the patient’s “internal reality” as 
reflected by both what the patient explicitly said and what the patient 
communicated in more subtle ways. Good ability to listen and empathize. 
 
6 Therapist seemed to understand the patient’s “internal reality” 
thoroughly and was adept at communicating this understanding through 
appropriate verbal and non-verbal responses to the patient (e.g., the tone 
of the therapist’s response conveyed a sympathetic understanding of the 
patient’s “message”). Excellent listening and empathic skills. 
 
4. INTERPERSONAL EFFECTIVENESS 
0 Therapist had poor interpersonal skills. Seemed hostile, demeaning, or 
in some other way destructive to the patient. 
 
2 Therapist did not seem destructive, but had significant interpersonal 
problems. At times, therapist appeared unnecessarily impatient, aloof, 
insincere or had difficulty conveying confidence and competence. 
 
4 Therapist displayed a satisfactory degree of warmth, concern, 
confidence, genuineness, and professionalism. No significant 
interpersonal problems. 
 
6 Therapist displayed optimal levels of warmth, concern, confidence, 
genuineness, and professionalism, appropriate for this particular patient 
in this session. 
 
5. COLLABORATION 
 
0 Therapist did not attempt to set up a collaboration with patient. 
 
2 Therapist attempted to collaborate with patient, but had difficulty either 
defining a problem that the patient considered important or establishing 
rapport. 
 
4 Therapist was able to collaborate with patient, focus on a problem that 
both patient and therapist considered important, and establish rapport. 
 
6 Collaboration seemed excellent; therapist encouraged patient as much 
as possible to take an active role during the session (e.g., by offering 
choices) so they could function as a “team”. 
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6. PACING AND EFFICIENT USE OF TIME 
 
0 Therapist made no attempt to structure therapy time. Session seemed 
aimless. 
 
2 Session had some direction, but the therapist had significant problems 
with structuring or pacing (e.g., too little structure, inflexible about 
structure, too slowly paced, too rapidly paced). 
 
4 Therapist was reasonably successful at using time efficiently. Therapist 
maintained appropriate control over flow of discussion and pacing. 
 
6 Therapist used time efficiently by tactfully limiting peripheral and 
unproductive discussion and by pacing the session as rapidly as was 
appropriate for the patient. 
 
 
Part II. CONCEPTUALIZATION, STRATEGY, AND TECHNIQUE 
 
7. GUIDED DISCOVERY 
 
0 Therapist relied primarily on debate, persuasion, or “lecturing.” 
Therapist seemed to be “cross-examining” patient, putting the patient 
on the defensive, or forcing his/her point of view on the patient. 
 
2 Therapist relied too heavily on persuasion and debate, rather than 
guided discovery.  
However, therapist’s style was supportive enough that patient did not 
seem to feel attacked or defensive. 
 
4 Therapist, for the most part, helped patient see new perspectives 
through guided discovery (e.g., examining evidence, considering 
alternatives, weighing advantages and disadvantages) rather than 
through debate. Used questioning appropriately. 
 
6 Therapist was especially adept at using guided discovery during the 
session to explore problems and help patient draw his/her own 
conclusions. Achieved an excellent balance between skillful questioning 
and other modes of intervention. 
 
8. FOCUSING ON KEY COGNITIONS OR BEHAVIORS 
 
0 Therapist did not attempt to elicit specific thoughts, assumptions, 
images, meanings, or behaviors. 
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2 Therapist used appropriate techniques to elicit cognitions or behaviors; 
however, therapist had difficulty finding a focus or focused on 
cognitions/behaviors that were irrelevant to the patient’s key problems. 
 
4 Therapist focused on specific cognitions or behaviors relevant to the 
target problem. However, therapist could have focused on more central 
cognitions or behaviors that offered greater promise for progress. 
 
6 Therapist very skillfully focused on key thoughts, assumptions, 
behaviors, etc. that were most relevant to the problem area and offered 
considerable promise for progress. 
 
 
 
9. STRATEGY FOR CHANGE (Note: For this item, focus on the quality of 
the therapist’s strategy for change, not on how effectively the strategy 
was implemented or whether change actually occurred.) 
 
0 Therapist did not select cognitive-behavioral techniques. 
 
2 Therapist selected cognitive-behavioral techniques; however, either the 
overall strategy for bringing about change seemed vague or did not 
seem promising in helping the patient 
 
4 Therapist seemed to have a generally coherent strategy for change that 
showed reasonable promise and incorporated cognitive-behavioral 
techniques. 
 
6 Therapist followed a consistent strategy for change that seemed very 
promising and incorporated the most appropriate cognitive-behavioral 
techniques. 
7  
 
10. APPLICATION OF COGNITIVE-BEHAVIORAL TECHNIQUES (Note: For 
this item, focus on how skillfully the techniques were applied, not on 
how appropriate they were for the target problem or whether change 
actually occurred.) 
 
0 Therapist did not apply any cognitive-behavioral techniques. 
 
2 Therapist used cognitive-behavioral techniques, but there were 
significant flaws in the way they were applied. 
 
4 Therapist applied cognitive-behavioral techniques with moderate skill. 
 
6 Therapist very skillfully and resourcefully employed cognitive-behavioral 
techniques. 
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11. HOMEWORK 
 
0 Therapist did not attempt to incorporate homework relevant to cognitive 
therapy. 
 
2 Therapist had significant difficulties incorporating homework (e.g., did 
not review previous homework, did not explain homework in sufficient 
detail, assigned inappropriate homework). 
 
4 Therapist reviewed previous homework and assigned “standard” 
cognitive therapy homework generally relevant to issues dealt with in 
session. Homework was explained in sufficient detail. 
 
6 Therapist reviewed previous homework and carefully assigned 
homework drawn from cognitive therapy for the coming week. 
Assignment seemed “custom tailored” to help patient incorporate new 
perspectives, test hypotheses, experiment with new behaviors 
discussed during session, etc. 
 
 
 
 
 
 
 
 
 
Study used a mixed method repeated single case design. 
5 participants, recruited from community adult mental health team, all 
presenting with low mood. 
Baseline phase (3 weeks) measuring low mood.
Received 8 weekly sessions of CBT focussing on low mood. Participants 
and therapist completed measures at end of each session.
Four participants took part in a change interview. 
Formulation was delivered in two ways:
Process Formulation – Verbal summaries that aimed to assist 
understanding of difficulties, delivered at any point throughout CBT.  
Consisted of; antecedent (A), belief/cognition (B), consequence (C).
Product Formulation – Diagrammatic using Beck longitudinal model.  
Delivered twice (session 3 and 7).
Data Analysis
Process formulations were coded and frequency counted.
Visual analysis and Simulation Modelling Analysis (SMA) undertaken.
Reliable Change (RC) and Clinically Significant Change (CSC) calculated.
Key themes identified in change interview data. 
Impact of Psychological Formulation on Working Alliance
A Mixed Method Repeated Single Case Design
Hannah Daniels, Mark Gresswell, David Dawson & Louise Braham
Trent Doctorate in Clinical Psychology 
Introduction
Background
Psychological formulation can be defined as a number of hypotheses 
that offer an explanation of the development and maintenance of a 
client’s difficulties.¹  Formulation is a key process in many evidence-
based psychological therapies and is outlined as a core competency in 
clinical psychology training and practice and within wider mental 
health professions.²
Despite the emphasis on formulation in clinical psychology, there is 
limited and inconsistent evidence to show that formulation improves 
outcomes of distress and the working alliance.³⁴
Reasons for an absence of evidence include; formulation is difficult to 
operationalise, it may look different across therapies and there are 
issues of quality and reliability.  Also, it is difficult to disentangle 
formulation from processes such as specific factors of the therapeutic 
model and non-specific factors such as the working alliance. 
Common factors approach suggests that if all factors are present (e.g., 
strong bond, safe space), any therapy regardless of the model will be 
effective. Research has shown that working alliance correlates with 
improved outcomes. ⁵
Present Study
Aimed to examine and disentangle whether formulation drives 
outcomes (depression and wellbeing) or other non-specific processes 
(working alliance) in 8 sessions of CBT, targeting low mood.  
Method
Aims
Results
Discussion
Study aimed to examine whether:
1. Formulation impacts on working alliance.
2. There is a relationship between formulation, working alliance and 
psychosocial outcomes.
Does Formulation Impact Working Alliance?
- Visual analysis showed slight peaks in participant working alliance (n=3) when product 
formulation was delivered but not consistent with therapist reports.
- SMA showed two significant correlations (at lag -1) between an improvement in 
working alliance and increased frequency of process formulations delivered in the next 
session. 
- In change interviews, all participants talked about aspects of the alliance, but did not 
link this with formulation. 
What is the relationship between Formulation, Working Alliance and 
Secondary Outcomes?
- Visual analysis and RC analyses showed some trend between formulation (process and 
product), depression and wellbeing but minimal replications across participants.
- SMA showed some correlations between variables but little repetition across 
participants.
- Participants reported mixed emotional reactions to the formulation. 
- Study showed a slight relationship between formulation and working alliance, but evidence not robust enough to confirm whether formulation directly impacts 
working alliance.  Data shows mixed results in terms of the relationship between formulation, working alliance and psychosocial outcomes. Although some participants 
improved across measures at post-intervention, this could not be attributed to the formulation. 
- Most significant challenge was disentangling formulation from other specific and non-specific processes.  Potentially an overlap between concepts of formulation, 
working alliance and CBT.  
- A strong attempt at contributing to sparse literature and studying formulation using scientific methodology within clinical practice. 
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